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Abstract
Introduction: In Canada, people with HIV are legally required to disclose their HIV status to
their sexual partners prior to having sex that presents a “realistic possibility of HIV
transmission”. This policy has been criticized for failing to consider the safety and autonomy
of women with HIV, which can be compromised following disclosure.
Objectives: To investigate whether experiences of childhood physical or sexual abuse
(CPSA) affect barriers to HIV disclosure to partners in adulthood, which include: later
physical or sexual abuse, sexual agency, HIV stigma, and perceived social support.
Methods: Propensity scores and inverse probability of treatment weights were used to
estimate the difference in barriers to HIV disclosure attributable to CPSA among n=1307
women with HIV. Effects were reported for the total sample, and within ethnoracial groups
(Indigenous, Black African, Black Caribbean, white, and “other”).
Results: CPSA increased prevalence of both physical and sexual abuse in adulthood in the
total sample and within ethnoracial groups, while effects for other barriers were subgroup
specific.
Conclusion: This study illustrates that the environment in which women are legally expected
to disclose their HIV status is often characterized by abuse, with high risk of revictimization
from childhood to adulthood. While further research should investigate mediating pathways
between CPSA and disclosure barriers across ethnoracial groups, this study provides the first
targeted evidence suggesting that the causes of HIV disclosure may be more distal and more
complex than presumed under Canadian non-disclosure policy.

Keywords
Women with HIV; child abuse; violence; HIV disclosure; intersectionality; propensity
scores; generalized boosted modelling
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Chapter 1

1

Introduction and Objectives

This chapter will provide background information to contextualize the study rationale,
discuss the data source, identify study objectives, and specify my role in the project.

1.1 Study Rationale
The Canadian legal system (and in some provinces, the Public Health system) enforces
regulations requiring the sexual and/or needle-sharing partners of people living with HIV
to be notified that they may be at risk for HIV.1 The legal precedent set by the Supreme
Court of Canada in 2012 requires people living with HIV to disclose their HIV status to
their sexual partners prior to having sex that presents a “realistic possibility of HIV
transmission”, with potential legal consequences including criminal charges of
aggravated sexual assault.2 Canada’s position on HIV criminalization has been criticized
for failing to account for scientific advances in HIV treatment, and for diminishing the
safety and autonomy of people with HIV.3,4 This precedent-setting case law purports to
enhance public safety, but does not acknowledge what all people with HIV know:
disclosure of one’s HIV status can be dangerous, sometimes leading to discrimination,
loss of resources, and life-threatening violence. For women with HIV, disclosure is often
inextricably tied to gendered power imbalances which intersect with other social
positions including race, class, and Indigeneity.5 However, the criminal justice system
frames HIV disclosure as a fairly simplistic choice, with limited understanding of how
violence against women and girls influences decision making. Thus, the overarching goal
of this thesis is to complicate how the system understands “choice” as related to HIV
non-disclosure.
Among women in the general population, childhood physical or sexual abuse (CPSA) is a
salient risk factor for adverse outcomes in adulthood. Women who experience CPSA are
at greater risk for further violence in the future (“revictimization”)6,7 and may be more
vulnerable to power-imbalanced sexual relationships than women who did not experience
CPSA.8–10 Importantly, CPSA is also known to increase HIV risk.11–13 While the
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pathways between violent victimization and HIV infection have been studied widely, less
attention has been given to how experiences of violence may produce further
vulnerability among women with HIV. Of particular interest is whether experiences of
childhood violence have an impact on factors which enable or disenable women to
disclose their HIV status to sexual partners in adulthood. These include experiencing
physical or sexual abuse in adulthood, having low sexual relationship power,
experiencing high HIV stigma, and perceiving oneself to have low social support. If
CPSA has a causal effect on these outcomes (as has sometimes been found among the
general population), the implication is that adverse childhood experiences not only
increase risk for HIV, but for further vulnerability among women with HIV. In the
Canadian context of HIV criminalization, this vulnerability to non-disclosure translates
into socio-legal risk. Thus, the goal of this research is to assess whether women with HIV
who experienced abuse during childhood experience barriers to partner disclosure
differently from the larger population of women with HIV. This question will be explored
using intersectionality theory in an eco-social framework in order to account for aspects
of CPSA which may be unique to women with HIV at particular intersections of gender,
HIV, and ethnoracial identity.
This project is positioned to advocate for women living with HIV by highlighting
potential inequities that are not addressed by Canadian HIV criminalization. Additionally,
this research has the potential to reach women with HIV who have experienced child
abuse and assure them that their experiences with HIV disclosure are valid, shared, and
not their own fault.

1.2 Thesis Objectives and Hypotheses
1. Objective: To adapt a theoretical model which incorporates an eco-social
intersectionality perspective with the goal of appropriately contextualizing the
causes and consequences of CPSA among women with HIV in Canada. This
objective will be addressed as part of the literature review.
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2. Objective: To assess whether women with HIV who experienced CPSA
experience greater barriers to disclosing their HIV status to partners [(a) current
experiences of physical or (b) sexual violence, (c) low sexual relationship power,
and (d) high levels of HIV stigma, and (e) reduced perceived social support]
compared to women with HIV who have not experienced child abuse.
Hypothesis: It is expected that among women with HIV, as for other women not
in the study, exposure to CPSA will impact later experiences of (a) physical or (b)
sexual violence, (c) sexual relationship power, and (d) perceived social support,
but with additional HIV-specific consequences such as (e) heightened feelings of
HIV stigma. On average, it is expected that women with HIV who have
experienced child abuse will face greater barriers to partner disclosure during
adulthood.
3. Objective: To evaluate the aforementioned causal relationships across strata of
ethnoracial groups, specifically: Indigenous, Black African, Black Caribbean, and
white women, as well as a group for other ethnoracial groups limited by sample
size (e.g. Latin American, South Asian women).
Hypothesis: It is expected that the causal relationships between child abuse and
barriers to HIV disclosure will be somewhat distinct across these groups. Lasting
familial effects of institutionalized abuse within residential schools, as well as
current experiences of colonialism will impact Indigenous women in causal
pathways not experienced by non-Indigenous women. At a structural level,
racialization may also be a determinant of access to treatment and services
following child abuse and into adulthood. Furthermore, cultural perceptions and
acceptance of child abuse can be highly heterogeneous, potentially affecting the
nature and sequelae of child abuse.
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1.3 Canadian HIV Women’s Sexual and Reproductive
Health Cohort Study
The Canadian HIV Women’s Sexual and Reproductive Health Cohort Study (CHIWOS)
is a national prospective study developed in response to a lack of research on women
with HIV outside of studies on reproductive health.14 The overarching objective of this
study is to identify the barriers and facilitators to accessing women-centred HIV care
experienced by HIV positive women in Canada.15 Here, women-centred HIV care is
briefly defined as “care that supports women living with HIV to achieve the best health
and wellbeing as defined by them.”15 In order to establish a basis for women-centred HIV
care in Canada, the CHIWOS team operates under several guiding
frameworks/principles, including: community based research (CBR), Greater (and
Meaningful) Involvement of People Living with HIV (GIPA, MIPA), as well as
intersectionality, critical feminism, and anti-oppression.14 CBR is an increasingly
common research method which prioritizes community needs and ideas by placing
decision-making power into the hands of community members working alongside
researchers.16 The involvement of the community under study not only maximizes the
relevance of research results, but ensures that results are properly contextualized as well
as communicated to all relevant stakeholders.16 In CHIWOS, CBR has been
operationalized by involving women with HIV in identifying study objectives, as well as
developing and testing the survey.17 Most notably, the CHIWOS team hired and trained a
national team of 39 women with HIV as Peer Research Associates (PRA) responsible for
data collection, among other research activities.15 CHIWOS is one among few studies
which have successfully implemented CBR on a national scale, especially within
quantitative research. The heavy involvement of women with HIV in study design
through to knowledge translation and exchange also speaks to the principles of GIPA and
MIPA.18 Finally, CHIWOS applies several feminist and social justice frameworks such as
intersectionality and anti-oppression in order to create a study that acknowledges the
diverse experiences of women with HIV while shedding light on social
privilege/oppression, and striving for meaningful change.
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In addition to peer research associates, the CHIWOS research team consists of a national,
multi-disciplinary team of principal investigators, led by nominated principal investigator
Mona Loutfy (MD, FRCPC, MPH) at the University of Toronto. Each province where
CHIWOS collects data has a research coordinator, as well as a Community Advisory
Board. Along with the Community Advisory Boards, the study is led by the National
Steering Committee. Women with HIV are active decision makers at all levels of the
CHIWOS team. The study is also supported by an extended team of co-investigators,
collaborators, and students. As of June 2018, knowledge and data from CHIWOS has
supported the publication of 25 papers along with multiple webinars and conference
presentations.

1.3.1

My Role in the Project

Under its Project and Data Request Policy, CHIWOS allows researchers (including
principal investigators, co-investigators, students, and collaborators) access to CHIWOS
data under several conditions. Students, in particular, must be under the supervision of a
CHIWOS-affiliated researcher, and anyone who accesses data must be added to the
regional ethics board statement and submit a Data Request Form for acceptance by the
National Management Team. My thesis supervisor, Dr. Greta Bauer, is a CHIWOS coinvestigator who participated in survey development and provides ongoing support to the
study team, especially concerning studies of transgender health. The idea for the current
study was formulated by Dr. Bauer and myself, born from my interest in the effects of
trauma from a life course perspective, a mutual interest in quantitative intersectionality,
and Dr. Bauer’s knowledge of community perspectives of HIV non-disclosure policy in
Canada.
Under Dr. Bauer’s supervision and with the support of two CHIWOS peer research
associates (Shazia Islam, Mary Ndung’u), my thesis supervisory committee (Dr. Greta
Bauer, Dr. Igor Karp), other CHIWOS students (Mostafa Shokoohi, Ashley LacombeDuncan), research objectives and methodology were developed and submitted to the
National Management Team for review. The form involved identifying a manuscript
preparation team, a plan for meaningful involvement of people with HIV, study rationale
and objectives, and detailed statistical methods. While the form was being refined for
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submission, a novel theoretical model to support the research question was adapted by
myself along with Dr. Bauer, Shazia Islam, and Mary Ndung’u. The form was accepted
with minor revisions in December 2017, with data cleaning and analysis conducted by
myself (supported by Dr. Greta Bauer, Dr. Igor Karp, Dr. Guangyong Zou, and Dr. Dan
Lizotte) over the next several months. Results were interpreted with the use of personal
and community knowledge along with quantitative expertise by my CHIWOS study team
(myself, Dr. Bauer, Shazia Islam and Mary Ndung’u). During the preparation of this
thesis, a corresponding manuscript for submission to a scientific journal was developed.
While the entirety of this thesis was written by myself, the journal manuscript will be coauthored by myself, Dr. Bauer, Shazia Islam, Mary Ndung’u, Angela Kaida, Alexandra
de Pokomandy, and Mona Loutfy on behalf of the CHIWOS Research Team. Prior to
publication, the journal manuscript (though not the body of this thesis) will be reviewed
for acceptance by the CHIWOS National Management Team.
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Chapter 2

2

Literature Review

This chapter introduces the medical and social history of HIV, and describes the
population of women with HIV in Canada, contextualizing their experience using
intersectionality theory. Canada’s current legal policy of criminalizing HIV nondisclosure to sexual partners is discussed, alongside scientific and ethical objections to
this practice. Literature on selected barriers to partner disclosure among women with HIV
is presented, with barriers chosen being those identified from previous research, and
which are also available in the CHIWOS dataset. Child abuse is defined and its causes are
discussed using eco-social theory and intersectionality. Finally, a novel theoretical model
integrating the aforementioned theories is presented, with the objective of outlining the
causes of child abuse, as well as how child abuse may cause barriers to HIV disclosure
later in life.

2.1 HIV in Canada
Human immunodeficiency virus (HIV) is a viral infection affecting an estimated 63,400
to 87,600 Canadians as of 2014.19 Symptomatology of HIV was first documented in 1981
among patients with late stage HIV infection which would come to be known as acquired
immune deficiency syndrome (AIDS).20 From the beginning, AIDS was a disease steeped
in stigma and exceptionalism, stemming from prejudicial fear of the populations affected
by the virus, and fear of the death sentence that it carried.21,22 In particular, AIDS was
first documented among American gay men and intravenous drug users.21 The symptoms
included skin lesions, enlargement of the lymph nodes, pneumonia, and apparent
immunosuppression leading to opportunistic infection.20 By 1984, it was established that
AIDS was likely a sexually transmitted disease also transmitted by exposure to blood
products,23 the retrovirus implicated as the cause of AIDS was isolated,24 and the
biological mechanisms driving the shift from HIV infection (“pre-AIDS”) to
symptomatic AIDS were under investigation.25 It is now known that HIV can be
transmitted by exchange of specific body fluids from an infected person via contact with
the blood, a mucous membrane, or damaged tissue.26 Furthermore, untreated HIV

8

infection begins with a latent period of an estimated 4.2 to 15 years27 characterized by a
progressive decline in CD4 lymphocytes28 and increase in plasma viral load.29 The latent
period is followed by onset of symptoms (wasting, fatigue, pain, pyrexia, and coughing)30
often attributable to immunosuppression by way of CD4 lymphocyte deficiency.31
Without treatment, the current estimated survival time after a diagnosis with AIDS is two
years, but this estimate can vary greatly based on age at diagnosis and comorbid
conditions.32,33
Elucidation of the HIV mechanism has led to the development of anti-retroviral therapy
(ART).34,35 Where such treatment is accessible, HIV can be treated as a communicable
chronic condition rather than a deadly infectious disease.36 ART, established as the
standard of care for HIV in 1996,37 refers to a given combination of antiretroviral
medications which can render plasma viral load undetectable, increase CD4 cell count,
and increase lifespan to match that of those without HIV.34,35,38 Consequently, more
people than ever are living with HIV.39 Since the uptake of ART in the 1990s, cases of
AIDS in Canada have dropped 90% to 188 reported cases in 2014,19 an indicator of
people with HIV living longer on treatment. Additionally, because ART can reduce
plasma viral load, transmission rates among couples where one partner is HIV-positive
have been estimated at 0 events per 100 couple-years, with some variability based on
sexual behaviour.40 As of 2016, Health Canada has also approved the use of pre-exposure
prophylaxis (PrEP), an antiretroviral medication aimed at reducing transmission risk by
treating those at risk for HIV.41
While medical advances since 1981 have succeeded in allowing people with HIV who
have access to treatment to live long and healthy lives, the social stigma surrounding HIV
infection remains pervasive in Canadian society. Since the onset of the epidemic,
widespread homophobia and misinformation about HIV led many members of the public
to hold prejudicial beliefs about HIV and the people affected by it, so much so that HIV
has been theorized to occupy a dual status as both an infectious disease and social
phenomenon.42 Today, public and institutionalized HIV stigma is less overt but remains
an issue affecting people with HIV every day. As of 2012, 29% of Canadians still held
medium or high levels of stigmatizing beliefs about those with HIV (e.g. fear, belief that
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people with HIV are to blame for their HIV status) and 34% held medium or high levels
discriminatory beliefs (e.g. the rights to employment, sexual activity, and privacy of
people with HIV should be restricted).43 The discrimination experienced by those with
HIV and the internalized stigma that results from it can have widespread and devastating
effects including lack of access to healthcare44 as well as loss of income or housing.45
HIV stigma is also known to affect a person’s ability to disclose their HIV status to
family, friends, and sexual partners.44 While many campaigns and programs have been
implemented in Canada with the goal of reducing HIV related discrimination, it remains a
pervasive determinant of health and wellness for people with HIV.

2.2 Women Living with HIV
An estimated 15,219 women in Canada are have been diagnosed with HIV since the
onset of the epidemic, with adult women accounting for 23.3% of incident cases
nationally in 2016.46 This proportion has remained stable since 2004.46 While the
incidence of HIV is lower among women compared to men (3.0 per 100,000 and 9.8 per
100,000, respectively),47 women with HIV face unique challenges that make them a key
population in the study of HIV. Until very recently women in Canada tended to be, on
average, diagnosed with HIV and AIDS at younger ages than men, though it was unclear
whether this difference was attributable to differences in age of infection or diagnosis
itself.19 As of 2016 these age differences are negligible, with the majority of HIV
diagnoses for both men and women (27.7% and 31.8%, respectively) occurring between
ages 30 to 39.46 The majority of women with HIV in Canada, since the start of the
epidemic, have been diagnosed in the most populous provinces: Ontario (ON), Quebec
(QC), and British Columbia (BC) (Table 1). However, the 2016 HIV diagnosis rate per
100,000 population indicates that incidence of HIV among women is highest in
Saskatchewan, Yukon, and Manitoba. CHIWOS data reports that 81.7% of women with
HIV in Canada (ON, QC, and BC) live in a large city as opposed to a small or medium
city, a factor which likely impacts access to HIV care.48 According to the same study,
3.7% of Canadian women with HIV have not engaged in HIV care in the past year while
2.8% have never accessed HIV care.48
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Table 1: All-ages Canadian HIV cases by sex and province/territory, 1985-2016
Total number of reported
cases, 1985-2016
Females
Males

Province/territory
British Columbia

Diagnosis rate per 100,000
population, 2016
Females
Males

2,270

12,913

1.7

9.0

Yukon

19

44

10.8

0.0

Alberta

1,617

5,362

4.0

9.1

12

45

DS

DS

0

4

DS

DS

Saskatchewan

921

1,410

13.6

16.5

Manitoba

690

1,660

6.0

13.0

Ontario

5,690

29,590

2.5

10.1

Quebec

3,745

14,155

2.8

11.5

Northwest Territories
Nunavut

New Brunswick

70

374

1.3

0.5

114

729

0.6

2.4

9

32

DS

DS

Newfoundland and Labrador

62

250

0.4

1.9

TOTAL

15,219

66,568

3.0

9.8

Nova Scotia
Prince Edward Island

Data source: Canadian Community Disease Reports, HIV in Canada – Supplementary tables, 2016.47
Data on sex were submitted for 99.6% of reported HIV cases in 2016. DS: indicates cases where data
has been suppressed per the request of the province or territory. Reporting of HIV cases for individuals
younger than two years of age varies among provinces and territories. For Quebec, the number of HIV
cases is based on the minimum number of HIV-positive individuals.

HIV exposure patterns are also distinct among women compared to men; while men who
have sex with men (MSM) remains the predominant HIV exposure category among men,
three times as many cases among women are attributable to heterosexual contact (63.5%
versus 21.6%) and approximately twice the proportion of cases are attributable to
injection drug use (IDU) (27.3% versus 10.9% IDU and 5.1% MSM/IDU) (Table 2).46
Other exposure categories commonly applied in public health surveillance are perinatal
transmission, receipt of blood or blood products, no identified risk (NIR), and other,
which may include less common exposures such as receipt of semen from an HIVpositive donor.19 Furthermore, the heterosexual contact category is broken down into
exposure from heterosexual contact with a person at risk (Het-risk, i.e. heterosexual
contact with someone who has HIV, who injects drugs, is a bisexual male, or is a person
from an HIV-endemic country), heterosexual contact with no identified risk factors (Het-
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NIR), and origin from an HIV-endemic country (Het-endemic).19 HIV-endemic countries
are those with an HIV prevalence greater than 1% and either (a) 50% or more HIV cases
attributable to heterosexual transmission, (b) a male to female ratio of 2:1 or less, or (c)
HIV prevalence greater than or equal to 2% among women receiving prenatal care.19
While cases originating from HIV-endemic countries may not necessarily have acquired
HIV in the HIV-endemic country or be attributable to heterosexual contact, they are
presumed to be so based on the above conditions. In 2016, origin from an HIV-endemic
country was the most common heterosexual exposure for incident HIV cases among
women, followed by heterosexual contact with no identified risk and heterosexual contact
with a person at risk (Table 2). Data on exposures from HIV-endemic countries may be
more complete than domestic exposures as Citizenship and Immigration Canada has
conducted mandatory HIV screening for permanent resident applicants over the age of 15
(or under the age of 15 with given risk factors) since 2002.19,49
Table 2: Number and percentage distribution of Canadian HIV diagnoses among adults
(≥ 15 years old) by sex and exposure category, 2016
Females
Exposure category

n

MSM

%
-

MSM/IDU

Males
n
-

%
633

59.0

-

-

55

5.1

99

27.3

117

10.9

Recipient of blood/clotting factor

0

0.0

1

0.1

Recipient of blood

0

0.0

1

0.1

Recipient of clotting factor

0

0.0

0

0.0

Origin from HIV-endemic country

85

23.5

66

6.2

Sexual contact with person at risk

67

18.5

60

5.6

No identified risk, heterosexual

78

21.5

106

9.9

33

9.1

33

3.1

362

100.0

1,072

100.0

IDU
Blood/blood products

Heterosexual contact

Other*
Subtotal
No identified risk
Not reported
TOTAL**

18

N/A

69

N/A

160

N/A

640

N/A

540

N/A

1,781

N/A
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Data source: Canadian Community Disease Reports, HIV in Canada – Supplementary tables, 2016.47 Data
on exposure category were submitted for 61.6% of reported HIV cases in 2016. Exposure categories are
mutually exclusive and are meant to identify an individual’s most likely transmission route. Where multiple
potential transmission routes are reported, a hierarchy is used to assign the case to a single category (see
Appendix 1).
*For Alberta, cases identified as Citizenship and Immigration Canada/Out of Country (CIC/OOC) were
classified in the exposure category of “Other”
**Excludes 2,612 cases where sex was not reported or reported as transsexual or transgender.

Due to inter-provincial and territorial heterogeneity in case reporting practices, some
surveillance data may not completely represent the current state of the HIV epidemic. In
particular, surveillance data on race/ethnicity and exposure category is often incomplete
or is not submitted by some provinces.46 At the national level, only 48.6% of reported
cases among adults included information on race/ethnicity and 61.6% specified an
exposure category in 2016.46 With the understanding that this limitation severely impacts
the interpretability of this data, existing data indicates that there may be greater racial
diversity among women compared to men with HIV in Canada.46 Black women made up
36.5% of incident diagnoses among women in 2016, followed by Indigenous First
Nations women (32.7%) and white women (21.0%) (Table 3).46 Comparatively, half
(47.8%) of 2016 male cases were among white men, followed by Indigenous men and
Black men.46 While greater sex-stratified proportions of new cases are among Black and
Indigenous women than Black and Indigenous men, the proportion of new cases among
white, South Asian/West Asian, Arab, Asian, and Latin American women is lower than
that of males of the same racial/ethnic group.46
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Table 3: Number and percentage distribution of all-ages Canadian HIV cases by sex and
race/ethnicity, 2014, 1998-2014
Females
2016
Race/ethnicity

n

Males

Total (1998-2016)
%

n

%

2016
n

Total (1998-2016)
%

n

%

Indigenous
First Nations

103

32.7

1,082

30.2

113

13.7

1,149

13.0

7

2.2

117

3.3

11

1.3

166

1.9

1

0.3

5

0.1

2

0.2

13

0.1

3

1.0

256

7.2

1

0.1

287

3.2

7

2.2

38

1.1

37

4.5

249

2.8

4

1.3

69

1.9

62

7.5

458

5.2

115

36.5

1220

34.1

135

16.4

1,226

13.8

3

1.0

36

1.0

52

6.3

386

4.4

White

66

21.0

730

20.4

394

47.8

4,792

54.1

Other

6

1.9

27

0.8

17

2.1

136

1.5

315

100

3580

100

824

100

8,862

100

232

N/A

7083

N/A

964

N/A

23,782

N/A

547

N/A

10,663

N/A

1,788

N/A

32,644

N/A

Métis
Inuit
Indigenous,
unspecified
South Asian/West
Asian/Arab
Asian
Black
Latin American

Subtotal
Race/ethnicity not
reported
TOTAL*

Data source: Canadian Community Disease Reports, HIV in Canada – Supplementary tables, 2016.47 Data
on race were submitted for 48.6% of reported HIV cases in 2016. For all provinces and territories,
race/ethnicity information is not available before 1998. Race/ethnicity information is not submitted by
Quebec or British Columbia, and is not available for Ontario before 2009. Reporting of HIV cases for
individuals younger than two years of age varies among provinces and territories. *Excludes 291 cases
where sex was not reported or reported as transsexual or transgender.

Presumably due to the aforementioned reporting limitations, Public Health Agency of
Canada surveillance reports do not provide sex-segregated rates of exposure by category
and race/ethnicity simultaneously. However, based on cross-classification of exposures
by category and race/ethnicity for males and females combined (Figure 1) as well as
some regional sex-stratified data,50 there is reason to believe that exposure category
varies by race and sex. Where race and exposure category were reported, IDU was the
primary exposure category among Indigenous populations in 2016.46 53.2% of people
with HIV who are Black were classified as Het-Endemic, though, as previously noted,
this does not necessarily mean that exposure was actually heterosexual, or took place in
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the HIV-endemic country.46 Among people with HIV who are South Asian, West Asian,
or Arab, as well as white, Asian, Latin American, or another ethnicity, exposures were
primarily MSM followed by heterosexual contact.46 Some provinces provide a more
nuanced breakdown of incident HIV cases by sex, race, and exposure category. Looking
to Saskatchewan, where the 2016 HIV diagnosis rate for women was the highest in
Canada,46 88% of newly diagnosed women were Indigenous and 58% of newly
diagnosed Indigenous women reported IDU while 38% reported heterosexual activity as
their primary HIV risk factor.50 This speaks to a larger trend elucidated by Roy and
colleagues, whereby IDU in general is becoming less common, however, specific drugs
and/or drug use practices may contribute to increased risk of blood-borne infection.51 Roy
specifically points to the growing opioid epidemic, and a recent study of people who
inject drugs in Montreal which found that people who injected opioids exhibited more
behaviours related to transmission risk (syringe sharing, injecting more frequently and in
public places), and greater Hepatitis C risk than people who inject drugs other than
opioids.51,52 In this way, increased injection of opioids may drive HIV incidence, even in
the context of reduced IDU in the general population. This illustrative example points to
the need for further research on HIV transmission patterns in Canada, while reporting
quality of surveillance data indicates the need for such data at the intersection of race and
sex.
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Figure 1: Percentage distribution of all-ages Canadian HIV cases by race/ethnicity and
exposure category, 2016 [n=2,344]

Data source: Canadian Community Disease Reports, HIV in Canada – Supplementary tables, 2016.47 Data
on race were submitted for 48.6% of reported HIV cases, while data on exposure category were submitted
for 61.6% cases in 2016. Reporting of HIV cases for individuals younger than two years of age varies
across provinces and territories. Abbreviations: MSM=Men who have sex with men, MSM/IDU= men who
have sex with men and use injection drugs, IDU=injection drug use, Blood= receipt of blood or blood
products, Het-risk= heterosexual contact with risk factor, Het-NIR= heterosexual contact with no identified
risk factors, Het-Endemic= origin from HIV-endemic country, NIR= no identified risk.

The social position occupied by women with HIV can be articulated within the
framework of intersectionality, a term coined by Black feminist legal scholar Kimberlé
Crenshaw.53 Intersectional perspectives posit that embodied social positions and identities
interact in the context of structural power inequities, resulting in inequities across
population groups.53–55 In this context, intersectionality theory suggests that population
characteristics of women with HIV are determined by the systematic factors such as
sexism, racism, colonialism, transphobia, and homophobia which interact with gender
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(and one another) to make women vulnerable to HIV. The result of intersecting power
inequities such as racism and transphobia impacting vulnerability to HIV is that the
population of women with HIV tends to be multiply-marginalized, further affecting
health and access to care, as well as other aspects of life such as stigma and
discrimination. Furthermore, the HIV care women receive is often not populationspecific, but rather tailored to men with HIV, posing a systematic obstacle to women
achieving optimal health and wellness.14 Systematic intersectional disadvantages for
women with HIV are also visible in fields outside of health, one notable example being
that the majority of women convicted in HIV non-disclosure cases occupy
intersectionally marginalized positions which likely influence their ability to disclose.56
Indigenous women are particularly over-represented, accounting for an estimated 42% of
women charged.57 An intersectional framework will be used to contextualize the
experiences of women with HIV throughout this thesis.

2.3 Criminalization of HIV Non-Disclosure in Canada
Under Canadian case law (R v Mabior), criminal charges may be laid against people with
HIV who do not disclose their HIV status to sexual partners prior to having sex that poses
a “realistic possibility of HIV transmission”.2 Charges can be laid regardless of whether
transmission actually occurred, and can range from common nuisance to murder, with the
most common charge being aggravated sexual assault.1 However, the precedent set in the
2012 R. v. Mabior case does not specify which sexual acts under which circumstances
constitute a realistic possibility of transmission. Guidelines created by the Canadian
HIV/AIDS Legal Network interpret the R. v. Mabior ruling such that people with HIV
have a legal obligation to disclose prior to engaging in vaginal sex with a condom if their
plasma viral load is not “low,” or prior to condomless vaginal sex regardless of viral
load.1 Based on risk of transmission, the guidelines estimate that disclosure requirements
for anal sex would be at least as strict, and requirements for oral sex may be more
lenient.1 Notably, in 2017, the Ontario Attorney General and Ontario Minister of Health
and Long Term Care announced that cases of HIV non-disclosure in Ontario would not
be prosecuted where the person with HIV has had a suppressed viral load for six
months.58 However, this decision is limited to Ontario and (similarly to the Supreme
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Court decision) does not specifically address other situational factors which may make
HIV transmission risk negligible. As of 2016, at least 184 individuals in Canada have
been charged in cases of HIV non-disclosure, 101 have been convicted, and 93% of those
convicted have received a prison sentence.57 As of 2014, Canada was second to only the
United States, a population ten times its size, in the number of arrests and prosecutions in
cases of HIV non-disclosure.1,59
Another consequence of criminalization is that it renders the empirical study of HIV
disclosure to sexual partners unethical. Because information exchanged between
researchers and participants may be subject to subpoena in a court of law investigating
claims of non-disclosure, researchers often deliberately avoid asking participants whether
they have disclosed their HIV status to their sexual partners. One way to circumvent this
obstacle is to study barriers to HIV disclosure rather than disclosure itself.

2.3.1

Evidence-Based Objections to HIV Criminalization

While HIV status disclosure prior to sex represents a “best-case scenario” in some
circumstances, research does not support the use of criminal law to encourage this
behaviour. Canada’s legal enforcement of HIV disclosure in particular has been criticized
for failing to take into account scientific evidence regarding transmission risk; the
Supreme Court of Canada’s vague definition (“realistic possibility of HIV transmission”)
has allowed for charges to be laid where evidence shows the risk of transmission to be
insignificant.60 To reiterate the evidence supporting use of ART, risk of HIV transmission
when viral load is suppressed is estimated to be near zero for all sex acts, even without
the use of condoms.40 If prosecution was consistently carried out with attention to such
evidence, condomless sex with suppressed viral load would no longer be considered to
pose realistic possibility of HIV transmission.
From a policy perspective, public health professionals have criticized the Canadian legal
system for undermining HIV prevention strategies.60 In particular, criminalization may
serve as a disincentive for HIV testing: it is theorized that those who suspect that they
have HIV may knowingly avoid HIV testing in order to claim inculpability should they
expose someone else.61 This concern is significant, as an estimated 21% of people with
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HIV in Canada do not know their HIV status,19 and this population is more likely to
engage in condomless sex than their HIV status-aware counterparts.62 In addition to the
potential for unintended consequences due to HIV criminalization, there remains
uncertainty regarding whether the law actually prevents HIV transmission in the
population. Canadian policy research accounting for the coverage and efficacy of HIV
criminalization as an intervention concluded that non-disclosure law is likely a poor tool
to promote population change.63 Because HIV criminalization only targets those who are
aware of their serostatus (and who transmit HIV at rates far lower than those who are
unaware), the intervention does not apply to the population with the highest potential for
impact.63 In fact, if criminalization does serve as a disincentive for HIV testing, the
intervention may actually increase the rate of HIV transmission among people with HIV
who do not know their serostatus.63 The inconsistent use of scientific evidence in
convictions related to HIV non-disclosure, and the potentially dysfunctional mechanism
of HIV criminalization call to question the practical value of this approach.

2.3.2

Ethical Objections to HIV Criminalization

From an ethical perspective, the use of criminal law to enforce HIV disclosure has been a
highly contested topic in Canada and around the world. Beyond the efficacy of such laws,
many have argued that HIV non-disclosure should be criminalized based on two main
legal philosophies: the harm principle and legal moralism. The harm principle, proposed
by John Stuart Mill,64 argues that an action should only be criminalized if it causes harm
to another person, regardless of whether the action was moral or was done for the good of
the person committing it. However, Mill states that if the harm is consented to by the
person being harmed, or if a person harms themselves, there should be no legal
consequences.64 By his definition, “harm” is inclusive of not only intentional harms but
also negligent harm such as failure to meet an obligation;64 the majority of HIV nondisclosure cases would meet this definition. However, when applied to cases of HIV nondisclosure the harm principle raises several issues, primarily, what constitutes harm?
Some scholars argue that only transmission of HIV without disclosure constitutes harm,65
while others argue that exposure to HIV without disclosure can also potentially represent
harm, analogous to endangerment.66 Non-disclosure itself, regardless of whether
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transmission occurs, has also been deemed by some to be a moral wrong.65,67 Moral
wrongs are actions which violate some ethical standard, and under the principle of legal
moralism may be punished by criminal law.68 Criminalization of moral wrongs functions
to hold society to a given moral standard and disincentivize behaviour that the society
decides is immoral, including acts that do not harm others. This principle has been
applied to HIV criminalization, arguing that failing to disclose information that might
otherwise cause someone to withdraw consent to sex invalidates that consent.67 However,
simply because an act causes harm or is judged to be morally wrong does not mean that
this act has sufficient cause to be criminalized. Both the harm principle and legal
moralism warn that if criminalization causes more harm than it prevents, application of
criminal law is not justified.69
In order to judge whether HIV non-disclosure should be criminalized, attention must be
given to practical factors including the efficacy (or inefficacy) of the current law,
definitions of harm in the context of improved HIV treatment, potential disclosure-related
harm to people with HIV, and criminalization as it relates to HIV stigma. Without
minimizing the gravity of an HIV diagnosis, it is important to note that since the Supreme
Court of Canada first addressed HIV non-disclosure in 1998,70 significant advances in
HIV research have rendered HIV a largely treatable chronic condition for those with
access to care.36 Considered alongside the dearth of cases prosecuting instances of nondisclosure for other treatable but serious communicable diseases (herpes, hepatitis B and
C),1 one must ask whether harms resulting from HIV exposure today are truly significant
or the result of longstanding HIV stigma and exceptionalism. The drastic and exceptional
treatment of HIV underpins other aspects of HIV criminalization as well; criminalization
purports to protect the general population (especially heterosexual women) from
contracting HIV5 but fails to consider that legal obligations to disclose place people with
HIV (especially women) in vulnerable situations. In fact, it is not uncommon for ethical
analyses of HIV disclosure to explore exclusively the potential harms to HIV negative
partners without so much as mentioning the harms that disclosure can inflict on people
living with HIV.65,66 For some, disclosure of one’s HIV status can result in financial
instability, loss of relationships, loss of social support, social defamation, and physical,
sexual, or emotional abuse.71 In the context of financial dependence or intimate partner
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violence, non-disclosure can be an act of survival. Non-disclosure law in Canada does not
adequately address any of these factors,5 and in-fact allows for estranged or abusive
partners of people with HIV to file or threaten to file a non-disclosure lawsuit. In this
way, the law not only holds people with HIV accountable for disclosing but gives the
people who make disclosure impossible the power to enforce that accountability.
At the societal level, criminalization has been criticized for contributing to the HIV
stigma and exceptionalism that drives the epidemic.1 Attribution of social stigma to a
behaviour deemed to be immoral is at the heart of legal moralism’s mechanism, and
existing stigma is reinforced when legitimized by Canadian law.61 The fact that the legal
system most often treats cases of non-disclosure as aggravated sexual assault further
problematizes this issue. Sexual assault charges imply that, as with sexual assault,
responsibility for the act lies only with the actor.1 However, the responsibility for
engaging in safer sex lies with both partners and cannot be wholly attributed to people
with HIV.1 Non-disclosure law tells the public otherwise, generating additional stigma,
the effects of which are not insignificant. The UN Secretary-General has famously stated
that “[stigma] helps make AIDS the silent killer, because people fear the social disgrace
of speaking about it, or taking easily available precautions. Stigma is a chief reason why
the AIDS epidemic continues to devastate societies around the world.”72 Reflecting on
the justification of applying the harm principle and legal moralism in cases of HIV nondisclosure given the surrounding context, it is difficult to argue that criminalization
prevents more harm than it incites. This position has been upheld by expert groups
including the Joint United Nations Programme on HIV/AIDS and an international team
of twenty HIV scientists who strongly condemn non-disclosure laws for reasons related
to lack of evidence based justification and respect for the autonomy and safety of people
with HIV.3,4

2.4 Barriers to Partner Disclosure
A woman’s decision to disclose (or not to disclose) her HIV status to a sexual partner is
known to be informed by several factors related to herself, her relationships, and her
support system. These factors may serve as barriers to, or facilitators of partner
disclosure. Despite differing cultural perceptions of HIV, studies across the world report
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that fear of rejection and abandonment serves as a major barrier to partner disclosure
among women with HIV.73–75 Fear of rejection in an intimate relationship is tied to the
relationship’s power dynamics, including whether the relationship is abusive. The threat
of violence, whether physical, sexual, or emotional, can make partner disclosure
dangerous.73,75–77 Factors outside of the relationship may also have bearing on disclosure;
at the level of the individual, people who feel internalized stigma about their own HIV
status are known to struggle with disclosure.78 Furthermore, those without adequate
social support may be hesitant to disclose due to the possibility of rejection or
abandonment, especially in the presence of societal HIV stigma.78
The following paragraphs on the barriers to partner disclosure are cognizant of the
varying theoretical models and corresponding measures of disclosure, which have
changed over the years. A common practice has been to consider disclosure a
unidimensional process whereby an individual progressively informs their social network
of their HIV status one-by-one, with the same barriers and facilitators informing each
decision. The most common measure that maps onto this approach enquires about the
members of an individual’s social network, and which of those members are aware of the
individual’s HIV status. Using this information, the proportion of social network
disclosed to is calculated (e.g. 79,80). The creation of unidimensional disclosure indices
(e.g. 81,82) is a similar method in that neither allows the researcher to examine whether
disclosure practices vary based on the target of disclosure. Such measures may be a threat
to research validity, as research has demonstrated that disclosure rates80,83 as well as
reasons for disclosing80 vary by target. A recent study of 158 people with HIV (70%
women) in Tanzania investigated the dimensionality of voluntary disclosure to a
comprehensive list of 21 potential targets, finding that disclosure to children, close
family, larger community, and partners represented four independent factors.84 Moreover,
disclosure to targets across these categories was differentially associated with two of the
main determinants of disclosure: stigma and social support.84 These results indicate that
traditional conceptions of disclosure as a unidimensional process may be insufficient to
capture the true determinants of disclosure. Accordingly, while the following barriers to
partner disclosure may also apply to other disclosure targets, studies specific to partner
disclosure have been prioritized in order to maximize construct validity.

22

2.4.1

Physical and Sexual Abuse

Physical abuse refers to acts of physical violence against another person, while sexual
abuse refers to sexual acts which are forced or coerced.85 Often these types of abuse are
grouped together under the term intimate partner violence (IPV), which refers more
broadly to the perpetration of controlling behaviours, as well as physical, sexual, or
emotional abuse against an intimate partner.85 However, physical and sexual abuse do not
only occur within the context of intimate relationships, and IPV is not the only type of
abuse relevant to HIV disclosure. Physical and sexual abuse in any context may
undermine the personal agency of those who experience it and thus affect the perceived
costs of partner disclosure.86 Furthermore, physical and sexual abuse may be perpetrated
by and experienced by people of any gender.87,88 However, the majority of abuse against
women is perpetrated by men,87 a factor reflected in the literature and thus the following
paragraphs.
Women who experience physical or sexual violence, or who expect that their partner may
become abusive, cite fear of such abuse as a barrier to disclosing their HIV status to
sexual partners.73,75–77 This barrier is significant given that women with HIV experience a
high rate of violence, and that experiencing violence following disclosure of one’s HIV
status is not uncommon.89,90 The same survey of American medical and mental health
care providers that identified fear of abandonment as a prevalent concern for women with
HIV also found that 29% of their female patients feared physical abuse, and 56% feared
emotional abuse upon disclosing their HIV status to their partners.73 A qualitative study
of 50 mostly African-American women found similar results; 12% feared that people
would react violently to them disclosing their HIV status, and two women described
consciously choosing not to disclose because they feared that their partner would react
violently.76 Notably, one of these women described that her partner had not been
physically violent towards her in the past, but that the anger he had displayed in other
situations made her question whether communicating with him about safer sex was
worthwhile.76 This experience was echoed by women from a different American
disclosure study; one woman who experienced life-threatening IPV from a previous
partner would not disclose her HIV status to her current partner, stating that “…
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sometimes the sweetest men on earth will just turn on you … You just can’t tell”.77 Thus,
fear of violence even without current experiences of IPV, may be a barrier to disclosure.
HIV disclosure may also incite violence against women with HIV, even among those
who did not experience violence prior to disclosure. In a clinic sample of 310 HIV+
women, 4% reported physical abuse as a direct result of disclosing their HIV status to
somebody (i.e. not partner-specific).90 However, upon examining the prevalence of
physical and sexual abuse experienced before and after their HIV diagnosis (and
presumably some degree of disclosure), a larger gap was discovered: 45% of women had
experienced abuse after diagnosis, with 13% of that abuse being new, i.e. occurring only
after diagnosis.90 Among those who experience abuse prior to disclosure, disclosure may
also affect the frequency and severity of abuse as articulated by one participant from this
study: “He was abusive before I told him I was HIV-positive, and afterwards, well, the
beatings got worse and more . . . they happened more regularly.”90 Indeed, the majority of
abuse experienced after diagnosis is among those who also experienced abuse prior to
diagnosis.90 Because current abuse provokes fear of further abuse upon disclosure, and
this fear is shown to be valid, abuse represents a significant barrier to partner disclosure.

2.4.2

Sexual Relationship Power

According to Social Exchange Theory and feminist literature, power is defined as the
potential one has to influence the actions of another (“power to”)91,92 as well as one’s
ability to do something against another’s wishes (“power over)”.92 Sexual relationship
power (SRP) can be defined as the balance or imbalance of interpersonal power across
partners in an intimate relationship.93 Just as intersectional power differentials cause
health inequities at the societal level,94 an imbalance of interpersonal power can affect the
health of those within a sexual relationship.93 SRP dynamics often come to light in the
context of partnered decision making; a more dominant partner may take control of joint
decisions, a tendency that is especially relevant to HIV research in the context of sexual
communication and decision making.93 In fact, reduced sexual relationship power has
been repeatedly implicated as a risk factor for sexually transmitted infections (STIs)
including HIV,95 under the theory that gendered power imbalances disenable
heterosexual women from negotiating safer sex practices with their male partners.96 Since
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the advent of this theory in the 1990s, scholars have hypothesized that such power
imbalances are not only gendered but intersectional, mutually constructed by gender,
race, class, and sexual orientation.97 Furthermore, it is hypothesized that in addition to
being a barrier to safer sex practices, reduced SRP may be a barrier to HIV status
disclosure.
However, the construct of SRP is more often applied explicitly in research on HIV risk
than HIV disclosure, where SRP is evident in discussions of fear of abandonment,73–75
loss of economic support,74 rejection,75 abuse,73,75–77 and accusations of infidelity.75 Each
of these fears is indicative of reduced power under Social Exchange Theory, which
argues that power is based on the balance/imbalance of resources (e.g. emotional,
economic) across partners and any resulting interpersonal dependence.98,99 Fear of
abandonment, an indicator that the partner with this fear is in some way dependent on the
other partner, was reported by women with HIV in the Africa and North America. A
qualitative study of recently tested people with HIV in Tanzania found that fear of their
partner’s reaction was the most influential barrier to HIV disclosure, and among women,
abandonment was the most-feared reaction.100 This result was replicated in the partnered
quantitative study, where among a sample of 245 women who underwent HIV testing,
52% of those who had not disclosed their HIV status to their sexual partner after three
months cited fear of their partner’s reaction as their reason for non-disclosure.74 In
addition to fearing abandonment, these women feared loss of economic support,74 another
indicator of reduced SRP.75 North American studies also demonstrate women with HIV
fearing abandonment as a result of disclosure; Moneyham et al. conducted a series of
focus groups on disclosure with women in the southeastern United States, where
participants feared that disclosure would put an end to romantic relationships, resulting in
a loss of social support.101 Similarly, an American survey of 136 medical and mental
health care providers with experience treating women with HIV found that an estimated
35% of their female HIV patients had expressed fear of abandonment (defined as
withdrawal of resources) as a result of disclosure.73 While “abandonment” can refer to
withdrawal of both tangible resources and emotional support, “rejection” encompasses
the emotional aspects of abandonment. Fear of rejection was similarly reported by
women.75 Anticipated abuse and loss of social support as a result of disclosure, whether
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actualized or not, also represent aspects of SRP which may disenable women from
communicating with their partners about HIV.

2.4.3

HIV Stigma

HIV stigmatization has been conceptualized as a dynamic social process that marks
differences between groups of people, especially those experiencing social inequalities
pertaining to class, race, gender, and sexuality.102 Stigma is produced by these
inequalities, and reproduces them,102 affecting health outcomes for those who are
stigmatized.103 Furthermore, HIV stigma has been theorized to operate at multiple levels:
interpersonal, in the form of enacted stigma or discrimination, as well as intrapersonal in
the form of felt-normative or perceived stigma (the subjective awareness of societal
stigma) and internalized stigma (the degree to which individuals accept stigmatized
beliefs to be true).104 These types of stigma have the potential to enact different outcomes
for people with HIV, including in the context of partner disclosure.105
A 2016 systematic review gathered studies on the partner disclosure-specific effects of
enacted (n=1), felt-normative (n=6), and internalized stigma (n=7), as well as studies
where the type of stigma measured was multidimensional or not specified (n=14).105 This
review found that enacted stigma was often presented as a barrier to partner disclosure in
qualitative research, with two studies documenting abuse perpetrated by the partners of
seropositive individuals following disclosure,106,107 findings which have been mirrored in
other studies where enacted stigma is framed as acts of discrimination.90,108 Feltnormative stigma had a variable effect on disclosure to sexual partners, with three studies
reporting higher levels of perceived stigma to be associated with reduced partner
disclosure109–111 and two studies reporting no association between the two.84,112 These
studies come exclusively from Africa and the United States, with sample composition
ranging from 27% to 100% women. The largest sample (n=1552, 59% women) comes
from a longitudinal study of ever-married women and their husbands in Malawi.111 This
study provided HIV testing and counselling to each spouse in private, and two years later
investigated the factors associated with partner non-disclosure. Among women only,
higher levels of felt-normative HIV stigma were associated with non-disclosure to their
spouse (OR=1.22 [95% CI 1.05, 1.42]). While data on disclosure to extra-marital sex
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partners was also collected, the role of perceived stigma in this context was not reported
and thus this inference is limited to married heterosexual couples. An American study of
341 people with HIV (34% heterosexual women, 26% heterosexual men, 40% MSM)
investigated the role of relationship type further, finding that increased perceived HIV
stigma was associated with decreased odds of disclosing to all sex partners (OR=0.89
[95% CI 0.81, 0.93]), and that this relationship was not moderated by sexual behaviour
subgroup, the nature of sexual relationships (primary partner, casual partner(s), both) or
the HIV serostatus of sexual partners.109 However, perceived stigma in this study was
measured using an HIV stigma subscale specific to disclosure concerns (see Berger and
colleagues113), which may not be synonymous with felt-normative stigma, and
theoretically should be associated with disclosure. A similar study in South Africa
(n=630, 67% women) found the same association between perceived stigma and
disclosure, however, the effect was found to be significant only among those in steady
relationships as opposed to casual partners.110 Other studies reported no relationship
between perceived stigma and disclosure: the Dima study that investigated the
multidimensionality of disclosure among people with HIV in Tanzania (detailed in 2.4)
found that perceived stigma was unrelated to both cumulative disclosure and partner
specific disclosure, but was positively associated with level of disclosure to the larger
community.84 An American study found similar results; perceived stigma was unrelated
to partner disclosure, but negatively associated with disclosure to parents.112 Taken
together, these results indicate that felt-normative stigma may be a barrier to HIV
disclosure, however, further analyses should be mindful of gender differences and the
potential effect of partner relationship type.
While the effects of enacted and felt-normative stigma have not fully been established,
there is compelling evidence pointing towards internalized stigma as a barrier to partner
disclosure among women. However, the only identified North American study on this
topic is specific to middle-aged homeless and unstably housed people with HIV, the
majority (70.7%) of whom were male.114 This cross-sectional study found that higher
levels of internal HIV stigma were associated with 1.47 greater odds of non-disclosure to
at least one recent sex partner prior to their first sexual encounter, adjusted for variables
associated with general HIV stigma (including gender). While women reported higher
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levels of internalized stigma than men, the effect of gender on this relationship was not
reported. Similarly, in a sample of 862 people with HIV (56.3% women) in Ethiopia,
Mozambique, and Africa, Geary and colleagues found that women reported higher
internalized stigma compared to men, and that disclosure to one’s sexual partner was
significantly associated with lower levels of internalized stigma in bivariate analysis.115
Again, the effect of gender on the relationship between stigma and partner disclosure was
not reported, however gender was found to moderate associations between internalized
stigma and perceived wellbeing, indicating the potential importance of addressing
gendered aspects of internalized stigma. Partially filling this gap, a longitudinal study of
293 pregnant women recently diagnosed with HIV in South Africa measured internalized
HIV stigma during and post-pregnancy, finding that while stigma had no effect on partner
disclosure during pregnancy, higher internalized stigma predicted continuing partner nondisclosure at 3 months post-pregnancy among those who had not yet disclosed at
baseline.116 This result indicates that internalized stigma may develop over time, or be a
characteristic of women who chronically struggle with partner disclosure. Further
longitudinal research from Uganda (n=259, 67% women) found similar results;
internalized stigma measured at baseline was negatively associated with subsequent
partner disclosure in both univariable and multivariable models (ARR=0.94 [95% CI
0.90, 0.99]).117 Expressed as an average marginal risk, each additional point on the
study’s internalized stigma scale was associated with a 4.0% [95% CI 1.0%, 7.0%] lower
probability of disclosure to a primary sexual partner over the median 1.8 years of
observation. Interestingly, the magnitude of the relationship between internalized stigma
and disclosure increased with social distance from the participant, such that stigma was a
greater barrier to disclosure to neighbours and religious leaders, and the general public
than it was to sexual partners. Other studies have found no relationship between
internalized stigma and partner disclosure; a mixed-methods analysis found no
association between internalized stigma and partner disclosure in univariate or
multivariable models.118 However, a two-item measure was used to capture internalized
stigma, which may be insufficient compared to the psychometrically evaluated measures
applied in the other studies in question. Furthermore, outcome data on disclosure to
sexual partners was missing for 17.8% of respondents who knew their HIV status and
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were married/cohabitating with a partner, calling to question the validity of these results.
Interestingly, the methodologically sound Dima study of 158 people with HIV (70%
women) detailed prior found that internalized stigma was associated with cumulative
disclosure, as well as disclosure to close family, children, and the larger community, but
not sexual partners.84 The results of this analysis appear to support the social distance
hypothesis posited in the Tsai study. Taken together, current evidence does not discount
the presence of a relationship between internalized stigma and partner disclosure, though
this relationship may be more important to disclosure targets at greater social distance.

2.4.4

Social Support

Social support, or the security that we gain from positive interpersonal relationships, is a
known facilitator of positive health outcomes.119 Such support may come in the form of
tangible support (for example, someone who will take care of you when you’re sick),
emotional support, affection, and social companionship.119 In the context of HIV
disclosure, social support has been cited as both a reason for disclosing (i.e. desire for
support) and not disclosing (i.e. fear of losing social support). A meta-analysis (n=2253)
of the relationship between social support and HIV disclosure (inclusive of all targets)
revealed a weak positive correlation between the two (r=0.159), though the confidence
interval included zero.78 Furthermore, the analysis does not specify the temporal
relationship between the two variables, making it impossible to draw conclusions about
social support as a facilitator or barrier to HIV disclosure. Some quantitative studies
support the hypothesis that social support is associated with higher cumulative83 and
target-specific120,121 rates of disclosure, while others found no association between
cumulative disclosure and social support.79,121 Within these studies, it is important to
identify which types of social support are being measured. Social support measures often
tap into several dimensions (tangible support, emotional support, affection, and social
companionship,119 from any of the following perspectives: received support,83 perceived
support,79,84,120 reciprocated support,122 need for support,83 or satisfaction with
support.83,121 Additionally, measures may be HIV-specific83,84 or target-specific.79,120
Some domains and perspectives appear to be more salient to disclosure than others; both
Simoni83 and Petrak121 found no association between satisfaction with support and
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cumulative disclosure. Conversely, perceived social support has been associated with
cumulative disclosure,84 and target-specific disclosure,120 including disclosure to intimate
partners.84 Among a sample of 158 people with HIV (70% women) in Tanzania,
perceived instrumental support (specific to HIV) was positively correlated with voluntary
disclosure to intimate partners (r=0.14, p<0.05).84 Interestingly, neither HIV-specific
emotional/informational support nor adherence support were related to partner disclosure
in this study, indicating that the dimensionality of social support in addition to disclosure
target is of importance.
However, quantitative studies of disclosure and social support specific to intimate
relationships have been largely cross-sectional, raising the question of whether given
levels of social support preclude disclosure, or result from it. Qualitative research can aid
in nuancing this relationship; while some women report fear of losing social support from
their partners as a result of disclosing,101 others disclose because they desire additional
social support from their partners.100,101,123 It seems that social support can function as a
facilitator to disclosure, if it is perceived to be present already. One woman from Sowell
et al.’s study of American women with HIV spoke to this dynamic: “I tell people who I
know will be there for me no matter what. The people I have chosen has been there for
me with other problems”.124 This relationship has also been documented in the context of
HIV testing; one of the strongest predictors of partner disclosure is the degree of
awareness and involvement the partner has in the HIV testing experience.74,100
Additionally, women who chose not to involve their partners in the testing procedure
were more likely to experience abuse as a result of disclosure,100 indicating that their
partner’s negative reaction was likely anticipated. It appears that social support may drive
disclosure similarly to involvement with HIV testing such that women who experience
low social support anticipate low social support as a result of disclosure, and vice versa.
Further quantitative longitudinal studies of perceived social support and partner
disclosure would aid in substantiating this hypothesis.
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2.5 Childhood Physical and Sexual Abuse
2.5.1

Definition

Child abuse or maltreatment, as defined by the WHO, refers to “all forms of physical
and/or emotional ill-treatment, sexual abuse, neglect or negligent treatment or
commercial or other exploitation, resulting in actual or potential harm to the child’s
health, survival, or development of dignity in the context of a relationship of
responsibility, trust, or power”.125 This definition frames abuse based on the impact of
abusive behaviour on the child rather than the intention of the abuser, as the child is the
subject of interest for this study. Furthermore, this definition captures the main forms of
child abuse covered under the Criminal Code of Canada, including physical abuse, sexual
abuse, exposure to family violence, and neglect.126 According to retrospective self-report
from the 2001 wave of the Ontario Child Health Study, before the age of 16, 28.2% of
females had experienced physical abuse and 22.1% experienced had sexual abuse.127 The
combined proportion of females who experienced childhood physical and/or sexual abuse
was 38.8%.127 While these figures come from a representative population-based study,
the prevalence of child abuse tends to be elevated among community samples of women
with HIV.128

2.5.2

Child Abuse and HIV-Related Outcomes

The frequent co-occurrence of HIV and histories of CPSA among women has been the
subject of a great deal of research. Multiple meta-analyses have indicated significant,
positive relationships between both childhood physical11 and sexual abuse12,13 and HIV
vulnerability in adulthood. Factors increasing HIV vulnerability in these studies include
engaging in condomless sex, sex work, early first sexual experience, having multiple sex
partners, and experiencing sexual abuse in adulthood.11–13 Many theoretical models exist
to explain the relationship between CPSA and HIV, tending to focus on
intrapersonal/psychological factors such as learned sexual scripts.129 However, any such
model must be contextualized by accounting for social power hierarchies, particularly
with respect to gender. Gendered power imbalances have been articulated in several
models of HIV risk, 86,130,131 however, Rosenthal and Levy explicitly extend the definition
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of gender-based violence to include violence against young girls.86 Acts such as rape and
abuse (termed “force”) are said to undermine the personal agency of women and girls,
contributing to HIV vulnerability via reduced sexual relationship power.86 Recalling that
reduced sexual relationship power is also a barrier to HIV disclosure, CPSA is revealed
to not only be a risk factor for HIV, but may also impact a woman’s ability to disclose
her HIV status once diagnosed. In this way CPSA acts as a sort of “double jeopardy,”
increasing risk for HIV as well as for further vulnerability among those who are affected.
The relationship between CPSA and reduced sexual relationship power has been
investigated implicitly via factors contributing to relationship power including low selfesteem,9,10 distrust,10 lack of meaningful communication with partners,8 having a partner
who is controlling and/or uncaring8,10 and relationship dissatisfaction.8,10 However,
sexual relationship power is not the only HIV-related outcome of CPSA. Studies among
women in the general population have shown CPSA to be a risk factor for physical/sexual
abuse in adulthood (i.e. revictimization),10,132 as well as reduced perceptions of social
support.133,134 If these relationships hold among women with HIV, CPSA will be further
implicated as a cause of barriers to HIV status disclosure among women. There is also the
potential for experiences of CPSA to impact barriers to HIV disclosure that are not
investigable among the general population, such as HIV stigma. While theoretical bases
for these relationships have not been formally articulated in the literature, the effects of
CPSA are diverse and can reach far into adulthood. Women in the general population
who have experienced CPSA have reported stigma related to the abuse as well as distrust
and perceived powerlessness in adulthood.135 These outcomes, while not specific to HIV,
document connections between CPSA and later stigma, as well as relationships between
CPSA and factors known to contribute to HIV disclosure concerns. Whether the HIVspecific analogues of these outcomes are related to CPSA among women with HIV
should be the subject of further inquiry, including the current study.

2.5.3

Eco-Social Theory

Given that CPSA has been implicated as a cause of both HIV vulnerability and barriers to
HIV disclosure, it is of interest, from a causal modelling perspective, to understand the
causes of CPSA (i.e. the “causes of the cause”). While many theoretical models exist to
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explain the etiology of child maltreatment, the currently favoured model is Belsky’s
ecological or eco-social model.136 This model posits that CPSA is caused by socialpsychological forces acting and interacting across multiple domains: the developmental
experiences of the caregiver (termed “ontogenic environment”), the family
(“microsystem”), the community (“exosystem”) and the larger social culture
(“macrosystem”). Belsky identified several risk factors and potential mechanisms at each
level. Notably, risk factors stemming from colonization of Indigenous land are not
addressed in this theory, and are thus further discussed in section 2.6. Belsky’s analysis
of the ontogenic environment suggests that the child-caregiver relationship is likely
influenced by the caregiver’s childhood relationship with their own caregivers.
Intergenerational transmission of abuse is a widespread theory, though the relationship
between experience of abuse and perpetration of abuse is complex, depending on parental
and contextual factors.137–139 The family microsystem risk factors include characteristics
of the child that, in interacting with caregiver characteristics, may make the child more
vulnerable to abuse. These include low birthweight or premature birth, as well as
temperamental characteristics such as hyperactivity, lethargy, or disobedience.
Furthermore, family attributes such as having many family members and small living
spaces have been theorized to cause stress on the family, and may interact with caregiver
factors to increase the risk of CPSA. While caregiver factors are important, it must be
stated that parents/caregivers are not the only potential perpetrators of child maltreatment.
However, the Belsky model focuses on CPSA within families, stating that “the parentchild system is the crucible of child maltreatment” 136
In this eco-social model the family is nested within larger social units within the
community, or the exosystem.136 At this level, social isolation of the family may play a
role in potentiating abuse; families without support may lack friends or extended family
to aid with child care, and lack of close connections may lead to fewer “outsiders” in the
home observing or monitoring caregiving practices. The workplace represents another
major connection to the outside world, and workplace factors such as unemployment or
lack of job satisfaction are theorized to have bearing on a caregiver’s propensity to
maltreat children under their care. At the macrosystem, or societal level, national or even
global events can influence factors at other levels; an example is given of a global
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financial crisis causing mass unemployment, an exosystem factor relevant to CPSA. Also
existing at this level are cultural attitudes towards violence and child rearing; Belsky
presents cross-cultural descriptive evidence suggesting that societies where corporal
punishment is not accepted have lower rates of child maltreatment.136 It is important to
consider that such societal attitudes can shift dramatically over time. At the time that
Belsky’s theory was published in 1980 most forms of corporal punishment were legal in
North America, while as of 2004 corporal punishment was significantly sanctioned under
Canadian law,140 and mass social campaigns exist with the intent of criminalizing all
forms of corporal punishment.141 Furthermore, while Belsky’s ecological model
represents a significant advancement in the history of CPSA research, the theories
presented in this model should be further substantiated with more contemporary research.
Since the publication of Belsky’s theory, the four ecological levels have been reconceptualized and additional risk factors have been identified. In 2002 the World Health
Organization published the World Report on Violence and Health, undertaking a review
of the literature on the causes and consequences of child maltreatment that have been
implicated repeatedly in studies across the world.142 Rather than the first level focusing
on the child-caregiver relationship, or ontogenic environment, this model focuses on
factors increasing a child’s vulnerability as the initial level nested within the other three.
Risk factors identified at this level include the child’s age (cases of physical abuse occur
more commonly among pre-pubescent children while rates of sexual abuse generally
increase after puberty),142 the child’s sex (female children are at greater risk for most
forms of abuse other than harsh physical punishment)142–144, and special characteristics of
the child. Special characteristics increasing children’s vulnerability to abuse, like low
birth weight or disobedience as identified in Belsky’s theory, have been expanded to
include children who are twins,142,145–147 and children who have a disability or
illness.142,148,149 When considering such risk factors, it is important to reiterate Belsky’s
condition stating that a child cannot sufficiently cause their own abuse; it is only through
interaction with risk factors at other levels that these child-level risk factors may have an
effect.136 These may include attributes of the child’s caregiver and family, as well as
others. In particular, the type of abuse perpetrated may be related to the sex of an abusive
caregiver. For example, while physical discipline is more common among female
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caregivers,142,150–153 sexual abuse142,154,155 and severe physical abuse142,156,157 are
committed largely by male caregivers. As in Belsky’s original theory, the WHO model
notes the potential importance of the caregiver’s history of abuse,137,156,158 family and
household size,158,159 social isolation of the family,158 and stress.142,156,160 Furthering these
theories, recent research has conceptualized family risk factors as resources, or lack
thereof, that the family may draw on to care for the child and the family as a whole.
These include caregiver education/income,158,160 age,158 employment status,158 and the
number of caregivers in a household.142,151,156,158 Additionally, a lack of stability in the
household (i.e. the environment changes often or people come and go frequently) is
known to be related to CPSA.142,161 This risk factor speaks to the fact that CPSA is not
exclusive to parents or caregivers, but may be perpetrated by others present in a child’s
household and life more broadly. Finally, children have been found to be at increased risk
of experiencing CPSA in households where a caregiver perpetrates intimate partner
violence.142,156,162 Taken together, many of these caregiver and family characteristics are
indicative of the reserves a family draws upon to raise and protect children, and the ways
that these resources may become depleted.
In both Belsky’s theory and the updated WHO model, the child and family are nested
within their community. While Belsky placed the family’s access to social support and
workplace satisfaction at this level, the WHO model focuses more explicitly on poverty
and social capital.142 Communities where many people are living in poverty, and
experiencing unemployment, overcrowding, and population instability are known to be
high-risk sites for CPSA.163–165 Social capital was not directly addressed in Belsky’s
theory but refers to the interpersonal connectivity drawn on by a community in order to
live and work together.166 Research has shown that social capital, as measured by
neighbourhood instability (e.g. high turnover, vacancy) has been predictive of
neighbourhood-level maltreatment rates.167 Norms, a component of a network’s social
capital may also be determinants of CPSA. According to both the Belsky and WHO
models, societal norms regarding violence as well as value of children can affect child
maltreatment rates by positioning violence and abuse as more or less socially
acceptable.136,142 While risk factors at this level have not been adequately investigated,
the WHO identifies several potential social forces and resulting norms that may influence
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rates of child maltreatment, including: gendered income inequality, gender roles, public
policy related to children and families, the role of preventative health care and social
services in identifying and preventing cases of CPSA, and social or political conflicts
including war.142

2.5.4

Intersectionality Theory

Expanding further upon the eco-social model of CPSA, Nadan et al. provided insight on
how intersectionality can be incorporated into this framework.168 Applied to the
ecological model, intersectionality emphasizes that while children and families are nested
in communities and culture, they also exist at the intersection of multiple social positions
such as gender, race, ethnicity, and socioeconomic status. While children and to some
extent families occupy intersectional positions, at a higher level interlocking social and
structural forces affect these children and families at all eco-social levels. These forces
are not limited to sexism and ageism as identified in the WHO model, but can include
racism, ableism, colonialism, and others. Race has sometimes been erroneously treated as
a potential risk factor in the child maltreatment literature, incorporated at the child/family
levels often without addressing the mechanisms by which race may impact experiences of
CPSA. Intersectionality asks researchers to consider the higher-level social and structural
impacts of racism and other axes of oppression given that society systematically
advantages people who are white and disadvantages those who are not. For example,
while cases of CPSA involving Indigenous children are disproportionately reported to
and substantiated by child protection services,169 this effect has been attributed to the
poverty, family disruption, and lack of access to government services often experienced
by Indigenous families.170,171 While the systematic and ongoing disenfranchisement of
Indigenous peoples in Canada and other countries has not been addressed specifically in
the Belsky or WHO models, multilevel intersectional thinking allows for the
incorporation of these and other factors.
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2.6 Theoretical Model: Eco-Social Intersectionality for
Women with HIV
Building on the foundational models of eco-social theory and intersectionality, a new
theoretical model is proposed to contextualize the relationship between childhood
maltreatment and HIV disclosure among women with HIV in Canada. The adaptation of
this model, as follows, fulfils Objective 1 of this thesis. Belsky and WHO provide us with
the nested levels at which risk and protective factors for CPSA exist: child/individual,
family, community, and society.136,142 Nadan has tied eco-social theory of child
maltreatment to feminist intersectionality by locating these four levels within
intersectionality’s “matrices of domination”.54,168 In order to adapt these existing theories
to the context of the study at hand it is of interest to (1) clarify the role of culture as
related to CPSA; (2) understand how intersectionality and axes of oppression operate at
the four eco-social levels; and (3) address colonialism as an axis of oppression affecting
Indigenous women in Canada. Finally, this model will be used as a roadmap to
understand the objectives and study design for the current project.
In the past, race and cultural factors have been wrongfully treated and studied as potential
risk factors for CPSA. In more recent years, efforts have been made to unpack race and
culture to gain a more nuanced understanding of how not only race and culture, but
systematic racism affect health and social outcomes for people of colour. It has been
shown that use of broad phenotypic racial categories is the most superficial means of
studying race, as race and culture as constructs are undoubtedly multidimensional.172 In
order to understand the dimensions of race and ethnicity that are relevant to studies of
CPSA, these constructs must be unpacked. Unpacking culture refers to examining
specific traits associated with given cultures which have the potential to impact child
maltreatment, rather than bluntly assuming that the culture itself is the cause.172 Examples
of such traits include familism (a value elevating the importance of family bonds, often
attributed to Latinx families)173 ‘ohana (a similar construct in Hawaiian American
families),174 and machismo (valuing male pride and dominance, also an aspect of Latinx
culture).175 These values have been found to predict CPSA such that familism173 and
‘ohana174 are protective factors, while machismo represents a risk factor.175 When
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unpacking culture into values, it is imperative to remember that no culture is monolithic
and that culture, values, and race are not synonymous. Another important attribute of
cultural values is their potential to be protective against CPSA. Furthermore, culture does
not exist in a vacuum; as posited by intersectionality, individuals exist within larger
interlocking axes of oppression.54 Racism, colonialism, and xenophobia intersect with
other axes including sexism/patriarchy and ableism to affect our lives, social structures,
policies, and institutions. Paired with eco-social theory, these interlocking axes can be
visualized as reaching over all levels of analysis, while individuals and to some extent
families occupy intersectional social positions which exist within the larger social
hierarchy (Figure 2). To illustrate, hypothetical examples of given intersections and their
potential impact at each eco-social level are provided in Table 4.
Table 4: Mapping intersectionality onto eco-social theory levels with examples
Eco-Social
Theory
Level
Macrosystem

Level applied to Intersectionality at this
level168
contextualize
child abuse
Societal level
Societal factors are
impacted by larger
intersecting power
differentials in the
context of that society

Exo-system

Community
level

Community level factors
are impacted by larger
intersecting power
differentials in the
context of that
community

Meso-system

Family level

Micro-system

Individual
(child) level

As a unit, families
occupy intersectional
positions within a larger
system of intersectional
social inequality
Individuals occupy
embodied intersectional
positions existing within

Hypothetical example
intersection and outcome
Sexism (male dominance) and
ageism (the value a society
places on children) intersect to
produce societal norms, such
as the normativity of physical
punishment of children
Racism and classism intersect
resulting in discriminatory
practices within local child
welfare agencies, such as a
system that removes racialized
children without class
privilege from the home,
where while children lacking
class privilege would not be
removed
Discrimination based on
immigration status and racism
intersect resulting in a family
being socially isolated and
without access to childcare
Sexism and ableism intersect
resulting in increased
vulnerability to sexual abuse
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a larger system of
intersectional social
inequality

for a female child with a
disability

The number of social positions and their intersections at which an individual exists is
virtually unknowable, as the matrices of oppression that govern our society are vast,
varying, and dynamic. Furthermore, some intersectional positions are present/relevant in
given contexts but non-existent in others. In a Canadian context (as well as American,
Australian, and others) theories of child maltreatment are incomplete without
consideration of the intersecting axes of colonialism and sexism resulting in the historic
and ongoing systematic oppression of Indigenous peoples, and Indigenous women.
Colonialism here refers to “Indigenous peoples’ forced disconnection from land, culture
and community by another group.”176 When European settlers colonized Indigenous land
and imposed both patriarchal gender roles and racist cultural assimilation efforts upon
Indigenous communities, the position of Indigenous women was transformed.177 While
First Nations varied in structure, Indigenous women had traditionally occupied positions
of power and leadership in their communities, such as that of the Clan Mother, working
in non-hierarchical balance with men in the community.177 After colonization, Indigenous
women were harshly punished for not conforming to patriarchal European expectations
of womanhood: domesticity, perceived sexual virtue, and monogamy.177 Formal policy
was used not only to punish those who did not conform to European standards, but to
indoctrinate Indigenous children with such values, alienating them from their own
culture. One of the largest efforts to eliminate Indigenous family structures and values
was the government-funded residential school system, operating from 1870-1996.178
Attendance at off-reserve residential schools was mandatory for Indigenous children aged
7-16, and parents were forced to rescind legal custody of their children to the principals
of these schools.178 The abuse perpetrated by employees of residential schools unto
children under their care took many forms, including forced abandonment of Indigenous
language and beliefs, unsafe/unsanitary living conditions, as well as physical, sexual,
emotional, and medical abuse.178 If/when children returned home outside of the school
terms, the cultural fabric that bonded families together was tarnished: parents and
children spoke different languages and were taught different values.178 Forced cultural
and familial disruption, including trauma inflicted by the residential school system, is
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widely regarded as the root cause of health and social inequities among Indigenous
people today.176 Furthermore, colonial practices continue to impact the lives of
Indigenous women and children, one example being the “sixties scoop” (1960s-1980s)
during which Canadian authorities forcibly placed thousands of Indigenous children into
the foster care system, again disrupting families and placing Indigenous children at
risk.179 To this day, 48% of children in the foster care system are Indigenous and 54% of
Indigenous children in foster care live in homes without an Indigenous foster parent.180
The causes of CPSA among Indigenous people are qualitatively different from
determinants for people without a history of systematic colonialism and sexism. The
proposed theoretical model acknowledges that causes of CPSA within Indigenous
populations stem from this ongoing history of institutionalized child maltreatment and
family disruption. The mechanisms by which European colonization have affected (and
continue to affect) Indigenous people living in Canada are clearly traceable, and the
effects of these actions are visible today. Survivors of this legacy of cultural disruption
are remarkably resilient, but carry with them the burden of intergenerational trauma.
Multiple generations of familial disruption can result in cyclical generations of parents
who were raised in the absence of a healthy parenting model and thus are disadvantaged
when attempting to provide such a model for their own children.181 In particular, this
cycle can include intergenerational transmission of abuse. Illustrating the overarching
impact of colonization on this outcome, it is worth noting that physical discipline of
children was reportedly an uncommon practice prior to implementation of the residential
school system.181 However, as of 2008, the Canadian Incidence Study of Reported Child
Abuse and Neglect reports that the rate of substantiated maltreatment investigations
among Indigenous children was 5.1 times that among non-Indigenous children (noting, of
course, the potential for substantiation judgements to differ for Indigenous vs. nonIndigenous children). The lasting effects of this familial disruption, institutionalized
abuse and systematic disenfranchisement of Indigenous women are expected to impact
Indigenous women in causal pathways not experienced by non-Indigenous women. Thus,
the proposed theoretical model will include risk factors from multiple eco-social levels
that acknowledge the intersectional position and experiences of Indigenous women in
Canada.
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Figure 2: Intersectional/eco-social model of determinants of childhood physical or sexual
abuse
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2.7 Current Study
A final objective of the proposed theoretical model is to use intersectionality and ecosocial frameworks to understand the relationship between CPSA and HIV. Briefly, CPSA
has repeatedly been implicated as a risk factor for HIV.11–13 Additionally, child
maltreatment is known to affect other outcomes in adulthood (e.g. sexual relationship
power, experiences of abuse, perceived social support, etc.). Among women with HIV,
these outcomes hold particular significance, as they may be barriers or facilitators of HIV
disclosure to sexual partners. If CPSA is a cause of HIV, as well as a cause of barriers to
partner disclosure among women with HIV, abuse during childhood may represent a
“double jeopardy” of sorts. By acting as a risk factor for HIV and disenabling those
women who acquire HIV from disclosing their HIV status, child abuse may substantially
affect both the quality of life and the socio-legal vulnerability of women with HIV in
Canada. Portions of this causal chain are already well described in the literature. These
include the relationship between CPSA and HIV risk,11–13 CPSA and outcomes such as
experiences of abuse/disempowerment in adulthood among the general population,8–10,132
and the relationship between HIV disclosure and legal risk.1 The causal relationship that
has yet to be examined is that between CPSA and barriers to disclosure among a
population of women with HIV (Figure 3).

Figure 3: Sequential model contextualizing hypothesis to be tested (*)
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The eco-social intersectionality framework will be incorporated in investigating this
causal question. In particular, the eco-social framework will be used to identify CHIWOS
variables at the level of the individual, family, community, and society which may affect
risk for CPSA. In contrast to past models, variables acknowledging the effects of colonial
practices such as family attendance at residential school will be incorporated. Using
advanced statistical methods, the eco-social risk factors will be balanced across the group
of participants with and without histories of CPSA as a method of confounding control.
Furthermore, an intersectional framework will be incorporated in calculating measures of
effect for the given hypothesis. This involves allowing effects to vary across population
groups defined by intersecting social positions/identities that exist within larger systems
of power and oppression: here, defined by gender, HIV status, and ethnoracial group.
Among women with HIV, it is expected that experiences of CPSA as well as its
consequences will be qualitatively different based on ethnoracial group. Thus, measures
of effect for CPSA on barriers for HIV disclosure will be reported separately for
Indigenous, Black African, Black Caribbean, white, and other women.
The need for this study arises from not only the documented barriers to disclosure faced
by women with HIV, but also from the Canadian legal precedents which fail to protect
them. Investigating the causes of disclosure barriers can create space for future
interventions, shed light on the disclosure experiences of women with HIV, and highlight
the lack of understanding of these experiences implicit in Canadian HIV non-disclosure
policies.
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Chapter 3

3

Methodology

This chapter will describe the methodology used in the study, including: study design,
recruitment procedures, statistical methods, variable selection rationale,
measurement/coding, and approaches to missing data.

3.1 Canadian HIV Women’s Sexual and Reproductive
Health Cohort Study
3.1.1

Ethics and Funding

Ethics approval for CHIWOS was provided by the research ethics boards for Women’s
College Hospital, McGill University Health Centre, University of British
Columbia/Providence Health, Simon Fraser University, and recruitment sites with
independent REBs. CHIWOS is funded by the Canadian Institutes of Health Research
(CIHR) and the Ontario HIV Treatment Network, with support from the CIHR Canadian
HIV Trials Network. In addition to institutions already mentioned, CHIWOS is supported
by Women’s College Research Institute, Women’s Health in Women’s Hands
Community Health Centre, and the British Columbia Centre for Excellence in
HIV/AIDS.

3.1.2

Recruitment and Sampling

CHIWOS is a multi-province prospective study, collecting data at three time-points:
baseline (Wave 1), 18-months (Wave 2), and 36 months (Wave 3).14 Originally, three
provinces were selected to participate based on the relatively high estimated prevalence
of women with HIV in each area: ON, QC, and BC.14,19 Wave 1 data collection for these
provinces occurred from August 2013 through May 2015,14 while Wave 2 data were
collected from June 2015 to January 2017.14 Wave 3 data for ON, QC, and BC started in
February 2017 and is scheduled to finish in August 2018.14 Data from Waves 1 and 2 are
included in the present analysis. Since data collection began for these provinces, a
decision was made to also collect data in Saskatchewan (SK) and Manitoba (MB), based
on the relatively high HIV incidence in these regions.19 Alternative research methods
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including arts-based data collection has been used to draw inference from these
provinces, and thus these data were not included in the present analysis.14 Within the
selected provinces, a non-random quota sampling method was applied, starting with
overall provincial quotas of n=700 for ON, n=350 for BC, and n=350 for QC. The
decision to use sampling quotas was informed by the objectives to compare outcomes
across health service delivery areas, and to collect data on key subgroups of women with
HIV who may not be captured by traditional sampling methods.14 Provinces identified
“health regions” based on existing data on HIV prevalence among women in order to set
regional sampling quotas; in ON, the Ontario HIV Epidemiologic Monitoring Unit health
regions were used,182 collapsing some regions with low HIV prevalence. BC based their
sampling frame on Drug Treatment Program data across Regional Health Authorities. In
QC, surveillance data from Institut National de Santé Publique du Québec characterized
the distribution of HIV cases among women across geographic regions. Based on
community and clinician expertise, as well as data availability by province, sampling
quotas were also created for priority populations within provinces and sometimes within
health regions. In Ontario, sampling quotas of n=70 per strata were set for priority
populations including: younger women, older women, trans people, lesbian, gay,
bisexual, queer, questioning, and Two-Spirit women, Indigenous women, African and
Caribbean Black women, other women of colour, those not accessing care, women with a
history of IDU, and women with a history of sex work. BC and QC set similar quotas for
recruiting women diverse in terms of age, ethnoracial group, language, and HIV exposure
category.
Recruitment procedures for CHIWOS were driven by the PRAs alongside the research
team.15 Potential participants were identified through the personal networks of PRAs,
community advisory board members, and other women in the community, as well as
AIDS service organizations, HIV clinics, social media promotion, and posters circulated
in non-HIV specific organizations such as women’s shelters.14 Screening of potential
participants was done by PRAs or provincial research coordinators either in person or by
phone when required, and those who met the inclusion criteria and provided informed
consent were enrolled. In order to be included in CHIWOS at baseline, participants were
required to (1) identify as women (inclusive of cisgender, transgender, intersex, Two-
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Spirit, and gender queer or questioning women); (2) be at or over the age of 16; (3) have
been diagnosed with HIV; and (4) reside in one of the included provinces.14 In some
cases, women who met these criteria were not enrolled in the study in order to comply
with the quota sampling targets.14 Inclusion was not restricted by language, as surveys
were administered in either English or French, or with the assistance of a translator for
other languages.14 PRAs administered the survey in person or by phone/Skype183 using
White Label FluidSurveys™,184 a web-based platform allowing for automatic skippatterns.14 Median time to complete the survey was 120 minutes for Wave 1, while the
mean time to completion at Wave 2 was 111 minutes. Participants were compensated $50
cash after completing an interview, while PRAs were compensated $75 for every
interview they conducted. Follow-up contact from one wave to the next was made by the
same PRA who conducted the previous interview, by means of contact indicated by the
participant.14 PRAs attempted contact three times, and if all were unsuccessful attempted
contact through community organizations or clinics associated with the participant.14
Where follow-up interviews could not be conducted and reasons for loss-to-follow-up
were known, these reasons were recorded in the dataset.
The Wave 1 CHIWOS questionnaire, developed with CBR methods, contained 436 items
and spanned nine general content areas (Table 5).14 Participants had the option to skip
items (response options: “don’t know” or “prefer not to answer”) or subsections (e.g.
questions on residential school) as they deemed appropriate. The sections on violence and
abuse and women’s sexual health contained sensitive content with the potential to invite
response bias in the presence of a survey administrator, thus, these sections could
optionally be self-administered rather than administered by a PRA.14 The Wave 2 survey
included a subset of sections/items from Wave 1, with the addition of some new
sections/items. Most relevant to the present study, Wave 2 collected supplementary
information on immigration experiences.
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Table 5: CHIWOS Survey content areas by wave
Section

Wave 1 Section Topic

Wave 2 Section Topic

1.

4.

Demographics and Socio-economic
Status
Medical and HIV Disease
Information
Health Care and Support Service
Utilization
Women’s Reproductive Health

5.

Stigma and Discrimination

Demographics and Social
Determinants of Health
Medical and HIV Disease
Information
Health Care and Support Service
Utilization
Emotional Wellbeing, Resiliency,
and Health Related Quality of Life
Women’s Reproductive Health

6.

Substance Use

Stigma and Discrimination

7.

Violence and Abuse

Substance Use

8.

Women’s Sexual Health

Violence and Abuse

9.

Emotional Wellbeing, Resiliency,
and Health Related Quality of Life
N/A

Women’s Sexual Health

2.
3.

10.

Resilience

3.2 Summary of Statistical Methods
Section 3.2 introduces theory, rationale, and statistical specifications for the analytic
methods applied in this study. Counterfactual theory and the corresponding potential
outcomes framework are outlined as the chosen approach for addressing confounding.
Following this, propensity score methodology is described, along with the chosen
propensity score estimation method (generalized boosted modelling), application method
(inverse probability of treatment weighting by weighted regression), and counterfactual
estimand (average treatment effect among the treated). Rationale based on causal
modelling and counterfactual theory is provided for variable selection, and corresponding
measurement/coding information is provided.
For the present study, the exposure variable was a measure of ever experiencing
childhood physical or sexual abuse (CPSA), while the outcomes were barriers to HIV
disclosure to sexual partners. These included ever experiencing physical abuse in
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adulthood, ever experiencing sexual abuse in adulthood, sexual relationship power, HIV
stigma, and perceived social support. The causes of the exposure to be balanced across
groups, referred to hereinafter as propensity score covariates, were participant age, sexual
orientation, gender identity, immigration to Canada before age 16, indicator for stressrelated circumstances surrounding that immigration, being a survivor of the residential
school system, and having one or more family members who attended residential school.
For the sensitivity analyses, child physical abuse (CPA) and childhood sexual abuse
(CSA) became the exposure variables.

3.2.1

Counterfactual Theory & Potential Outcomes Framework

Counterfactual theory, born in philosophy, conceptualizes causation using multiple
realities: one where a potential causal factor exists, and another reality identical but for
the potential cause and its subsequent effects.185,186 If a given outcome occurs in the first
reality where the causal factor is present, but not in the second, the factor is indeed
causal. When translating this philosophical concept into empirical research we are
presented with several issues, most significantly the existence of a single reality. Aiding
in the explanation of empirical counterfactual thinking is Rubin’s potential outcomes
framework for binary exposures.187 Within this framework, an exposure and its
counterfactual opposite (i.e. lack of exposure) are denoted T=1 and T=0, respectively
(Table 6).187 Each study subject has the potential to be exposed or unexposed, as well as a
potential outcome under each exposure [Yi(1) denoting the outcome of an exposed
individual, and Yi(0) denoting the outcome of that same individual under the unexposed
condition]. Clearly, only one of these situations (exposed vs. unexposed) represents an
observable reality, while its opposite represents a counterfactual reality.188 At a
population level, Y(1) refers to the average outcome of a group of exposed individuals,
while Y(0) refers to the average outcome of the same group were they unexposed.
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Table 6: Rubin’s potential outcomes framework for binary exposures
Individual level

Group level

Exposure

Ti =1 for exposed individual,
Ti=0 for unexposed individual

Outcome

Yi = the outcome level (i.e. mean,
proportion) for an individual
Yi(1) = outcome level for individual i if this
individual were exposed, Yi(0) = outcome
level for individual i if this individual were
unexposed

T=1 for a group where all individuals were
exposed,
T=0 for a group where all individuals were
unexposed
Y= the outcome level (i.e. mean,
proportion) for a group of individuals
Y(1) = mean outcome level for a given
group, if everyone in the group were
exposed.
Y(0) = mean outcome level for a given
group, if everyone in the group were
unexposed.

Outcome
at given
exposure
level

Sources: Rubin 1974 and Hirano & Imbens 2001187,189

If we could observe the same group of people in each reality, we could calculate the
difference in average outcomes between the two conditions, and thus the causal effect.
Because this is impossible, the next best solution is to observe the outcomes of two
groups that are exchangeable, i.e. under the same exposure conditions, group A would
experience the same outcome as group B. This exchangeability of groups can be achieved
by randomization, which is why randomized control trials (RCTs) represent the gold
standard for causal effect estimation. Causal effects that can be estimated directly from
RCTs include the Average Treatment Effect (ATE=E [Y(1) - Y(0)]) or the effect
attributable to the exposure among the population, and the Average Treatment Effect
among the Treated (ATT=E[Y(1) – Y(0)|T=1]) or the effect attributable to the exposure
among those actually exposed. Estimation of causal effects in observational research
presents another issue: other factors (potential confounders) may select subjects nonrandomly into the exposed and unexposed groups, rendering them un-exchangeable.
Because these groups differ based on factors other than the exposure itself, the ATE and
ATT cannot be estimated directly.
In different research settings, one of the ATE or the ATT may be more meaningful than
the other. Austin gives the example of providing people who smoke with a brochure, or
some other intervention easily applied to the total implicated population.190 In this
situation where treatment of the total population is realistic, it is most useful to base
inference on the total population sampled by calculating the ATE. Conversely, if the
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intervention is an intensive cessation program, it may be unrealistic to provide the
treatment to all people who smoke, and thus the effect of the program on those who
actually received it (ATT) is more valuable.190 Likewise, in a non-experimental context,
it is often of interest to estimate the effect of a factor that (1) can only be studied
observationally and (2) does not warrant inference for the total population based on its
lack of desirability. CPSA falls into this category, where inference based on the ATT
allows us to estimate the effect of counterfactually eliminating CPSA experiences among
the women who actually experienced them. Because the undesirable nature of CPSA also
means it should not be called a “treatment”, the ATT will hereinafter be referred to as the
AEE, or average effect of the exposure among the exposed.

3.2.2

Propensity Scores

Propensity scoring is a statistical method for controlling multiple confounders in
observational studies, allowing them to mimic the exchangeability of an RCT (with the
understanding that residual confounding is ubiquitous in observational research).191 First
proposed by Rosenbaum and Rubin in 1983, a propensity score (PS) represents the
probability that an individual experiences a given exposure, conditional on a set of
covariates preceeding that exposure (Formula 1).191 In the case of this study, a PS will be
the probability from 0-1 (exclusive) that an individual experienced CPSA, as predicted by
the potential causes of child abuse. PSs can be used to control for confounding in several
ways, most generally: matching on the PS,191 creating PS strata,191 regression adjusted for
the PS,191 and PS weighting192 (also called model-based direct adjustment, or inverse
probability of treatment weighting). Inverse probability of treatment weighting (IPTW)
was selected for the present study on the basis of its superior ability to achieve covariate
balance (i.e. bias reduction), 193–196 greater interpretability (as compared to stratification
or adjustment for the PS), and minimization of data loss (as compared to certain types of
matching).197
IPTW, when implemented to calculate the AEE, creates a population that is
representative of the exposed group in terms of distribution of potential
confounders.198,199 As demonstrated in Table 7 and Formula 2, exposed individuals
receive a weight of 1, while unexposed individuals receive a weight equal to their odds of
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exposure. Thus, unexposed individuals with greater odds of exposure (i.e. greater
similarity to the exposure group) are weighted heavier than those unexposed with reduced
odds of exposure. In the weighted sample, membership in the exposed or unexposed
group is independent of the measured causes of such membership, thereby mimicking the
exchangeability generated by randomization.190 Another way of stating this is that the
causes of the exposure (confounders) are balanced across the exposed and unexposed
groups, blocking all measured non-causal pathways between the exposure and the
outcome. Thus, such weighting allows for estimation of the AEE, controlled for
measured confounders. The AEE, which represents the average effect of the exposure
among those actually exposed (and thus, the level of outcome that can be reduced by
eliminating the exposure) is calculated using Formula 3.
Table 7: AEE weighting notation
xi
PSi
ê(xi)
wi
τt
τt,w
Nt
i∈T
i∈C

Represents a given model of the propensity score covariates for individual i
Actual (theoretical) propensity score for individual i
Propensity score for individual i, estimated by model of propensity score covariates
Inverse probability of treatment weight for individual i
Average treatment effect among the treated (AEE)
Average treatment effect among the treated (AEE) calculated using IPTW
Number of individuals in the exposed group
The ith observation in the exposed group
The ith observation in the unexposed group

Sources: Hirano & Imbens 2001, Hirano, Imbens, & Ridder 2003, McCaffrey, Ridgeway, & Morral,
2004189,198,199

𝑃𝑆𝑖 = 𝑒̂ (𝑥𝑖 ) = 𝑃(𝑇𝑖 = 1|𝑥𝑖 = 𝑥) =

𝑒𝑥𝑝(𝑥𝑖 )
1 + 𝑒𝑥𝑝(𝑥𝑖 )

Formula 1: Propensity score for individual i
𝑤𝑖 =  𝑇𝑖 + (1 − 𝑇𝑖 )

𝑒̂ (𝑥𝑖 )
1 − 𝑒̂ (𝑥𝑖 )

Formula 2: Inverse probability of treatment weight for the AEE, individual i
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𝜏𝑡,𝑤 = ∑
𝑖∈𝑇

𝑦𝑖 ∑𝑖∈𝐶 𝑤𝑖 ∗ 𝑦𝑖
−
∑𝑖∈𝐶 𝑤𝑖
𝑁𝑡

Formula 3: AEE calculated using IPTW
Estimates of treatment effects based on IPTW will be essentially unbiased upon meeting
several assumptions: (1) each participant has the potential to experience either exposure;
(2) the stable unit treatment value assumption holds; and (3) the outcome is independent
of the exposure after accounting for differences in the pre-exposure PS variables (i.e.
exchangeability is achieved).191,199 Assumption 1 is satisfied in that no child is exempt
from vulnerability to maltreatment. With regard to item 2, we make the assumption that
any given participant’s outcome is not influenced by another participant’s history of
CPSA. This assumption seems reasonable, except in the situation that multiple
participants were raised in the same household and/or are part of the same family. Given
that CHIWOS does not collect household or family-level data, the actual risk of peer
effects is not estimable, however is presumed to be negligible. Assumption 3, which
maps onto counterfactual theory/exchangeability, can be addressed with extension to
causal modelling. Briefly, conditioning the exposure on all of its potential causes blocks
all non-causal paths which may lead to exposure-outcome confounding.200 It is this
capability which makes PS analyses particularly well-suited to studies with a single
exposure and multiple outcomes. While theoretically the causes of the exposure create a
sufficient set, in practice, the ability to measure and operationalize a sufficient set of all
causes becomes less realistic and the selection of variables which cause not only the
exposure but also the outcome becomes more important. Inclusion of these “true
confounders” has been shown to result in improved PS overlap and reduced mean
squared error when compared to conditioning the PS only on variables related to
treatment allocation.201 For this reason, PS variable selection was implemented by
identifying the ecological causes of CPSA, and within these causes identifying variables
available from the CHIWOS dataset with an eye towards non-mediating causes of study
outcomes (see 3.3.3 Propensity Score Covariates).
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3.2.3

Generalized Boosted Modelling for Propensity Score
Estimation

Traditionally, PSs are estimated using a logistic regression model with the exposure as
the dependent variable, and its causes as the independent variables.202 In creating the
scores, researchers are encouraged to iteratively re-specify the model (adding interaction
terms and/or higher order functions) until an optimal covariate balance is reached.202
Ideally, weighting participants using the given scores would result in the exposed and
unexposed groups having effectively the same distribution of the covariates, thereby
controlling their effects. However, considering that PS modelling is equipped and even
intended to accommodate a large number of covariates, the re-specification process can
be tedious. The traditional logistic regression method for PS estimation also specifies a
linear relationship between covariates and the logit of the PS, an assumption which may
or may not be satisfied. Furthermore, PS estimates based on logistic regression models
can be unstable, generating extreme weights and imprecision.203
Several PS modelling techniques have been developed in response to these issues,
including Generalized Boosted Modelling (GBM), proposed in the context of PSs by
McCaffrey, Ridgeway, and Morral in 2004.199 GBM is a nonparametric, machinelearning method that fits many multivariate models of a dependent variable which are
combined to produce a probability estimate, such as a PS.204–206 The method proposed by
McCaffrey and colleagues uses regression trees which algorithmically partition the
dataset based on covariate splits which minimize prediction error for the PS.199
“Boosting” generally refers to an algorithm which adaptively combines weakly predictive
models to produce a final model that is more predictive than those that it is derived
from.204 GBM for PS modelling works by modelling the log-odds of treatment
assignment (i.e. log-odds of actually experiencing CPSA) denoted g(x), then searching
for an adjustment to the model, h(x), that improves model fit.199 H(x) is a regression tree
where the residual error of current model fit is the dependent variable and independent
variables that cause the exposure variable are the covariates.199 In the case that the
regression tree improves model fit (i.e. that particular covariate split minimizes
residuals), the model for the log-odds of treatment assignment becomes g(x) + h(x).199
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This process of selecting and incorporating sub-models that improve model fit happens
iteratively, however, because the overall model changes with the addition of each submodel [g(x) + h(x) + … h(x)], the dependent variable for each new sub-model (i.e. the
residuals of the new overall model) is also different. In plain language, this means that
with each iteration, the sub-model selection criteria adapt to improve overall model fit.199
The data-adaptive nature of this method means it is a sequential ensemble method that
learns with each iteration, standing in contrast to parallel ensemble methods such as
bootstrap-aggregating (“bagging”) which fit many sub-models at once to generate an
overall average model.
GBM has been demonstrated to outperform traditional logistic regression models, as well
as other ensemble specification methods,207 especially when estimating the AEE by
IPTW.208 In a comparative study by Harder et al., GBM with IPTW was the only method
of nine competitors (logistic regression, logistic regression with iterative inclusion of
covariate interactions, and GBM each applied using 1:1 matching, full matching, and
IPTW) which achieved adequate covariate balance for estimation of the AEE.208 GBM
has also outperformed other ensemble methods such as bagged classification and
regression trees as well as random forests in terms of covariate balance, confidence
interval coverage, and tendency to produce extreme weights.207 For these reasons, GBM
was selected as the method of PS estimation. In the present analysis, GBM was
operationalized using RAND Corporation’s toolkit for weighting and analysis of nonequivalent groups (“TWANG”) macro for SAS,209 carried out in SAS 9.4.210 Use of this
macro required installation and background use of R software version 3.4.3.211 CPSA was
specified as the binary exposure variable across which PS covariates would be balanced
(Section 3.4.3). Per the recommendations of Ridgeway et al., the maximum number of
iterations (i.e. classification trees) was specified as n=5000 in order to allow ample space
for model optimization.209,212 Also per recommendations, up to 3-way interactions were
allowed within models. In order to avoid overfitting, the shrinkage parameter was
specified at 0.01, striking a balance between an overly smooth model with many
iterations (i.e. over-fit) and a more “jagged” model which does not adequately fit the
data. Two types of balance criteria were applied to evaluate the optimal iteration; these
are also called “stopping rules”. The iterations which minimized the absolute
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standardized mean difference (or effect size, ES), and the mean Kolmogorov-Smirnov
(KS) statistic for PS variables, respectively were identified. The standardized ES
identifies differences in covariate balance across the CPSA+ and CPSA- groups while the
KS test identifies differences in covariate distribution.209,213 Because the KS stopping
point minimized the mean and maximum ES and KS statistics equally or in some cases
better than the alternative stopping point, the KS mean stopping point was selected.

3.2.4

Propensity Score Overlap and Balance Diagnostics

In order for inferences based on PS weighting to be valid, the PS distributions for the
exposed and unexposed groups must overlap,214,215 and the weighting must demonstrably
balance measured covariates across these groups.191,216 In order to avoid potential offsupport inference, PS distributions were evaluated by comparing box plots for the
CPSA+ and CPSA- groups. Balance diagnostics, which show whether weighting
successfully balanced covariates across exposure groups, were evaluated as suggested in
Austin and Stuart’s best practice guidelines.216 Specifically, Wald Chi Square tests, t-tests
and KS tests (where applicable) of the PS covariates across exposure groups were
compared before and after weighting. These tests were conducted for the distribution of
covariates across CPSA for the total analytic sample as well as within each ethnoracial
group in order to identify potential stratum-specific confounding.209 The TWANG macro
also creates indicator variables for the level of missingness on each PS covariate,
allowing users to achieve and evaluate balance on covariate missingness. Balance of
covariate missingness was evaluated in the same way as covariate balance.

3.2.5

Outcome Analysis

Several approaches exist for outcome analysis using IPTW with AEE weights, including
direct estimation using weighted means, and regression modelling. There are also several
different approaches for calculating the standard error and confidence intervals for these
estimates. Ideally, calculation of outcome variance should account for variability in the
original propensity score model.199 However, for GBM, as for other propensity score
estimation methods, such a method has not been proposed. Solutions to account for this
excess variance include estimating bootstrap or jackknife confidence intervals,199 or using

56

robust standard errors.217 Additionally, because outcome estimates are weighted,
precision calculations must account for the potential increase in variance due to
weighting.218 Joffe and colleagues suggest that regression models that accommodate
weighting, along with robust variance estimators can accomplish this.218 This direction
combined with the desire to estimate prevalence ratios rather than odds ratios for binary
outcomes led to the decision to use modified Poisson regression with robust variance
estimators, weighted for the AEE, implemented using PROC GENMOD as per Sato and
Matsuyama.219 For continuous outcomes, PROC GENMOD with robust variance
estimation and AEE weights was also implemented, but specifying a normal distribution.
SAS code is available in Appendix 2.
In order to account for potential moderating effects differentiating key populations of
women with HIV, the AEE for all outcomes was calculated for the total population
(Objective 2), as well as within 5 ethnoracial strata: Indigenous, Black African, Black
Caribbean, white, and “other” women. Then, interaction terms between CPSA and
ethnoracial group were used to compare effects across subgroups, with white women as
the reference group (Objective 3). When comparing effects across subgroups, confidence
intervals that did not cross the null value were interpreted as evidence of effect
modification. This subgroup analysis applied the propensity scores and corresponding
weights calculated using the total sample, rather than generating unique propensity scores
for each subgroup. Scores derived from this approach are termed cohort propensity
scores, in contrast to subgroup propensity scores. This decision is justified based on prior
studies which found that using cohort propensity scores for subgroup analysis resulted in
effect estimates not significantly different from those obtained with subgroup-specific
propensity scores, with some variation where subgroups were small.220,221 Cohort scores
have also performed similarly to subgroup scores across multiple conditions when
evaluated on covariate balance, bias, and precision.221 There is still debate as to the
validity of cohort scores as compared to subgroup scores; however, the literature does not
provide sufficient evidence to recommend one approach over the other.222 In order to
ensure that the cohort propensity score weights balanced covariates across exposure
groups in the overall sample and within ethnoracial groups, traditional balance
diagnostics were supplemented by stratum-specific balance diagnostics.
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3.2.6

Sensitivity Analysis

In order to test the assumption that CPA and CSA have sufficiently similar effects to use
the composite outcome of CPSA, two alternative sets of propensity scores were generated
for sensitivity analysis: one predicting CPA, and the other predicting CSA. The methods
for generating and applying these scores were identical to the methods described for
CPSA, however, scores for CPA included CSA as a covariate and vice-versa. Controlling
the effect of each variable on the other allowed for the identification of CPSA effects that
were potentially driven by CPA or CSA only.

3.2.7

Temporality

While the CHIWOS project has collected two waves of cohort data, it is important to note
that the present analysis represented a cross-sectional approach with an aspect of nested
temporality. Because women were asked retrospectively about their experiences of CPA
and CSA including an age cut-off of 16, any reported abuse could be attributed to the
time period prior to outcome measurement. Additionally, variables selected as PS
covariates were those known to occur or be potentially identifiable prior to that same age
cut-off. Thus, while it is known that covariates precede outcome measurement, it is
possible that some covariates measured factors occurring after the exposure. Efforts to
address this limitation are addressed in 3.3.3. While the present analysis applies a causal
framework and epidemiological method, the inherent limitations of cross-sectional data
should be considered when interpreting the results.

3.3 Study Variables
3.3.1

Outcomes

Outcomes were identified using a literature review of qualitative and quantitative
research documenting determinants of partner HIV status disclosure among women.
Briefly, these barriers included factors related to current or past relationships (trust,
dependence, security, abuse), internal factors (HIV stigma) as well as expectations of the
effects of partner disclosure (perceived social support, expected discrimination, abuse).
These factors were then mapped onto similar variables available in the CHIWOS dataset:
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sexual relationship power, history of physical abuse in adulthood, history of sexual abuse
in adulthood, perceived HIV stigma, and perceived social support. Because sexual
relationship power was only measured among those women who indicated they had been
sexually active in the past month (Wave 1) or the past 6 months (Wave 2), the
relationship between CPSA and sexual inactivity was examined. This outcome was
intended to add to the interpretability of sexual relationship power, rather than to
represent a barrier to HIV status disclosure.

3.3.2

Exposure Variable

The decision to examine the effect of childhood physical or sexual abuse rather than the
independent effects of each was based on theoretical and practical considerations. Prior
research suggests that psychological outcomes among adults with a history of abuse
during childhood do not vary greatly by the nature of the abuse.9,223 Furthermore,
physical and sexual abuse during childhood (CPA, CSA) often co-occur,224 making
effects statistically difficult to tease apart. However, in the interest of testing this
assumption to the best of our abilities, effects were reported for PS models predicting
CPSA (main analysis), as well as models predicting CPA and CSA (sensitivity analyses).

3.3.3

Propensity Score Covariates

As specified by the statistical analysis plan, the PS estimation variables for this study
were causes of CPSA, especially causes of CPSA which may also be causes of the
outcomes. Furthermore, PS estimation variables should not be mediators along the causal
pathway. A literature review of causal theories for CPSA was conducted, leading to the
integration of eco-social and intersectional theoretical models for the context of Canadian
women with HIV (2.6). Using this model, causes of CPSA at the level of society,
community, family/caregiver, and child were identified. Within these domains, causes of
vulnerability available from the CHIWOS dataset that could identifiably have an effect
during childhood were identified. These variables included: age as an indicator for
society’s shifting acceptability of child abuse over time, sexual orientation, gender
identity, immigration to Canada at or before the age of 16, stress-related immigration
circumstances among those who immigrated to Canada in childhood, unstable or refugee
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housing prior to immigration in childhood, being adopted, spending time in foster care or
a group home, being a survivor of residential school, and having family members who
attended residential school. These factors span all eco-social domains identified in the
theoretical model. Within this set of variables, it was necessary to remove any variable
which could be caused by CPSA (i.e. potential mediators). Because foster care, group
home residence, and adoption are so often consequences of CPSA, a decision was made
to not include these variables in the PS model. Furthermore, the variable related to living
in unstable or refugee housing prior to immigration in childhood was excluded based on
low prevalence (0.15%) and thus low potential impact.
Based on the condition that all variables in a PS model should precede the exposure of
interest, some may question the inclusion of sexual orientation and gender identity in this
study. Arguments on the etiology of sexual orientation and gender identity aside, this
decision was made based on evidence demonstrating that adults who identify as a sexual
orientation other than heterosexual and/or a gender that doesn’t align with the sex
assigned to them at birth retrospectively report elevated rates of CPSA compared to their
heterosexual/cisgender peers.225–227 While opinions on the cause of this relationship vary,
it is theorized that whether or not an individual is aware of their sexual orientation/gender
identity during childhood, perceived atypicality with respect to gender/sexual norms
during childhood can result in increased targetability for abuse.226 In fact, signs of gender
atypical behaviour during childhood have been associated with onset of verbal and
physical abuse from both parents and peers.226 This ties into the eco-social framework
which identifies individual-level markers that may increase likelihood of maltreatment,
though only in the presence of risk factors at other levels (i.e. children are not responsible
for their own abuse).136,142

3.4 Measures
3.4.1

Outcomes

All outcomes were measured at both Wave 1 and Wave 2, with the exception of social
support which was measured at Wave 1 only. Because the measures for physical and
sexual abuse in adulthood allowed for collapsibility across waves, single “ever-
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experienced” variables are used for these outcomes. Where measures were available from
both waves but not collapsible as with physical and sexual abuse, the Wave 1 measures
were used on the basis of larger sample size. An exception to this rule was the sexual
relationship power variable, which was only asked of women who indicated that they had
been sexually active in the past month at Wave 1. An unexpectedly high prevalence of
sexual inactivity at Wave 1 prompted the decision to push the referent time frame for
sexual activity to the past 6 months in the Wave 2 questionnaire. In addition to potentially
better validity (this measure can be answered hypothetically for those who are not
currently sexually active) this decision resulted in a greater number of non-missing
responses at Wave 2 rather than Wave 1 (n=486 and n=440, respectively). For these
reasons the sexual relationship power measure (and the corresponding measure of sexual
inactivity, for interpretability) were based on Wave 2 outcome data.
Physical Abuse During Adulthood (Ever)
Experience of physical abuse during adulthood was measured using two yes/no items:
“As an adult, has someone ever physically hurt you?” (Wave 1) and “Since your last
CHIWOS interview, has someone physically hurt you?” (Wave 2). Participants who
reported abuse in either interview were coded “yes” while participants who reported no
abuse in both interviews were coded “no”. Where Wave 1 was missing and no physical
abuse was reported in Wave 2 (n=1), the participant was coded as missing as the Wave 2
item does not capture “ever” abuse, which is the construct of interest. Conversely, where
Wave 1 was missing but physical abuse was reported in Wave 2 (n=1), the participant
was coded “yes” since any abuse is “ever” abuse. When Wave 2 responses were missing,
Wave 1 responses were coded, and if both waves were missing, the final variable was
also missing. The amount of missing information for this variable in the analytic sample
was 0.08%.
Sexual Abuse During Adulthood (Ever)
Experience of sexual abuse during adulthood was measured using two yes/no items: “As
an adult, has someone ever sexually forced themselves on you, or forced you to have
sex?” (Wave 1) and “Since your last CHIWOS interview, has someone sexually forced
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themselves on you, or forced you to have sex?” (Wave 2). Participants who reported
abuse in either interview were coded “yes” while participants who reported no abuse in
both interviews were coded “no”. If Wave 1 was missing but no sexual abuse was
reported in Wave 2 (n=11), the participants were coded as missing as the Wave 2 item
does not capture “ever” abuse, which is the construct of interest. No participants who
were missing Wave 1 reported experiencing sexual abuse at Wave 2. When Wave 2
responses were missing, Wave 1 responses were coded, and if both waves were missing,
the final variable was also missing. The amount of missing information for this variable
in the analytic sample was 0.92%.
Sexual Relationship Power
The Sexual Relationship Power Scale (SRPS) was developed by Pulerwitz, Gortmaker,
and DeJong in 2000 in order to test the hypothesized relationship between low sexual
relationship power and condom efficacy among women.93 The SRPS consists of two subscales: relationship control (Cronbach’s alpha=0.86) and decision-making dominance
(Cronbach’s alpha=0.62), using metrics from the original validation study.93 The
regularly weaker internal consistency as well as questionable construct validity of the
decision-making dominance subscale has led some researchers (including the CHIWOS
team) to use only the relationship control subscale.228 The relationship control subscale
has 15 items, focusing on sexual violence and risk as well as other aspects of power
including the amount of control a sexual partner has over the participant’s day-to-day
life.93 In CHIWOS, the SRPS was preceded by the statement: “The following questions
ask about your relationship with your partner. If you currently have more than one sexual
partner, please think about the person you consider your primary sexual partner”.
Furthermore, the partner pronouns from the original scale were changed to “s/he” in order
to account for non-heterosexual relationships. A four-point Likert scale including
“strongly agree,” “agree,” “disagree,” and “strongly agree” are the response options, with
agreement to statements corresponding to lower scores and thus lower sexual relationship
power in the summed score. Summed scores were divided by the number of non-missing
items, with participants missing ≥ 20% of items (≥ 3/15) marked as missing (867/1307
missing at Wave 1, 821/1307 missing at Wave 2). While traditionally the SRPS has been
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recoded into a categorical variable with three tertiles indicating low, medium, and high
sexual relationship power,93 these are not validated cutpoints and thus may not represent
meaningful differences. For this reason, the SRPS was treated as a continuous scale, with
scores ranging from 1 to 4.
Sexual Inactivity
As previously discussed, sexual inactivity as a screening question for the SRPS was
measured with different referent time frames from Wave 1 to Wave 2. At both waves,
participants who indicated they would complete the Women’s Sexual Health section were
asked “Have you had consensual sex in the past 6 months? This includes any type of
sexual intercourse you willingly engaged in, including getting or giving oral sex, vaginal
sex, and/or anal sex with people of any gender” with response options: yes, no, and prefer
not to answer. In the Wave 1 questionnaire only, participants were also prompted
with “[t]hese next questions are in regards to your sexual activity in the past month. Have
you been sexually active during the past month?” and the same response options.
Participants deemed sexually active using the first item answered the SRPS at Wave 2,
and participants deemed sexually active using the second item answered the SRPS at
Wave 1, yielding the smaller sample and leading us to focus on the Wave 2 data. Thus,
those who answered no to item 1 in Wave 2 were coded as “sexually inactive”, with this
binary item being used to enhance the interpretability of the SRPS at Wave 2. The
amount of missing information for this variable in the analytic sample was 6.2%.
HIV Stigma
HIV stigma was measured using Wright’s ten-item version of the forty-item HIV Stigma
Scale,229 which was originally developed by Berger and colleagues.113 Both the original
and abbreviated scales contain four subscales: personalized stigma (fear of rejection),
disclosure concerns, negative self-image, and concerns related to public attitudes about
people with HIV. Similarly, both versions of the scale demonstrated good internal
consistency and construct validity for subscales as well as the total scale.113,229 Response
options are on a five-point Likert scale (strongly agree, agree, neither, disagree, strongly
disagree) with stronger agreement corresponding to higher scores. Items were summed
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resulting in final scores ranging from 0 to 40. As with other continuous variables,
participants missing ≥ 20% of items (i.e. ≥2/10 items) were excluded from analysis of
this outcome (missingness rate of 1.15%).
Perceived Social Support
Perceived social support was captured using a shortened four-item version of the Medical
Outcomes Study Social Support Scale (MOS-SSS).119,230 The abbreviated MOS-SSS has
been shown to have comparable internal consistency, test-retest reliability, and construct
validity to the original 18-item scale.230 Each of the four items taps a different domain of
social support as identified in factor analysis of the original scale: emotionalinformational support, tangible support, affectionate support, and positive social
interaction.119,230 In CHIWOS, the abbreviated MOS-SSS items are preceded by the
statement: “People sometimes look to others for companionship, assistance, or other
types of support. How often is each of the following kinds of support available to you if
you need it?” and followed by a five-point Likert scale: all, most, some, a little, or none
of the time. Greater frequency of support corresponds to higher scores, which are
summed to create the final score which ranges from 4 to 20. As with other continuous
measures, participants missing ≥ 20% of items (i.e. ≥1/4 items) were excluded from
analysis of this outcome (missingness rate of 3.29%). The abbreviated MOS-SSS was
only asked in the Wave 1 questionnaire.

3.4.2

Explanatory Variables

Childhood Physical or Sexual Abuse
Experience of physical or sexual abuse during childhood was assessed using two yes/no
items broadly defining each type of abuse: “During your childhood, did an adult ever
physically hurt you?” and “During your childhood, did someone ever sexually force
themselves on you, or forced you to have sex?”. Prior to asking these questions PRAs
informed participants that here “child” is defined as less than 16 years old. PRAs could
also further define physical abuse, stating “in some cultures, physical discipline of
children is common; for our purposes, we are including such physical discipline” as well
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as sexual abuse, stating “this can include the fondling of your private parts, oral sex,
vaginal sex, and anal intercourse. It can be either forced or with your consent because
you feared the consequences of resisting the person”. These items were only asked in
Wave 1. A single variable was created using these two items: participants who answered
yes to either question were coded as having experienced CPSA, while participants who
no to both were coded as not experiencing CPSA. Those missing one item (n=19) were
coded according to their response on the other, while those missing both items were
excluded from the analysis, yielding an analytic sample size of n=1307/1422.
Childhood Physical Abuse (for sensitivity analysis)
CPA was coded as a binary variable using only the physical abuse item from the CPSA
measure. The analytic sample for the CPA sensitivity analysis included the n=1311/1422
participants for which the CPA variable was non-missing.
Childhood Sexual Abuse (for sensitivity analysis)
CSA was coded as a binary variable using only the sexual abuse item from the CPSA
measure. The analytic sample for the CSA sensitivity analysis included the n=1291/1422
participants for which the CSA variable was non-missing.
Ethnoracial Group
Participants self-identified their racial and/or ethnic background on an extensive “check
all that apply” list including: Aboriginal person living in Canada, Indigenous Person from
a country outside of Canada, Black African, Black Caribbean, Black Other,
Caucasian/White, Chinese of Taiwanese, Filipino, Japanese, Korean, Latin American,
South Asian, Southeast Asian, Arab, West Asian, Central Asian, Multiple races /
Multiracial / “Mixed”, or “Other, specify”. Any participant who reported identifying as
an Indigenous person in Canada was classified as Indigenous (n=289), while participants
who identified as Black African only or Black African and Black Other were classified as
Black African (n=302). Similarly, those who identified as Black Caribbean only or Black
Caribbean and Black Other were classified as Black Caribbean (n=64). Participants who
selected only Caucasian/white were classified as white (n=549). The “other” category
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(n=103) included participants who did not fall into the parameters above, including
multiracial individuals, those who selected single ethnoracial groups for which the subsample was not large enough to constitute its own strata, and 6 participants who selected
“Black, Other” with no additional Black ethnoracial group. This coding resulted in no
participants missing data on race.
Because of within-group heterogeneity, results pertaining to the “other” group were not
interpretable in any way other than to serve as a call for further research. To emphasize
this necessity and remain accountable to the women from under-represented ethnoracial
groups who participated in CHIWOS, results for the “other” group were reported
alongside those for the four main ethnoracial groups, and of course included in effect
estimates for the total sample. In order to provide some insight into the individuals who
constituted the “other” group, Table 8 provides a breakdown of their ethnoracial
identities.
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Table 8: Ethnoracial groups identified by the women classified in the "other' ethnoracial
group (n=103)
Ethnoracial group

Percentage (n)

Indigenous person living in Canada (e.g., First Nations, Métis, Inuit)

0

Indigenous person from a country outside of Canada

0

Black African (e.g., Nigerian, Somali)

5.83% (6)

Black Caribbean (e.g., Haitian)

1.94% (2)

Black Other (e.g., Black Canadian)

5.83% (6)

Caucasian/White

13.6% (14)

Chinese or Taiwanese

3.88% (4)

Filipino

2.91% (3)

Japanese

5.83% (6)

Korean

3.88% (4)

Latin American (e.g., Chilean, Costa Rican, Mexican)

20.4% (21)

South Asian (e.g., Indian, Bangladeshi, Pakistani, Punjabi, and Sri Lankan)

13.6% (14)

Southeast Asian (e.g.,Cambodian, Laotian, Malaysian, Vietnamese)

5.83% (6)

Arab (e.g., Egyptian, Kuwaiti, and Libyan)

5.83% (6)

West Asian (e.g. Iraqi, Isreali, Lebanese, Afghani, Iranian)

2.91% (3)

Central Asian (e.g., Kazakhstan, Krgyzstan, Tajikistan, Turkmenistan)
Multiple races / Multiracial / “Mixed”

0
34.0% (35)

Participants could select all ethnoracial groups that applied and thus percentages do not sum to 100%.

3.4.3

Propensity Score Covariates

Age
Age was measured continuously in years, subtracting the participant’s date of birth from
the baseline interview date. No participants in the analytic sample were missing data on
age.
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Sexual Minority
Sexual orientation was measured by self-identification, using the item “With respect to
your sexual orientation, how do you currently identify?” and a check-all-that-apply list
including Heterosexual/Straight, Lesbian, Gay, Queer, Bisexual, Two-Spirited,
Questioning, and Other, specify. Participants who only selected heterosexual/straight
were coded as the reference category, while participants who selected any other identity
alone or in combination with each other or heterosexual were coded as sexual minorities.
Write-in responses without accompanying checkbox responses were coded into these two
categories, with two participants identifying other sexual orientations coded as sexual
minorities. Five participants endorsed “don’t know” or “prefer not to answer” for this
item, and were marked missing. The amount of missing information for this variable in
the analytic sample was 0.38%.
Gender Minority
Gender identity was measured by self-identification using the items related to current
gender identity: “With respect to your gender, how do you currently identify?” and sex
assigned at birth: “What was your biological sex at birth?”. Response options for gender
identity included Woman, Trans Man (Female to Male), Trans Woman (Male to Female),
Two-spirited, Intersex, Gender Queer, and Other, specify. Response options for sex at
birth included “Male, Female, Intersex, Undetermined, and Other, specify. Respondents
who identified as trans men in the gender identity item were not included in the study as
per the inclusion criteria. Participants who were assigned female at birth and identified as
women were coded as cisgender (reference group), while participants who selected any
other combination of biological sex and gender identity were classified as gender
minorities. There was no missing data for this variable in the analytic sample.
Immigrating to Canada at or before age 16
Immigration to Canada at or before age 16 was measured using items on year and country
of birth, and year of immigration to Canada. Among participants born outside Canada,
age at immigration was calculated by subtracting year of birth from year of immigration,
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with those who immigrated after age 16 being classified as the reference group. Nonimmigrants were also placed in this reference group, creating a binary indicator variable
for those who came to Canada at or before age 16. Participants who immigrated but were
missing information on year of immigration were marked as missing. The amount of
missing information for this variable in the analytic sample was 0.69%.
Stress-related immigration circumstances among those who immigrated to Canada at or
before age 16
Among those who immigrated to Canada at or before age 16, stress-related immigration
circumstances were coded using the item “What were your reason(s)/your family’s
reasons for immigrating to Canada?”. If participants selected 1 or more stress-related
reason (Living conditions, Escape socio-political conditions in home country: political
persecution, Persecution as a member of a sexual minority group or because of sexual
orientation, Religious persecution, Conditions of war, slavery, or forced labour, or
Domestic violence/intimate partner violence) and immigrated at or before 16 they were
coded as 1, while others, non-immigrants, and those who immigrated after made up the
reference group. The amount of missing information for this variable in the analytic
sample was 4.44%.
Survivor of the residential school system
Participants who indicated that they were Indigenous and who agreed to answer questions
about residential school were asked whether they ever attended one of these institutions.
Participants who answered yes were coded as one, while those who did not attend or were
not Indigenous constituted the reference group. Indigenous participants who declined to
answer this section (n=123) or item (n=42) were marked missing. The total amount of
missing information for this variable in the analytic sample was 12.6%.
Family member(s) who attended residential school
Similarly, Indigenous participants living in Canada who agreed to answer questions about
residential school were asked whether their mother, father, maternal grandmother,
maternal grandfather, paternal grandmother, paternal grandfather, or any siblings had
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ever attended residential school. Those who had at one or more family member attend
were classified accordingly, while those with no family members who attended or were
not Indigenous were the reference group. Participants who declined to answer this section
(n=123) or item (n=17) were marked missing. The total amount of missing information
for this variable in the analytic sample was 10.7%.

3.5 Missing Data
3.5.1

Outcomes

In the analytic sample, outcome missingness ranged from 0.08% to 3.29%, with the
exception of the SRPS which was considerably higher (62.8% at Wave 2). Because
missing data for outcomes other than the SRPS was low and missing data for the SRPS
was derived almost entirely from a known survey design feature for which further
interpretation is provided (i.e. effect of CPSA on sexual inactivity), analyses were
conducted on the available data for each outcome.

3.5.2

Explanatory Variables

The analysis was restricted to the 1307/1422 cases where the exposure variable (CPSA)
was non-missing, as calculation of the propensity score depends on valid exposure data.

3.5.3

Propensity Score Covariates

Missingness for propensity score covariates ranged from 0% to 12.6% in the analytic
sample. As addressed in 3.2.4, the generalized boosted modelling algorithm creates
missingness indicators for each propensity score covariate, and balances missing data
across exposure groups as it does for non-missing data.

70

Chapter 4

4

Results

This chapter will provide the results of IPTW using GBM in the form of propensity score
overlap and balance diagnostics. It will then describe the unadjusted differences in
analytic variables observed across ethnoracial strata. With respect to the analytic results,
the propensity score analysis will provide AEE estimates (prevalence ratios, regression
coefficients, and robust 95% confidence intervals) in tables and figures for the effect of
CPSA on barriers to HIV disclosure among women who experienced CPSA. AEE
estimates will be compared across ethnoracial groups. Finally, the results of the
sensitivity analysis testing the effect of CPA and CSA on disclosure variables will be
provided.

4.1 IPTW using GBM
The GBM algorithm with a KS mean stopping point successfully balanced all propensity
score covariates and their missing values at 784 iterations for the main CPSA analysis
(see Appendix 3 for the optimization plot). The propensity scores generated by the
algorithm, while higher among women who experienced CPSA (as expected), did overlap
(see Appendix 4 for side-by-side box plots of propensity scores for CPSA+ and CPSAgroups). This indicated that the weights derived from these scores would produce
minimal off-support inference, and could be applied in analysis. The same was true for
both the CPA and CSA sensitivity analyses, which achieved covariate balance at 1767
and 1889 iterations, respectively.

4.2 Balance Diagnostics
Covariate balance in the total analytic sample:
As displayed in Table 9, there were several significant differences between women with
and without a history of CPSA prior to weighting. These differences rendered the
unweighted groups incomparable with respect to measured confounders. As expected,
women who experienced CPSA were more likely to report a minority sexual orientation
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(P<0.0001) or a minority gender identity (P=0.003). While the proportion of women who
were survivors of residential school did not reach statistical significance, the proportion
of women who declined to answer items on self-attendance at residential school was
greater among women who experienced CPSA (P=0.001). Women who experienced
CPSA also were significantly more likely to have one or more family members who
attended residential school (P<.0001) and to decline to answer items on family
attendance at residential school (P=0.005). While no statistically significant difference
was observed in the mean age of women in both groups, a Kolmogorov-Smirnov test (for
continuous variables) did detect a marginally significant difference in the distribution of
age across the two groups (P=0.062). Other imbalances approached statistical
significance, such as the difference across exposure groups in proportions of women
reporting that they immigrated at or before age 16 (P=0.101), or experienced stressrelated circumstances surrounding that immigration (P=0.106). In both cases, the
outcome was more common among women who experienced CPSA.
As displayed in Table 10, no statistically significant differences remained across the
weighted exposure groups. Thus, weighting rendered the groups comparable with respect
to measured confounders. In addition to all variables and their missingness indicators
rising above the significance cut-off of α = 0.05, the majority of these variables (even
those that were not significant before weighting) had P-values much higher than those
prior to weighting. For example, experiencing stress related to immigration was
approaching significance at P=0.106 prior to weighting, but any differences could be
definitively ruled out after weighting (P=0.993).
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Table 9: Covariate balance, unweighted
Variable

Age
Sexual minority
Missing
Gender minority
Immigrated at or
before age 16
Missing
Immigration
related-stress at or
before age 16
Missing
Survivor of
residential school
Missing
Family member(s)
attended residential
school
Missing

Measure

CPSAN=488

CPSA+
N=819

42.9
(0.53)
6.78
(1.14)
0.20
(0.20)
2.46
(0.70)
3.92
(0.88)
0.61
(0.35)

42.7
(0.35)
16.8
(1.31)
0.49
(0.24)
5.62
(0.81)
5.90
(0.83)
0.73
(0.30)

0.86
(0.43)

1.91
(0.49)

4.71
(0.96)
0.45
(0.32)
9.02
(1.30)

4.27
(0.71)
1.15
(0.40)
14.8
(1.24)

% (SE)

3.33
(0.85)

% (SE)

7.79
(1.21)

x̅ (SE)
% (SE)
% (SE)
% (SE)
% (SE)
% (SE)
% (SE)
% (SE)
% (SE)
% (SE)

Standardized
effect size
difference

P-value *

P-value
(KS-test)

-0.025

0.689

0.062

0.267

<.0001

N/A

0.041

0.373

N/A

0.137

0.003

N/A

0.084

0.101

N/A

0.014

0.799

N/A

0.075

0.106

N/A

-0.022

0.712

N/A

0.058

0.176

N/A

0.162

0.001

N/A

11.3
(1.18)

0.228

<.0001

N/A

12.5
(1.15)

0.141

0.005

N/A

SE denotes standard error.
* P-values for continuous variables were derived from weighted t-tests (PROC SURVEYMEANS) while
P-values for binary variables were derived from weighted Wald Chi Square tests (PROC SURVEYFREQ).
Kolmogorov-Smirnov tests are only intended for continuous variables and thus were only reported for age.
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Table 10: Covariate balance, AEE weighted
Variable

Age
Sexual minority
Missing
Gender minority
Immigrated at or
before age 16
Missing
Immigration
related-stress at or
before age 16
Missing
Survivor of
residential school
Missing
Family member
attended residential
school
Missing

Measure

CPSAN=744

CPSA+
N=819

42.8
(0.47)
14.2
(2.55)
0.17
(0.17)
5.49
(1.92)
5.82
(1.41)
0.95
(0.61)

42.7
(0.35)
16.8
(1.31)
0.49
(0.24)
5.62
(0.81)
5.90
(0.83)
0.73
(0.30)

1.92
(1.02)

1.91
(0.49)

4.74
(1.08)
0.97
(0.70)
12.4
(1.97)

4.27
(0.71)
1.15
(0.40)
14.8
(1.24)

% (SE)

9.15
(2.33)

% (SE)

11.2
(1.92)

x̅ (SE)
% (SE)
% (SE)
% (SE)
% (SE)
% (SE)
% (SE)
% (SE)
% (SE)
% (SE)

Standardized
effect size
difference

P-value*

P-value
(KS-test)

-0.01

0.873

0.77

0.068

0.362

N/A

0.046

0.281

N/A

0.006

0.949

N/A

0.004

0.959

N/A

-0.026

0.747

N/A

0.000

0.993

N/A

-0.023

0.716

N/A

0.013

0.831

N/A

0.068

0.296

N/A

11.3
(1.18)

0.059

0.409

N/A

12.5
(1.15)

0.038

0.573

N/A

SE denotes standard error.
* P-values for continuous variables were derived from weighted t-tests (PROC SURVEYMEANS) while
P-values for binary variables were derived from weighted Wald Chi Square tests (PROC SURVEYFREQ).
Kolmogorov-Smirnov tests are only intended for continuous variables and thus were only reported for age.
CPSA- sample size differs post-weighting because weights are calculated based on similarity to the CPSA+
group; CPSA- women with higher odds of exposure are weighted heavier, resulting in a greater postweighting sample size.

Covariate balance within ethnoracial strata:
In order to ensure that the use of cohort PSs as opposed to stratum-specific PSs balanced
measured confounders across exposure groups within each ethnoracial group, weighted
and unweighted balance diagnostics were calculated for each stratum (see Appendix 6).
As for the total sample, the unweighted prevalence of sexual minorities was higher
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among the CPSA+ groups for Black African and white women (P=0.018, P<0.0001).
Similarly, the prevalence of gender minorities was significantly higher among “other”
women who experienced CPSA compared to those who did not (P=0.025). Other
imbalances in the unweighted data were related to CPSA+ women being younger among
Black African women (P=0.003) and CPSA+ women being more likely to immigrate in
childhood among Black Caribbean women (P=0.019). Gender identity, however, did not
allow for calculation of balance diagnostics for any Black women, as no CPSA+ Black
African women and no CPSA- Black Caribbean women were gender minorities.
Similarly, no CPSA- Black Caribbean women had immigration-related stress in
childhood. Because there was no heterogeneity across CPSA groups here prior to
weighting, GBM could not balance said heterogeneity with weighting, and thus these
stratum-specific instances of data insufficiency remained. Apart from these stratumspecific instances of homogeneity in the data, weighting successfully remedied all of the
measured imbalances in the unweighted data apart from that with respect to the age
distribution among Black African women. Specifically, CPSA+ Black African women
had a mean age of 39.8 while CPSA- Black African women had a mean age of 43.4.
Concerns related to absolute standard effect size difference
While the AEE weights successfully balanced all measured exposure group differences
in the total sample, and the majority of stratum-specific differences, one concern with the
given weights was the limited effect sizes of the propensity score covariates on CPSA in
the unweighted sample, as represented by the absolute standardized effect size difference
(Table 9). McCaffrey and colleagues have loosely defined any standardized effect size
difference greater than 0.20 to be a potentially problematic imbalance.213 The
standardized effect size differences observed in the unweighted sample were low relative
to this metric, with only the effects of sexual minority identity and family member
attendance at residential school exceeding 0.20. The limited observed differences in the
unweighted sample lead to limited potential for adjustment and thus affected the
interpretation of AEE estimates as detailed in section 4.4.1
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4.3 Descriptive Statistics
Exposure variables:
The burden of CPSA (and CPA/CSA respectively) in the sample was very high, with the
majority of women (62.7%) having some experience of physical or sexual abuse in
childhood (Table 11). Physical abuse was more prevalent than sexual abuse in the total
sample and within each ethnoracial group. Proportionally, CPSA experiences were
highest among Indigenous women (76.8%) and lowest among Black Caribbean women
(46.9%). This trend held for experiences of physical abuse and sexual abuse, respectively.
More than half (56.7%) of the sample experienced CPA, while 39.6% of the sample
experienced CSA. Notably, for all ethnoracial groups, CPA and CSA co-occurred more
frequently than they occurred independently, with overall an prevalence of co-occurrence
equal to 34.1%. When measuring mutually exclusive CPA and CSA, experiencing only
physical abuse was consistently more common than experiencing only sexual abuse. The
prevalence of co-occurrence and independent occurrence is important when considering
the validity of the sensitivity analyses, which attempt to disentangle the effects of CPA
and CSA (see 3.2.6 Sensitivity Analysis).
Outcome variables:
Similar to childhood experiences of trauma, the burden of physical and sexual abuse in
adulthood in the sample was very high. More than half of women (63.6%) had ever
experienced physical abuse in adulthood (Table 12). This proportion was higher among
women who experienced CPSA compared to those who did not (79.0% and 37.7%,
respectively). Just under half of women (45.8%) had ever experienced sexual abuse in
adulthood. Similarly, adult sexual abuse was more prevalent in the CPSA+ group than the
CPSA- group (56.7% and 28.6%, respectively). The level of sexual inactivity in the
sample was also high. In the total sample, and across exposure groups, approximately
half of women had not engaged in consensual sex in the past six months. Furthermore,
among women who had engaged in consensual sex, levels of perceived sexual
relationship power were relatively high overall (x̅ = 3.30 on a 1-4 scale) and high across
the CPSA- and CPSA+ groups. These results cannot be taken as representative of the
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level of sexual relationship power among the sexually inactive women in the sample. The
sample mean score on the HIV stigma scale (which ranges from 0-40) was 22.8, with
higher scores indicating higher HIV stigma. This measure indicated mid-level HIV
stigma for the group as a whole. Exposure group means did not appear to differ
meaningfully from the overall mean. The same was true for perceived social support. The
sample mean score on the social support scale was 14.2 on a scale from 4-20, which may
denote mid-to-high levels of perceived social support.
Table 11: Unweighted prevalence of childhood physical or sexual abuse and associated
variables by ethnoracial group

Exposure
% (SE)
CPSA
CPA
CSA
CPA & CSA
CPA only
CSA only

Total

Indigenous

Black
African

Black
Caribbean

White

Other

N=1307
62.7 (1.34)
56.7 (1.37)
40.1 (1.37)
34.1 (1.32)
22.0 (1.16)
5.98 (0.66)

N=289
76.8 (2.49)
70.8 (2.68)
60.9 (2.92)
54.6 (2.98)
15.4 (2.16)
6.07 (1.43)

N=302
50.0 (2.88)
47.0 (2.88)
17.8 (2.22)
14.8 (2.06)
31.5 (2.70)
3.02 (0.99)

N=64
46.9 (6.29)
45.3 (6.27)
14.1 (4.38)
12.5 (4.17)
32.8 (5.92)
1.56 (1.56)

N=549
62.3 (2.07)
54.8 (2.13)
43.9 (2.13)
36.3 (2.06)
18.2 (1.65)
7.52 (1.13)

N=103
71.8 (4.45)
63.1 (4.78)
44.6 (4.97)
35.6 (4.79)
26.7 (4.43)
8.91 (2.85)

SE denotes standard error. CPSA= childhood physical or sexual abuse, CPA= childhood physical abuse,
CSA= childhood sexual abuse, CPA & CSA = co-occurrence of childhood physical and sexual abuse, CPA
only= occurrence of childhood physical abuse without sexual abuse, CSA only= occurrence of childhood
sexual abuse without physical abuse.

Table 12: Unweighted distribution of outcomes by exposure status

Outcome

Total

CPSA-

CPSA+

N=1307

N=488

N=819

Physical abuse in adulthood

% (SE)

63.6 (1.33)

37.7 (2.20)

79.0 (1.43)

Sexual abuse in adulthood

% (SE)

46.2 (1.39)

28.6 (2.05)

56.7 (1.74)

Sexual inactivity

% (SE)

54.4 (1.51)

54.7 (2.43)

54.1 (1.93)

Sexual relationship power (scale 1-4)

x̅ (SE)

3.30 (0.03)

3.39 (0.04)

3.25 (0.03)

HIV Stigma (scale 0-40)

x̅ (SE)

22.9 (0.23)

22.3 (0.36)

23.2 (0.29)

Social support (scale 4-20)

x̅ (SE)

14.2 (0.13)

14.5 (0.20)

14.0 (0.16)

SE denotes standard error. Sample sizes for Sexual Relationship Power are reduced due to survey design.
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4.4 Effect of CPSA on Disclosure Barriers
4.4.1

Interpretation of AEE

The AEE weighting scheme of the present analysis was meant to allow measures of effect
to be interpreted from a counterfactual perspective. For binary outcomes, prevalence
ratios and their robust 95% confidence intervals were calculated. An AEE weighted
prevalence ratio (PR) can be interpreted as the effect of an exposure on a given outcome
among those who actually experienced the exposure. For instance, “women who
experienced CPSA had 1.96 (95% CI 1.72, 2.25) times greater risk of physical abuse in
adulthood than they would have, had CPSA never occurred”. Similarly, for continuous
outcomes, effects were estimated using regression coefficients representing the adjusted
difference in mean outcome level for the CPSA+ group as compared to the CPSA- group.
For instance, “women who experienced CPSA had scores on the 40-point HIV stigma
scale that were 1.34 (95% CI 0.35, 2.40) points higher than they would have been, had
CPSA never occurred”. For the current analyses, AEE estimates were intended to
represent causal processes. However, the limited effects of propensity score covariates
and resulting limited potential for adjustment resulted in fewer than expected differences
between unweighted and weighted effect estimates. For this reason, among other
limitations such as the potential for unmeasured confounding, it is cautioned that AEE
estimates should be interpreted as adjusted risk estimates with CPSA+ women as the
referent group, rather than causal effects. This limitation is discussed further in Chapter
5.2.

4.4.2

Analytic Results

Objectives 1 through 3 are addressed by outcome within these analytic results. Objective
1 is addressed by presenting the effect of CPSA on outcomes for the group as a whole.
Objective 2 to compare the above effect across ethnoracial groups is then addressed by
presenting effect estimates stratified by ethnoracial group, then further effect estimates
comparing the groups with white women as the referent group. Finally, a sensitivity
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analysis is undertaken by repeating steps taken in Objectives 1 and 2 with different
exposure variables: CPA and CSA.
Physical abuse in adulthood
For the total sample as per Objective 1, CPSA had a positive effect on physical abuse in
adulthood, with women who experienced CPSA having 1.97 (95% CI 1.72, 2.25) times
greater risk of physical abuse attributable to their CPSA history after weighting for
measured confounders. Per Objective 2, the effect of CPSA on physical abuse persisted
within each ethnoracial group, both before and after weighting (Table 13). As reflected in
Figure 4 (a), the robust 95% confidence intervals for Black Caribbean women, as well as
for “other” women were relatively imprecise compared to other groups. Black Caribbean
women made up the smallest ethnoracial group under consideration (n=64), and thus
estimates for this group were relatively imprecise for all outcomes. Similarly, the mixed
ethnoracial group was the second smallest group under consideration (n=104) and thus
some imprecision was expected, however, the wide confidence intervals for this group
were likely also impacted by within-group ethnoracial heterogeneity. Interestingly,
despite the relative imprecision for the effect of CPSA on physical abuse among Black
Caribbean women, comparisons of prevalence ratios across ethnoracial groups revealed
that the effect was stronger among Black Caribbean women as compared to white women
(PR=1.12 95% CI 1.12, 4.60).
The sensitivity analyses for this outcome revealed some heterogeneity of effect; it
appeared that the effects of CPSA on physical abuse were more broadly attributable to
CPA than CSA in the weighted analysis. Both CPA and CSA had overall and stratumspecific effects on adult physical abuse in the unweighted sample, however, after
weighting, the effect of CSA on physical abuse was restricted to white women (Appendix
7). Conversely, the weighted effect of CPA on physical abuse persisted within each
ethnoracial group, and even appeared to differ significantly across ethnoracial groups. As
for CPSA, the effect of CPA on physical abuse was considerably stronger for Black
Caribbean women when compared to white women (PR=3.61 95% CI 1.58, 8.24).
However, in this case, the same was true for Black African women (PR=1.65 95% CI
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1.11, 2.46). Thus, for physical abuse in adulthood, CPA appeared to drive the observed
effect of CPSA, and when examined independently the CPA analysis revealed additional
nuance across ethnoracial groups.
Sexual abuse in adulthood
Similar to physical abuse in adulthood, CPSA increased risk for sexual abuse in
adulthood among CPSA+ women (weighted PR=1.80 95% CI 1.51, 2.13). Furthermore,
CPSA was found to increase risk of sexual abuse among all CPSA+ women outside of
Black Caribbean women (Table 13). Tests for effect modification across ethnoracial
groups did not find differences in the effect of CPSA on sexual abuse for any group when
compared to white women. It is possible that no effect was detected among Black
Caribbean women based on the small sample size for this group, allowing less power to
detect an effect if one was truly present. As expected, the confidence interval for this
estimate was wider relative to other ethnoracial groups (Figure 4 b).
As with the sensitivity analyses for adult physical abuse, it was found that the effect of
CPSA on adult sexual abuse may have been driven more by CSA than CPA. Both CSA
and CPA had an effect on adult sexual abuse prior to weighting, however, after
weighting, the effect of CPA on adult physical abuse was much lower in magnitude than
the weighted CPSA effect. The CPA confidence interval, while small, approached the
null (PR=1.20, 95% CI 1.02, 1.43). Conversely, the effect of CSA on adult sexual abuse
was more similar to the CPSA effect both overall (CSA PR=1.63, 95% CI 1.38, 1.93) and
within ethnoracial groups (Appendix 7). Furthermore, like CPSA, neither CPA or CSA
analyses revealed any effect modification across ethnoracial groups for adult sexual
abuse.
Sexual inactivity and sexual relationship power
In order to understand the effect of CPSA on sexual relationship power (SRP), it was first
necessary to examine its effect on sexual inactivity given that SRP was only asked of
sexually active women. CPSA did not appear to have an effect on sexual inactivity for the
overall sample (PR=1.02, 95% CI 0.90, 1.16) or within ethnoracial groups (Table 13).
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Knowing that the sexually active women who answered the SRP items had comparable
histories of CPSA to those not asked the SRP items, it was possible to proceed in
interpreting the effect of CPSA on SRP. Overall, women who experienced CPSA had
lower scores on the SRP scale than they would have had CPSA never occurred, after
adjusting for confounding. The estimated difference in scores attributable to CPSA was 0.13 (95% CI -0.23, -0.02). On the SRP scale, which ranged from 1-4, this meant that
women who experienced CPSA had an estimated score of 3.25 (95% CI 3.19, 3.31);
according to the scale’s original unvalidated cut-points, this would still be considered as
having high sexual relationship power. It is important to note that, because of the survey
design which restricted the SRPS to sexually active women, sample sizes for this
outcome were reduced overall, but especially within ethnoracial groups. When
differences in SRPS scores attributable to CPSA were estimated within ethnoracial
groups, confidence intervals were fairly wide and only indicated a significant CPSA
effect among white women (Figure 5, Table 13). However, when compared to other
ethnoracial groups no differences were observed.
The sensitivity analyses for this outcome revealed some further nuance, particularly with
respect to the effect of CSA on SRP among white women. Neither CPA nor CSA had an
overall effect on SRP after weighting (CPA β=-0.03 95% CI -0.14, 0.09; CSA β =-0.07
95% CI -0.26, 0.11). However, the weighted effect of CSA among CSA+ white women
was relatively large (β=-0.41 95% CI -0.57, -0.24), such that white women who
experienced CSA had lower SRP, attributable to CSA. Furthermore, the magnitude of
effect was greater among white women compared to both Indigenous and Black African
women (Appendix 7). Thus, the effect of CPSA on SRP was more broadly similar to the
effect of CSA, and the CSA analysis revealed some further variability across ethnoracial
groups.
HIV stigma
For the total sample, women who experienced CPSA had HIV stigma scores 1.37 (95%
CI 0.35, 2.40) points higher than they would have had, had CPSA not occurred. On the
HIV stigma scale, which ranged from 0-40, this meant that CPSA+ women had an
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estimated score of 23.5 (95% CI 23.0, 24.1). While no reference scores for this scale were
identified, this appears to indicate mid-range HIV stigma. Interestingly, among Black
African women CPSA had a substantial effect on HIV stigma; Black African women who
experienced CPSA had HIV stigma scores 3.93 (95% CI 2.16, 5.70) points higher than
would be expected had CPSA not occurred (Table 13, Figure 6). This effect was 2.52
(95% CI 0.19, 4.86) points greater than that observed among white women.
Both CPA and CSA independently had overall effects on HIV stigma in the weighted
sample (CPA β=1.83 95% CI 0.58, 3.08; CSA β=1.33 95% CI 0.19, 2.48). These
estimated differences were broadly consistent with the result for CPSA which indicated
that CPSA+ women experienced slightly elevated HIV stigma because of their CPSA
experiences. However, in the CPA analysis, the effect among Black African women
which was observed for CPSA appeared to be attenuated; HIV stigma was only 1.40
(95% CI 0.44, 5.92) points greater because of CPA (Appendix 7). Furthermore, while
CSA had an effect among Black African women prior to weighting (β=2.83 95% CI 0.56,
5.09), the effect could not be attributed to CSA after weighting (β=2.34 95% CI -0.21,
4.90). It is possible that the construct driving the relationship between CPSA and HIV
stigma was not the presence of either CPA or CSA alone, but their co-occurrence, which
would be controlled for in the sensitivity analyses but not in the overall analysis where
the exposure was child physical or sexual abuse. It is also possible that because CPA and
CSA independently elevated HIV stigma among white women (CPA β=2.09 95% CI
0.24, 3.94; CSA β=1.75 95% CI 0.08, 3.41), their effects among Black African women
were more comparable.
Social support
CPSA had no overall effect on perceived social support among women who experienced
CPSA. In particular, a difference of -0.33 (95% CI -0.92, 0.24) points on the MOS-SSS
scale was attributed to CPSA, though the confidence interval crossed the null value of 1.
In the overall sample the estimated mean level of social support for women who
experienced CPSA+ was 14.0 (95% CI 13.7, 14.4) on a scale from 4-20, a value not
substantially different from mean level observed in the original 4-item MOS-SSS
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validation study (x̅ =14.88, standard deviation=3.97). The mean observed from the
validation study came from a sample of 330 low-income American mothers receiving
services for children with emotional or behavioural problems.230 When considering
stratum-specific estimates, among white women only a difference of -1.04 (95% CI -2.06,
-0.02) points was attributable to CPSA (Table 13, Figure 7). This effect was not
significantly different when compared to the effects among other ethnoracial groups.
The results of both sensitivity analyses were broadly similar to those from the main
analysis. Neither CPA nor CSA had an independent effect on perceived social support
among their exposed populations (CPA β=-0.43 95% CI -1.09, 0.21; CSA β=-0.31 95%
CI -1.01, 0.40). Within ethnoracial strata, CSA had no effect on perceived social support,
while CPA was linked to reduced social support among Black African women (β=-1.35
95% CI -2.58, -0.11) and women from the other ethnoracial group (β=-2.72 95% CI 4.88, -0.56) (Appendix 7). When the CPA effects were compared across strata, “other”
women experienced -2.81 (95% CI -5.18, -0.44) fewer points attributable to CPA relative
to white women. However, given the within-group heterogeneity of this stratum, the
interpretability of this potential difference was compromised. Thus, overall the observed
CPA and CSA effects did not diverge excessively from those observed in the main
analysis.
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Table 13: Effect of CPSA on barriers to HIV disclosure among women who experienced
CPSA

Social
support ±

HIV
Stigma ±

Sexual
relationship
power ±

Sexual
inactivity ¶

Adult
sexual
abuse ¶

Adult
physical
abuse ¶

Outcome

Ethnoracial group
White
Indigenous
Black African
Black Caribbean
Other
White
Indigenous
Black African
Black Caribbean
Other
White
Indigenous
Black African
Black Caribbean
Other
White
Indigenous
Black African
Black Caribbean
Other
White
Indigenous
Black African
Black Caribbean
Other
White
Indigenous
Black African
Black Caribbean
Other

Stratum-specific estimates
Unweighted
Weighted
1.72 (1.47, 2.03)
1.56 (1.31, 1.85)
2.34 (1.73, 3.18)
2.18 (1.56, 3.05)
2.10 (1.62, 3.18)
2.11 (1.62, 2.74)
3.12 (1.64, 5.93)
3.53 (1.78, 7.01)
2.69 (1.47, 4.93)
2.49 (1.27, 4.89)
1.83 (1.46, 2.28)
1.56 (1.23, 1.99)
2.52 (1.62, 3.91)
2.02 (1.27, 3.20)
1.77 (1.32, 2.37)
1.75 (1.30, 2.36)
1.98 (0.97, 4.06)
1.69 (0.79, 3.61)
2.74 (1.31, 5.75)
2.90 (1.32, 6.38)
1.00 (0.85, 1.19)
1.05 (0.87, 1.28)
0.99 (0.75, 1.30)
1.05 (0.76, 1.46)
1.10 (0.86, 1.41)
1.10 (0.86, 1.42)
0.93 (0.61, 1.44)
0.91 (0.59, 1.40)
0.68 (0.48, 0.95)
0.69 (0.47, 1.02)
-0.19 (-0.35, -0.04)
-0.17 (-0.33, -0.01)
-0.13 (-0.39, 0.13)
-0.06 (-0.32, 0.21)
-0.12 (-0.30, 0.06)
-0.15 (-0.33, 0.04)
0.04 (-0.34, 0.42)
-0.02 (-0.41, 0.36)
-0.33 (-0.70, 0.05)
-0.32 (-0.66, 0.02)
1.90 (0.50, 3.30)
1.41 (-0.12, 2.93)
0.07 (-2.25, 2.39)
-0.80 (-3.39, 1.78)
3.76 (2.05, 5.48)
3.93 (2.16, 5.70)
-0.54 (-3.93, 2.86)
-0.27 (-3.56, 3.02)
-0.25 (-3.31, 2.81)
0.53 (-2.39, 3.45)
-1.36 (-2.11, -0.61)
-1.04 (-2.06, -0.02)
-0.36 (-1.43, 0.70)
0.39 (-0.91, 1.69)
-0.36 (-1.35, 0.62)
-0.31 (-1.32, 0.70)
0.90 (-1.21, 3.01)
0.82 (-1.19, 2.83)
-2.33 (-4.32, -0.35)
-2.83 (-4.70, -0.96)

Effect modification
REF
1.40 (0.96, 2.04)
1.35 (0.99, 1.85)
2.27 (1.12, 4.60)
1.60 (0.80, 3.21)
REF
1.29 (0.77, 2.18)
1.12 (0.76, 1.65)
1.08 (0.49, 2.40)
1.86 (0.81, 4.23)
REF
1.00 (0.68, 1.46)
1.05 (0.76, 1.44)
0.86 (0.54, 1.38)
0.66 (0.43, 1.02)
REF
0.12 (-0.19, 0.42)
0.02 (-0.22, 0.27)
0.15 (-0.27, 0.56)
-0.15 (-0.53, 0.23)
REF
-2.21 (-5.21, 0.79)
2.52 (0.19, 4.86)
-1.68 (-5.31, 1.95)
-0.88 (-4.17, 2.42)
REF
1.43 (-0.22, 3.08)
0.72 (-0.71, 2.16)
1.86 (-0.39, 4.11)
-1.79 (-3.92, 0.34)

¶ Indicates binary outcome variables. Effect estimates are prevalence ratios and their robust 95%
confidence intervals. Shaded cells represent those where the confidence interval does not cross the null
value of 1.
± Indicates continuous outcome variables. Effect estimates are coefficients from linear regression (i.e.
estimated difference in mean outcome for CPSA+ compared to CPSA-) and their 95% confidence intervals.
Shaded cells represent those where the confidence interval does not cross the null value of 0.
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Figure 4: (a) Effect of CPSA on physical abuse and (b) sexual abuse by
ethnoracial group
Points represent estimated prevalence ratios for the effect of CPSA, the vertical axis at x=1 represents the
null value, and stems represent robust 95% confidence intervals.
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Figure 5: Effect of CPSA on sexual relationship power by ethnoracial group
Bars represent estimated mean outcome level by exposure status for the AEE weighted sample, while stems
represent robust 95% confidence intervals.
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Figure 6: Effect of CPSA on HIV stigma by ethnoracial group
Bars represent estimated mean outcome level by exposure status for the AEE weighted sample, while stems
represent robust 95% confidence intervals.
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Figure 7: Effect of CPSA on social support by ethnoracial group
Bars represent estimated mean outcome level by exposure status for the AEE weighted sample, while stems
represent robust 95% confidence intervals.
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Chapter 5

5

Discussion and Implications

This chapter will reiterate the main descriptive and analytic findings, discussing them in
the context of the literature and evaluating them in light of the study’s strengths and
limitations. Extensions for future research will be identified, and implications for policy
and practice will be described.

5.1 Main Findings
5.1.1

Summary

This thesis adapted a novel theoretical model based on eco-social theory and
intersectionality which contextualizes the causes and consequences of CPSA among
women with HIV in Canada. The framework relayed the importance of unpacking culture
as related to child abuse, described how intersecting systems of oppression operate at the
four eco-social levels to produce societies, communities, families, and individuals
vulnerable to child abuse, and introduced colonialism as an axis of oppression affecting
Indigenous women with HIV in Canada. In accordance with this model, it was of interest
to determine whether child maltreatment affected barriers to HIV status disclosure among
women with HIV after controlling for eco-social risk, and to determine whether these
relationships differed across intersectional ethnoracial groups. Results showed that CPSA
appeared to generate barriers to HIV disclosure, specifically increasing prevalence of
both physical and sexual abuse, and increasing levels of HIV stigma. Furthermore,
subgroup analysis showed that the effect of CPSA on some outcomes did vary across the
intersectional ethnoracial groups; CPSA significantly decreased sexual relationship
power among white women only, while increasing HIV stigma among only Black
African women. A sensitivity analysis found that CPA may account for effects of CPSA
on physical abuse in adulthood, while CSA may account for effects on sexual abuse in
adulthood, and sexual relationship power. In summary, women with HIV who
experienced CPSA did appear to face greater barriers to partner disclosure than those
without such experiences, and this relationship may be of a causal nature. The
relationship between CPSA and some barriers may not be homogeneous across
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ethnoracial groups, and thus intersectional perspectives should be of great importance for
research, intervention planning, and policy making in the future.

5.1.2

Descriptive Findings

Burden of Risk for CPSA
CPSA has been theorized to have causes at the level of the individual child, their family,
their community, and their society. As research has further disentangled the causes of
CPSA, Belsky’s original eco-social model has been adapted and refined, resulting in
several theoretical principles and broad risk factors for CPSA at each level.136,142 These
principles were applied in the current analysis when selecting propensity score covariates.
As expected, the prevalence of all CPSA risk factors was elevated among those who
reported experiencing CPSA, though not all differences reached statistical significance.
For example, the prevalence of sexual minority and gender minority women among those
who experienced CPSA was significantly greater than that among women who did not
experience CPSA (16.8% vs. 6.78% sexual minorities, 5.62% vs. 2.46% gender
minorities). These, and other observed disparities across exposure groups (e.g. with
respect to stress-related immigration in childhood and family residential school
attendance) illustrate the life circumstances of these women that may have preceded both
child maltreatment and HIV diagnosis. While the CHIWOS sample is not populationbased and exposure-stratified prevalence estimates for CPSA risk factors cannot be
interpreted as causal, the fact that the retrospective burden of risk for CPSA was
consistently greater among women who experienced CPSA lends support to the proposed
theoretical model and to the analysis as a whole.

5.1.3

Analytic Findings

Revictimization
Arguably the most important finding from this analysis was the rate of revictimization
from childhood to adulthood, in terms of both adult physical abuse and sexual abuse.
Women who experienced CPSA were consistently at higher risk for experiencing further
violence in adulthood. This relationship was expected, and contributes to the body of
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evidence reporting not only the descriptive rate of revictimization, but controlled risk
estimates. The relationship between CPSA (and CPA/CSA independently) and further
abuse in adulthood among the general population has been documented extensively in
longitudinal6,231 and meta-analytic studies.7 However, revictimization has more
frequently been studied as a risk factor for HIV (eg. 232,233) than a construct generating
further risk among people with HIV. Thus, the present study contributes new evidence
suggesting that the relationship between CPSA and violence in adulthood persists among
women with HIV in ways that may further complicate their lives and health.
Comparing the magnitude of the relationship between childhood violence and later
revictimization for women with HIV and the general population presents methodological
difficulties. Population-based studies of women with HIV are scant and likely underrepresent marginalized women, and thus convenience and quota samples become the
most optimal method for studying risk within the population of women with HIV.
However, the lack of a population-based sampling frame complicates comparisons to the
larger population of women in Canada. On the basis of measurement and study design
(though not geography or ethnoracial composition), the sample most comparable to
CHIWOS may be that of Simoni and Ng who produced descriptive estimates of
revictimization among a community-recruited sample of 230 women with HIV in New
York City.128 As with CHIWOS, prevalence estimates for CPSA (50%), adult physical
abuse (63%), and adult sexual abuse (46%) were alarmingly high. Furthermore, the study
found a zero-order correlation of 0.50 (p<0.01) between CPSA and physical or sexual
abuse in adulthood, demonstrating a substantial amount of recurring abuse. Community
samples like CHIWOS and Simoni and Ng demonstrate the high burden of abuse and
revictimization among women with HIV. When considered alongside studies implicating
revictimization as a risk factor for HIV in the first place,232,233 one can conclude that
revictimization, regardless of the magnitude of risk compared to the general population,
is an issue among women with HIV. While risk comparisons to the general population or
men with HIV may be interesting, they are not necessary in order to justify interventions
to reduce risk for violence against women with HIV, based on the high levels of violence
alone and the unique socio-legal implications that violence generates for this population.
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The present analysis also demonstrated the effect of CPSA on adult physical and sexual
abuse largely persisting within each ethnoracial group. The single exception to this
statement was the effect of CPSA on adult sexual abuse among Black Caribbean women,
where the effect was in the positive direction but the robust 95% confidence interval
crossed 1. Black Caribbean women constituted the smallest ethnoracial group under
consideration (n=64), and consequently estimates for this group were relatively imprecise
across all outcomes. The lack of observed relationship between CPSA and adult sexual
abuse for this group should not be interpreted as a lack of grounds for intervention among
this group, but rather as a potential type II error which warrants further investigation.
This point is bolstered by the observed relationships between CPSA and abuse in
adulthood across all other ethnoracial groups.
Another important result reflected in the main CPSA analysis as well as the CPA
sensitivity analysis was that the magnitude of effect for childhood maltreatment on adult
physical abuse was greater for Black women when compared to white women. This
phenomenon was especially prominent among Black Caribbean women who experienced
CPA; for this group, CPA multiplied risk of adult physical abuse by 3.61 (95% CI 1.58,
8.24) relative to white women. Published rates of physical and/or sexual revictimization
disaggregated by ethnoracial groups for comparison were difficult to locate. Two recent
studies have found that children and adolescents who identified as members of
ethnoracial minority groups were more likely to report sexual revictimization than their
white peers,234,235 however, further research is needed to examine revictimization at the
intersection of race, gender, and class. There is some evidence to suggest that that women
of colour are disproportionately affected by violence.236 However, when interpreting
ethnoracial inequities and especially when planning interventions, it is important to be
cognisant of the social and structural factors that may impact vulnerability to and
reporting of violence against women of colour. The results of the present study provide
further justification for developing anti-violence interventions that are appropriate and
accessible for women of colour with HIV.
Sexual Relationship Power and Sexual Inactivity
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This analysis found that, overall, women who experienced CPSA had lower sexual
relationship power than they would have had CPSA not occurred. When broken down by
ethnoracial group, it was revealed that this overall effect was primarily attributable to the
strong effect among white women. Furthermore, the adjusted mean level of sexual
relationship power possessed by women who experienced CPSA was still within the
range of high sexual relationship power, as dictated by the scale’s unvalidated tertile cutpoints. It was expected that this effect would be larger in magnitude and would persist
across ethnoracial groups, however, given the inherent limitations due to survey design
and measurement, this result was not entirely surprising. Sample sizes for the SRPS items
within ethnoracial groups were reduced compared those of other outcomes, lowering the
probability of observing the effect of CPSA if it was truly present.
During Wave 2 of the survey, the SRPS was only asked of women who reported
engaging in consensual sexual activity within the past 6 months. While the scale was
developed and validated among women with male sexual partners, it is possible that
sexual relationship power as a construct (or a related construct) may exist outside the
confines of a recent sexual encounter. For instance, the knowledge that one has the
tendency to become involved in controlling relationships, sexual or otherwise, may
prompt the conscious decision to avoid sexual relationships. This may be especially true
for women with HIV; a manipulative sexual partner can use one’s HIV status as a point
of power. Furthermore, CPSA may affect this potential sexual relationship power and
decision making just as it may affect enacted sexual relationship power. However,
because it is unknown whether the SRPS could measure potential sexual relationship
power, and thus sexual relationship power was only measured among sexually active
women, the relationship between CPSA and sexual agency cannot fully be described in
the present analysis.
In an effort to rule out or rule in the posited relationship between CPSA and consensual
sex, we measured the effect of CPSA on sexual inactivity over the past 6 months, and
found no statistically significant effects. This provided some indication that CPSA may
affect women who are sexually inactive in the same way as it does women who are
sexually active, though we cannot know this for sure. Furthermore, because the sub-
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sample who were sexually active and completed the SRPS consisted of only 486 of
n=1307 women, effect estimates for the SRPS (especially within under-represented
ethnoracial groups) were relatively imprecise. The fact that the only confidence interval
that does not cross zero was among white women, the largest ethnoracial group in the
sample, lends further support to the theory that CPSA driven differences in SRP (or lack
thereof) could be attributable to a lack of precision. Some imprecision relative to other
outcomes was expected, however, the SRPS outcome remained a part of the analysis plan
on the basis of its importance as a risk factor for HIV non-disclosure and as an effort to
encourage other researchers to incorporate SRP as not just a risk factor for HIV, but as a
potential cause of further vulnerability among people with HIV. To our knowledge, no
other studies have used specific measures of sexual agency or sexual relationship power
in relation to CPSA or HIV disclosure, rather opting to measure characteristics of
relationships with power imbalances. Because sexual relationship power is a construct
that aggregates across multiple controlling characteristics and is already in use within the
HIV literature, it is our hope that this concept can be further refined and applied more
widely in the future.
HIV Stigma
An unexpected finding from this analysis was the effect of CPSA on HIV stigma being
limited to Black African women. The relationship between CPSA and HIV stigma was
examined on the basis of HIV stigma’s ability to impact HIV disclosure, and the ability
of CPSA to engender perceived and internalized stigma related to the abuse. Furthermore,
in the context of HIV, stigmas are often co-occurring and not necessarily independent
(for example, stigmatizing attitudes about AIDS and people who inject drugs tend to cooccur,237 and internalized HIV stigma can be related to internalized blame about
experiencing abuse).238 Furthermore, dimensions of multiple stigmas can vary across
ethnoracial groups, for example, in one study negative attitudes towards people who
inject drugs predicted AIDS stigma among Black participants while negative attitudes
towards gay people predicted AIDS stigma among white participants.237 On the basis of
the present analysis, future research should explore what drives the relationship between
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CPSA and HIV stigma, whether it be cultural differences in measurement, attitudes, or
unmeasured confounders.
Wright’s abbreviated HIV stigma scale measured stigma across four dimensions:
personalized stigma, disclosure, negative self-image, and public attitudes – all of which
have been associated with HIV disclosure in previous research using various measures. In
investigating the unique relationship between CPSA and HIV stigma among Black
African women, we should consider whether the effect is driven by HIV stigma in the
broadest sense as captured in the given measure, or by certain dimensions within the
given measure. The full HIV stigma scale was chosen based on existing evidence linking
multiple dimensions of HIV stigma to partner disclosure, and the desire to examine
multiple barriers to disclosure rather than the dimensionality of a single barrier. The latter
option would have necessitated three additional study outcomes, which could potentially
overwhelm results pertinent to other important barriers to HIV disclosure. However, in
validation studies, both the full and abbreviated HIV stigma scales have demonstrated
differential relationships between the subscales and construct validity outcomes such as
perceived social support.113,229 Because HIV stigma as measured is truly a
multidimensional construct, further research should explore the relationship between
CPSA and multidimensional HIV stigma across ethnoracial groups.
Intersectionality theory helps us to understand that interlocking matrices of domination
affect the experiences of people as they sit at the intersections of multiple social
positions. A qualitative study of women with HIV in Ontario has explored the unique
experiences of Black women with HIV produced by the intersection of sexism, racism,
and HIV stigma.238 One Black African woman highlighted the enacted stigma she had
experienced while receiving HIV services, stating “I need you to listen me and to help
me. But you’re thinking ‘you come from Africa you don’t understand’”. This intersection
of HIV stigma, sexism, and racial discrimination against Black African (and Caribbean)
women and its effect on lived experiences has been explored in qualitative and
quantitative research in North America.238–241 However, it is less clear how experiences
of CPSA may fit into this picture.

93

While no studies specific to experiences of CPSA and HIV stigma among Black African
women in North America were identified, the narratives of Black African women who
experienced CPSA may provide a starting point for further inquiry among women with
HIV. One qualitative study of African American women who were survivors of CSA
highlighted how children often blame themselves for their own abuse.242 Through “truthtelling”, or reaching out to others who believed and validated their experiences, some
women were able to find greater self-acceptance. This pattern is common among
survivors of child abuse more generally.243 Among women with HIV, it is possible that
internalized blame about CPSA could be a component of internalized HIV stigma,
especially if the women perceive the two to be related. An aspect of this cycle of
internalization and truth-telling that may be unique to the intersection of anti-Black
racism and sexism is the pressure on Black CSA survivors to avoid disclosing their
abuse. In the same qualitative CSA study, one participant described hearing other women
express the idea that Black women who experienced abuse at the hands of Black men
should remain silent so as not to contribute to a legal system which is already pitted
against Black men.242 In addition to suppressing CSA disclosure, this pressure may close
women off from community support and self-acceptance. Thus, it is possible that barriers
to CPSA disclosure may mediate the relationship between CPSA and internalized stigma
related to abuse and HIV. However, this hypothesis results from piecing together CPSA
research on the intersections of gender and ethnoracial group with HIV research that is
not specific to CPSA. Further research should explore lived experiences at this particular
intersection.
Social Support
The effect of CPSA on perceived social support appeared to be negligible in the present
study. The weighted mean level of social support reported by women who experienced
CPSA was comparable to both the estimated mean level had those same women not
experienced CPSA, as well as to the average social support observed in the abbreviated
MOS-SSS validation study.230 Similar to the measure of HIV stigma, the abbreviated
MOS-SSS captures four dimensions of perceived social support: emotional-informational
support, tangible support, affectionate support, and positive social interaction.119,230 The
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literature review provided some indication that perceived or anticipated social support
was most salient to partner disclosure, such that women who felt that their partners would
support them regardless of their HIV status were empowered to disclose, while women
who were doubtful or unsure of how their partner would react were less likely to disclose.
While this was not the exact construct measured by the MOS-SSS, the two share some
overlapping dimensions such as love and acceptance. The most significant difference
between the two was that social support from sexual partners was most relevant to partner
disclosure, while the MOS-SSS measured global social support from no target in
particular. This limitation should be noted when considering the implications of these
results.
The lack of observed relationship between CPSA and perceived social support may have
been attributable to construct multidimensionality, or the two may simply not be related.
While the link between anticipated social support and HIV non-disclosure has been well
developed in the literature, that between CPSA and later perceived social support has
been under-researched among the general population and, to our knowledge, not
explicitly studied among people with HIV. The outcome was included based on its
relationship with HIV non-disclosure along with the rationalization that reduced social
support may be one of the many downstream consequences of CPSA. Additional
qualitative research should investigate whether and how CPSA may play into anticipated
social support just as such research has shed light on the relationship between social
support and disclosure. Furthermore, as qualitative research has identified anticipated
HIV-related social support as a construct of interest in the study of HIV disclosure, a
corresponding quantitative measure of the construct should be developed in order to
further investigate its relationships with both CPSA and partner disclosure.

5.1.4

Sensitivity Analysis

The planned sensitivity analyses revealed some heterogeneity in the observed effects of
CPA as compared to CSA. In particular, the relationships between CPSA and adult
physical abuse bore more similarity to the effects of CPA than CSA, while those between
CPSA and adult sexual abuse, as well as sexual relationship power appeared to be driven
by CSA. Furthermore, comparing the main analysis to the sensitivity analyses for the
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HIV stigma outcome raised the question of whether the co-occurrence of CPA and CSA
may have driven the observed effects. The observed heterogeneity according to the type
of abuse suggested that the sensitivity analyses were valuable additions to the study, and
that they may offer direction for future research. The segregation of effect such that
physical abuse more consistently predicted physical revictimization and sexual abuse
more consistently predicted adverse sexual experiences in adulthood was unexpected, but
not unreasonable. Furthermore, the propensity score model which allowed for the
collapsing of multiple confounders may have been an optimal way to control for the
effect of a covariate that is highly collinear to the exposure (i.e. controlling CSA when
studying CPA). However, it is acknowledged that the outcome analysis was unable to
definitively account for variability in the original propensity score model, and thus the
potential for misestimation exists as with traditional regression models. Future studies
should further explore the ability of propensity score models to collapse multiple
covariates in order to avoid multicollinearity issues; given the high frequency of cooccurring abuse, accurately estimated propensity score models may be ideally suited to
this problem.
Also related to abuse co-occurrence, the findings related to HIV stigma and the potential
interactivity of multiple types of abuse presented thought provoking ideas novel to the
current study. A growing body of literature has addressed the consequences of cooccurring types of abuse, termed “poly-victimization”.244 When studied as an antecedent
to mental health conditions and trauma symptomology in childhood, poly-victimization
has been found to almost completely eclipse single-type victimizations as a
predictor.245,246 Recent findings from poly-victimization research along with the results of
the sensitivity analyses suggest that future research should pay attention to the potential
for divergent effects by type of child abuse, as well as the potential synergistic effects of
multiple types of adverse childhood experiences.

5.1.5

Eco-Social Intersectionality

In fulfillment of Objective 1, this thesis produced a novel theoretical model to
contextualize the relationship between CPSA and HIV disclosure among women with
HIV in Canada. This model paired intersectionality with eco-social theory to understand
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vulnerability to CPSA at multiple levels, and at the intersection of gender, HIV status,
and ethnoracial group. The model illustrated how systemic oppression drives inequalities,
acknowledged culture as context rather than a cause of CPSA, described the effects of
colonialism and intergenerational trauma on Indigenous women, and integrated all of
these factors in the design of a quantitative analysis. While eco-social theory and
intersectionality have been considered jointly in the past,168 this model extended the
theories to incorporate novel concepts vital to the population at hand. Specifically, the
determinants of CPSA for Indigenous women are known to be qualitatively different
from populations that have not experienced colonial disruption of culture and family. For
this reason, it was important to not only be conscious of potential effect modification
across ethnoracial groups, but to include culturally specific determinants of CPSA in the
causal model. Unfortunately, this practice is less common in the wider literature, with
some publications reporting Indigenous data without giving consideration to Indigenous
determinants of health and wellbeing. Notably, in the present analysis, when survival and
family attendance at residential school were controlled for, there was no significant
difference in the effect of CPSA on disclosure barriers among Indigenous women
compared to white women. The value of approaches which model or control for the
effects of inequitable processes such as residential school attendance is their ability to
demonstrate that population inequities do not represent intractable differences.
Furthermore, some inequitable processes are amenable to intervention and thus reduction
of population inequities. Future research should take this eco-social and intersectional
approach into consideration, adapting the relevant determinants and axes of oppression to
the context at hand.
In addition to marking novel theoretical territory, this model appeared to demonstrate
some empirical validity in its use of eco-social risk factors for CPSA. Of the risk factors
considered, all those which different significantly across the CPSA+ and CPSAexposure groups did so in the expected direction. Specifically, the CPSA+ group was
composed of significantly more sexual minority women, trans or intersex women, women
with a family member who attended residential school, women and who declined to
answer items on self-attendance and family attendance at residential school. One area
where the theoretical underpinnings of this model could have been better incorporated
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into analysis is the inclusion of protective factors for CPSA, as well as additional higherlevel factors such as quality of the child protection system and societal attitudes towards
corporal punishment. However, these represented limitations to the data rather than the
theoretical model itself.

5.2 Limitations
Quota sampling
The use of quota sampling as opposed to population based sampling in CHIWOS
presented both a limitation and an advantage. Prevalence estimates reported in the
descriptive statistics section of this analysis are not necessarily generalizable to the larger
population of women with HIV in Canada. However, it is arguable that a population
based study of women with HIV (i.e. using household or clinical sampling frames) would
be inefficient and/or only representative of women with HIV accessing clinical care.247 It
is unlikely that a clinical sample would represent marginalized women with HIV, making
this strategy incongruent with the CHIWOS objective to apply an intersectional approach
in understanding the positionality and determinants of health for women with HIV. Thus,
the quota sampling method which allowed for relatively precise effect estimates within
key populations of women with HIV was likely an optimal approach. Furthermore,
CHIWOS coverage of the base population is numerically strong; the study is estimated to
capture 10% of women with HIV in Canada.14 Sociodemographic coverage of CHIWOS
is more difficult to evaluate, given the known under-coverage of women with HIV in
both surveillance and clinical data. Manipulation of the data to represent either of these
populations would therefore be inappropriate, as it would not meet the study objectives or
justifiably improve representativeness. Thus, the ability to draw causal inference from the
CHIWOS dataset fell on the assumption that exposure groups were comparable with
respect to potential confounders; the accuracy of this assumption is evaluated below.
Limited capability for adjustment
One potential limitation of the given study was the small effect size for propensity score
covariates on the exposure variable, leading to fewer than expected observable
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differences between the weighted and unweighted results. While all propensity score
covariates were selected in an a priori protocol developed using epidemiological theory
and were within the confines of an established theoretical model, the data presented
limitations that could not have been foreseen. The small covariate effect sizes and limited
effect of weighting may be indicative of issues with covariate selection, measurement,
temporality, or unmeasured confounding, as discussed below. However, given that CPSA
is an unfortunately common experience characterized more so by a network of risk
factors than strong causal factors, it is possible that the effect sizes for predictors on
CPSA are truly as small as estimated here. The consequence of these secondary data
limitations was that AEE estimates, which were intended to be causal, should be
interpreted with caution. As the first known study to suggest a link between CPSA and
barriers to HIV disclosure to sexual partners among women, the resulting exploratory
effect estimates are still valuable. Furthermore, where significant effects were observed
they were consistently in the hypothesized direction, providing support for the underlying
theory, and justification for further inquiry into the magnitude of any potentially causal
effects.
Temporality
The inability to definitively establish temporality presents an issue with most crosssectional research, including the present study. This issue is particularly common in child
maltreatment research, where most measures of CPSA are retrospective regardless of
study design. The cut-off age (<16) for the exposure variable in conjunction with the
CHIWOS inclusion criteria (age ≥16) allowed us to establish a temporal sequence such
that CPSA and propensity score covariates preceded measurement of outcomes.
Unfortunately, it was not possible to establish whether propensity score covariates
preceded the exposure. In an effort to mitigate this, propensity score covariates where
chosen from a pool of variables which were identifiable as having the potential to take
effect prior to age 16. Within this pool of variables, those which theoretically were more
likely to mediate relationships between CPSA and outcomes (i.e. experience with foster
care or adoption) than to cause CPSA were eliminated. However, it is possible that some
time-dependent propensity score covariates occurred after CPSA, meaning that
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propensity score models may control the effect of mediators along the causal pathway.
The consequence of this limitation may be that some of the true exposure effect was
adjusted away.248 However, this limitation was considered to be less significant in light of
the more considerable limitation presented by the small effect sizes for propensity score
covariates on CPSA.
Unmeasured confounders
Because CHIWOS is a study of adults focusing primarily on variables measured at
present, the ability to include variables from the eco-social intersectional model of child
maltreatment was limited. Some notable variables that were unmeasured included:
childhood health issues, caregiver (un)employment, family socioeconomic status, family
isolation and household composition, and instability outside of the context of
immigration. It is expected that the inclusion of a wider range of childhood variables
would block additional non-causal pathways and result in a more accurately specified
propensity score model. The implications of being unable to balance a more robust set of
variables are that the weighting did not render the CPSA+ and CPSA- groups sufficiently
balanced, and thus that the observed effects may have been attributable to unmeasured
factors. This possibility was mitigated to the best of our abilities by controlling for factors
not only identifiable as occurring during childhood (such as immigration prior to age 16),
but for factors which are measured in adulthood but retrospectively known to affect
childhood maltreatment (such as sexual and gender minority identities). Some results
from the present analysis such as the impact of CPSA on further abuse in adulthood have
been heavily documented in the literature (though not necessarily among women with
HIV) and thus are not expected to change dramatically (i.e. in significance or direction)
with additional adjustment. However, other results such as the effect of CPSA on HIV
stigma represent novel additions to the quantitative literature, and should be both
interpreted with caution and subjected to further scrutiny.
Collider-stratification bias
The CHIWOS sample, like most samples of people with HIV is a “selected population”,
defined by the condition that every woman in the study has been diagnosed with HIV.
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From a causal modelling perspective, a selected population may be problematic when the
exposure of interest (CPSA) precedes the selection/stratification factor (here, HIV) along
a causal pathway.249 In the present example, CPSA is a known risk factor for HIV, while
the causal pathway of interest is that between CPSA and barriers to HIV disclosure. The
issue of collider-stratification bias presents itself here when a common cause exists for
both HIV and an outcome, making HIV a collider along the causal CPSA to outcome
pathway. In this situation, effects observed between CPSA and the outcome among the
selected population would be biased unless the common causes could be controlled.
However, if no common causes of HIV and an outcome could be identified, then the
selected population variable would not be a collider, and collider-stratification bias would
not be an issue. Thus, for the present study, it is important to consider potential common
causes of HIV and outcomes in order to evaluate the risk and potential consequences of
collider-stratification bias. Because HIV risk has been studied extensively while some
outcomes such as sexual relationship power represent emergent concepts, a logical
strategy is to evaluate whether any of the causes of HIV may also cause the given
outcomes. A review of broad risk factors for HIV revealed three categories of potential
confounders as they relate to the present analysis: (1) those that were controlled by
propensity score weighting, (2) those what were not controlled, and (3) those that
represent mediators along the CPSA to outcome pathway.
Within the first category, sexual orientation and gender identity have been associated
with differential HIV risk profiles, especially among MSM. Risk differences also exist
among women, though these have been addressed less frequently in the literature. In
particular, self-identified lesbian and bisexual women may differ from heterosexual
women in terms of HIV testing250,251 and HIV risk behaviors251,252. While differences
between sexual minority and heterosexual women were addressed by propensity score
weighting, differences between lesbian and bisexual women may have been obscured by
collapsing these groups into a single category. Transgender women also likely differ from
cisgender women in terms of HIV risk behaviours and testing, though formal
comparisons between these populations are complicated by the frequent lack of explicit
inclusion of gender diverse people in population-based health studies. These differences
were addressed in the current study by propensity score weighting. Thus, it is unlikely
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that the effects of sexual orientation and gender identity on HIV risk and study outcomes
contributed to collider-stratification bias. However, knowledge about HIV is one factor
which affects HIV risk253 as well as HIV stigma,254 and thus may have biased measures
of effect for this outcome. Thus, it is possible that the observed positive relationship
between CPSA and HIV stigma may have been partially attributable to HIV related
knowledge. No explicit evaluation of HIV-related knowledge was available in the
CHIWOS dataset, but future researchers should be cognizant of this potential bias.
The third category of confounders which could potentially induce collider-stratification
bias are those which both affect HIV and outcomes, but may also be mediators along the
causal pathway from CPSA to outcomes. These include factors influenced by CPSA,
such as: alcohol use,255 injection drug use,256,257 and sex work.258 The existence of such
factors introduces a methodological limitation: controlling for these variables would
block causal pathways between the exposure and the outcome, while failing to control for
them leaves the analysis vulnerable to collider-stratification bias and spurious
associations. The consequence of this limitation in the present analysis is that the
observed effects may have been attributable to the effect of CPSA on stratifier-outcome
confounders. A review of methods to address such exposure-induced colliderstratification bias revealed no clear solution to this issue, as well as a lack of attention to
collider-stratification bias more generally. Given the high prevalence of “selected
populations” in clinical research, and the threat to validity posed by collider-stratification
bias, this is an issue that should be addressed with further methodological work.
Measures
All measures in CHIWOS were reliant on self-report, which meant that results were
vulnerable to potential response biases such as social desirability bias and recall bias.
Given the emotionally burdensome content of the survey, social desirability bias may
present the largest threat to measurement validity. For many reasons including
embarrassment or mistrust of researchers, participants may have felt uncomfortable
disclosing information on items related to experiences of abuse throughout the life
course, as well as sexual relationship power and residential school experiences. Notably,
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123 Indigenous women declined to answer the block of questions on residential school;
given the Canada’s history of exploitative research against Indigenous peoples, this level
of refusal was not unsurprising.259 While this was the largest identifiable example of item
non-response in the survey and other item refusals were much smaller in magnitude, there
was also the possibility for unidentifiable response bias. Most concerning given the
subject matter was the possibility for under-reporting of adverse experiences such as
physical or sexual abuse. Self-reporting of abuse is recognized as able to capture more
cases of violence as compared to abuse reported to police or child protective
services,260,261 however self-report measures are still vulnerable to response bias as well
as recall bias. Multiple strategies were used by the CHIWOS team to mitigate such
response bias, including: having interviews conducted by community-involved women
with HIV in order to establish rapport, assuring participants of data confidentiality,
allowing for self-completion of sensitive survey items, and using behavioural rather than
definitional measures of self-reported violence.262
No disclosure measure
Readers may wonder why no effort was made in the present thesis to establish links
between not only CPSA and barriers to disclosure, but between barriers to disclosure and
a measure of HIV disclosure to sexual partners. Given that much of the existing research
on disclosure to sexual partners is qualitative in nature, such an extension would bolster
the study’s relevance and make a valuable addition to the literature. However, it is worth
noting that the Canadian legal context which justified the current study on barriers to HIV
disclosure also made it unethical to measure HIV disclosure to sexual partners. The
Canadian Criminal Code allows courts to subpoena information from those who may
have information related to criminal cases. This information can include communications
between people with HIV and clinicians, counsellors and researchers, depending on
whether or not it was gained under certain circumstances which qualify the information
as “privileged” (i.e. inadmissible in court).263 Even in situations where privacy and/or
anonymity has been guaranteed by the researcher or service provider, information can
sometimes be subpoenaed. Not only do these conditions this make research on nondisclosure ethically unacceptable, but they bar people with HIV from seeking

103

professional counsel related to HIV disclosure. Thus, the CHIWOS team made a
conscious decision not to ask directly about HIV disclosure to sexual partners in order to
protect their participants and PRAs from legal vulnerability. Instead, the team surveyed
general knowledge and opinions on Canadian criminalization of non-disclosure, as well
as barriers to HIV disclosure as operationalized in the current study.

5.3 Strengths
One of the main strengths of the given analysis was its innovative approach to the study
of HIV disclosure via barriers and facilitators. Members of the CHIWOS team, legal
practitioners specializing in HIV non-disclosure, and women with HIV in Canada have
made it clear that the present study is well-justified and innovative, and that the results
will be valuable in informing policy and practice. Actionability was a main goal of this
thesis from the identification of research questions through design of the statistical
methods and interpretation of the results. In line with this goal, the present study (1)
adapted a theoretical framework which renders results (and future research on this topic)
interpretable in ways that are non-stigmatizing and true to community experience; (2)
centred effect estimates on CPSA+ women rather than the population as a whole in order
to estimate the impact of targeted intervention; and (3) leveraged data that was rendered
limited by the surrounding policy environment (i.e. no disclosure measure) in a way that
sheds light on the inadequacy of that same policy. While this thesis endeavoured to
produce causal effect estimates in order to accurately evaluate the level of socio-legal
vulnerability directly attributable to adverse childhood experiences, the resulting adjusted
risk estimates are still valuable. Both the descriptive and analytic results, while not
necessarily representative of all women with HIV, indicated an incredibly high burden of
recurring violence among marginalized women with HIV. Regardless of the causal root
of these experiences, the majority of women in CHIWOS had experienced physical or
sexual assault in adulthood, which translates easily into socio-legal vulnerability. While
estimates of the level of disclosure barriers attributable to HIV may have been vulnerable
to misspecification, this thesis succeeded in showing the heavy burden of violence in
adulthood and consequent need for interventions to temper the impact of such violence,
especially in the context of HIV criminalization.

104

This project also successfully responded to calls for research that conceptualizes violence
as not only a cause of HIV, but as a cause of further vulnerability among women with
HIV.89 Research on the causes and consequences of violence against women is plentiful,
and the concepts relayed in this body of work are easily extendable to women with HIV.
Furthermore, studying established concepts such as stigma and revictimization among
women with HIV provides the opportunity to investigate not only whether such concepts
hold across populations, but also how HIV may nuance these concepts. In 2018, when
medical advances have significantly bridged the life expectancy gap between people with
HIV and people without HIV, we must turn our focus on how people with HIV move
through the world, which is often skewed against them. The extension of existing
research paradigms to this population is one way to accomplish this. Here, the application
of a suite of barriers to HIV disclosure and their attribution to distal factors outside of
one’s own control represented a novel approach in the quantitative HIV literature. It is
our hope that, on the basis of these promising initial results, further research will build on
this conceptualization in an effort to necessarily complicate the legal system’s
understanding of HIV disclosure and its antecedents.

5.4 Directions for Future Research
Directions for future research have been identified intermittently throughout this
discussion, but will be briefly summarized in this section. In direct response to the
potential shortcomings of the present study, it is of interest to estimate the effects of
CPSA on barriers to disclosure while controlling for a more robust suite of potential
confounders in order to block all identifiable non-causal pathways. This could be
accomplished with access to a dataset that has a heavier focus on childhood experiences.
Alternatively, shifting the approach to confounding control from blocking non-causal
pathways proximal to the exposure to an approach controlling true confounders or parents
of the outcome may present viable methods for estimating causal effects with datasets not
focused on childhood variables. Furthermore, studies of HIV disclosure barriers should
pay attention to measurement limitations in the present study, with an eye towards
potentially developing new measures. The literature review identified several relevant
constructs for which no measure existed (e.g. potential sexual relationship power), as
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well as constructs for which the CHIWOS measure did not map neatly onto the construct
of interest (e.g. perceived social support versus anticipated partner support), and
multidimensional constructs that warranted further exploration (e.g. HIV stigma). If
ethically permissible, it would also be ideal to formally study the relationship between the
barriers to HIV disclosure and partner disclosure. Hopefully this will be possible in the
future given changes to the legal circumstances surrounding HIV disclosure or research
confidentiality.
The sensitivity analyses of the independent effects of CPA and CSA on barriers to HIV
disclosure revealed the potential for interactive effects (i.e. poly-victimization) when
compared to the main analysis of the effects of childhood physical or sexual abuse.
Moving forward, researchers should think critically about whether a unitary approach to
victimization is sufficient to address a given research question, and whether data will
allow for the estimation of interaction effects between multiple types of adverse
childhood experiences. These are not limited to childhood physical and sexual abuse, but
may also include emotional abuse (when appropriately measured), exposure to intimate
partner violence in childhood, and neglect. The relatively recent body of work on polyvictimization is compelling, and should be taken into consideration by researchers across
disciplines where childhood adversities are relevant predictors.246
The present analysis also provided a hypothesized causal framework well-suited to
mediation analysis. A wide range of factors may mediate the observed effects, and even
the relationships where no significant effect was detected.264 For some outcomes where
causal mechanisms have been well-established among the general population (e.g. known
mediators between CSA and revictimization include dissociation, targetability, and riskrecognition),265 concept validation and extension among women with HIV should prove
fairly straightforward. For others, such as the relationship between CPSA and HIV stigma
among Black African women, mediation analysis represents uncharted territory. While
navigating this territory, researchers should consider potential mediators that have proven
to be salient determinants of other CPSA sequelae in the literature. These include coping
strategies,266 exposure to interventions,267 self-blame,268 and family support.266 Mediation
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analysis will prove extremely valuable in identifying modifiable factors to target for
intervention.

5.5 Implications for Practice and Policy
Practice
The results of the present study in conjunction with prior research present several
potential points for intervention, including enhancing protection for children, intervening
on mediating pathways between CPSA and revictimization and/or HIV, and interventions
for adults who have experienced CPSA with the goal of maintaining personal safety and
understanding disclosure. In line with this study’s theoretical framework, any
intervention should be accessible and acceptable to women and girls across all
intersections of gender and ethnoracial group. In some cases, this will necessitate the
development of intersection specific resources. Authors Etherington and Baker provide a
useful guide for applying intersectionality theory in practice related to children exposed
to intimate partner violence, which could be easily adapted to interventions related to
CPSA.269 Institutions and individuals that are positioned to provide interventions and
resources along this pathway include: child protection services, schools, women’s
shelters, AIDS service organizations, physicians, psychologists, and other
health/wellbeing practitioners. Some potential interventions focused on recognizing and
reducing CPSA may include: educating children on personal autonomy and consent,
providing access to parenting classes, educating parents and teachers on the signs of child
abuse, recalibrating the child protection system to allow for lower caseloads, and
providing intersectional anti-oppression training to those who work closely with children.
Other interventions may focus on providing remedial support to children who have been
victims of CPSA, including services such as professional counselling for children and
their caregivers.
The results of this analysis also have implications specific to individuals and institutions
that work with HIV positive women. However, service providers must be aware of how
they as counsellors may open their HIV positive clients to legal vulnerability, and should
receive education on the intricacies of disclosure related counselling before engaging in
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any discussions on disclosure. The Canadian HIV/AIDS Legal Network in partnership
with other organizations has developed an online resource intended to educate those who
regularly work with people with HIV regarding client confidentiality, recommended
record keeping practices, and counselling people with HIV on matters related to
disclosure.263 This information is well disseminated among AIDS service organizations,
but should be increasingly targeted towards general practitioners and other health care
providers, who tend to engage less frequently in discussions of HIV criminalization with
their HIV positive patients even though they may also be vulnerable to disclosure related
legal action.270 On top of existing educational resources about HIV disclosure, the current
project presents new information that may be informative for individuals who engage in
disclosure counselling. Providers should understand that women with a history of CPSA
may be at greater risk for further abuse at present, and thus may be legally vulnerable. At
the individual level, this information may provide HIV positive women who have
experienced CPSA with some peace of mind in knowing that their experiences
negotiating partner disclosure are valid and at least partially rooted in factors outside of
their own control. At present, steps are already being taken to incorporate this
information into the harmonized volunteer training materials for AIDS service
organizations across Toronto, and consultations are underway with legal practitioners at
HIV & AIDS Legal Clinic Ontario (HALCO) to develop additional knowledge
translation strategies.
The information collated in this thesis on the burden of violence and abuse among
women with HIV merits further attention beyond knowledge translation strategies. Where
they are not already doing to, AIDS service organizations and health care providers
should offer programming teaching women with HIV who are at risk for violence about
how the law has typically handled cases of HIV non-disclosure, and how they can best
negotiate their bodily safety and legal vulnerability. A search for potential resources
yielded several components of what would make for a larger and more comprehensive
strategy. In 2015, HALCO developed a text-based resource for women with HIV who are
experiencing or at risk of experiencing violence.271 This resource was intended to provide
education on navigating the legal system as related to violence and HIV, including nondisclosure. The legal information contained in this resource is highly valuable and could
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provide the basis for a more accessible (i.e. face-to-face) intervention related to violence
against women with HIV. Additionally, a 2015 systematic review of interventions to
facilitate HIV disclosure in the context of violence identified two randomized trials from
Africa which both appeared to increase rates of partner disclosure, though the effect
could not conclusively be attributed to the disclosure counselling components as they
were both part of larger multifaceted interventions.272 The interventions included
screening all new HIV diagnoses among women for histories of violence, followed by an
evaluation of safety and best options for disclosure or non-disclosure if that was deemed
the best option.273,274 Concurrent screening for HIV and intimate partner violence is
already in practice in some Canadian clinics,275 though it is unclear the extent to which
this approach has been adopted nationally. Furthermore, screening for violence represents
only the first step in a comprehensive strategy to protect women with HIV from
additional vulnerability. An ideal intervention would incorporate the already established
strategies above, along with acknowledgement of intersectionality and social power in the
educational material and in the delivery of the intervention to women from multiply
marginalized populations.
Policy
The findings of this analysis indicated that women with HIV, like other women, are
vulnerable to physical and sexual violence in adulthood, and that experiences of CPSA
increase risk for such violence. This evidence, coupled with research establishing a
relationship between CPSA and HIV risk among women reiterates that recurring violence
is an issue within this community. Furthermore, in the context of criminalization of HIV
non-disclosure, violence against women with HIV has socio-legal implications beyond
the already devastating implications of violence against women in general. Experiences
of physical, sexual, and emotional violence undermine the power of women and girls,
including women’s power to disclose their HIV status to their sexual partners, whether or
not the current relationship is abusive. Within an abusive relationship, the decision to
disclose one’s HIV status is often a negotiation where acceptance, reputation, shelter,
financial security, bodily safety, and even one’s own life are on the line. In most of
Canada where HIV non-disclosure is a crime, women with HIV must also consider the
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potential for criminal charges and incarceration when negotiating disclosure. Sadly, even
if women do disclose their HIV status to their sexual partners, they are not protected from
false legal accusations by abusive partners attempting to exact control or revenge.
What the current analysis provides is an additional piece within the larger body of
evidence which tells us that children cannot cause their own abuse, girls who experience
abuse are at risk for HIV as well as revictimization, and the co-occurrence of HIV and
abuse makes HIV disclosure dangerous. When legal bodies ignore scientific evidence on
HIV transmission and fail to recognize disclosure-related risks for people with HIV they
are not only complacent to this cycle of abuse and vulnerability, but they enable it. As a
consequence, these systems may be disproportionately punitive to those who are
especially vulnerable based on early-life violence.
Steps are being take to remedy this as newer scientific evidence becomes incorporated
into the legal system. Most recently, in December 2017 the Ontario Attorney General and
Ontario Minister of Health and Long Term Care announced that in light of scientific
developments, Ontario’s crown prosecutors would no longer pursue HIV non-disclosure
cases where an individual has had a suppressed viral load for six months.58 This decision
represents an important step towards achieving justice for people with HIV in Canada,
however, the policy’s reach is limited to Ontario and does not yet address the legal
precedent for other situations where HIV transmission risk is known to be negligible,
including: oral sex, anal or vaginal sex with a condom, and anal or vaginal sex without a
condom while having low viral load.58 A community consensus statement signed by over
150 Canadian organizations in 2017 further advocated for the application of nondisclosure law only as a last resort in the case of intentional HIV transmission, which is
very rare.276 Their call to action included the following demands:
1. Federal and provincial Attorneys-General should develop sound prosecutorial
guidelines to preclude unjust HIV prosecutions.
2. The federal government should reform the Criminal Code to limit the unjust
use of the criminal law against people living with HIV.
3. All three levels of government should support the development of resources
and training to address misinformation, fear and stigma related to HIV.276
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This position was echoed by the Department of Justice’s 2017 commissioned report on
the criminal justice system’s response to non-disclosure of HIV.277 These advances are
highly promising, and represent exciting potential for advancement of human rights in
Canada.

5.6 Conclusion
In summary, the findings of this thesis confirmed that women with HIV in Canada
experience a high burden of violence which may be at least partially attributable to earlier
experiences of violence in childhood. Such experiences may also be associated with
adverse outcomes in adulthood, such as low sexual relationship power or high HIV
stigma, that disenable women from disclosing their HIV status to their sexual partners.
These barriers and facilitators to HIV disclosure are especially relevant in Canada where,
as of August 2018, people with HIV continue to be charged and convicted for HIV nondisclosure despite heavily documented scientific and ethical objections to this practice.
While the current analysis was not able to ascertain causality, adjusted risk estimates
provided some indication that women with HIV who experienced child abuse may be
more vulnerable than women without such experiences to non-disclosure, and thus legal
actions or threats. These results introduce the possibility that HIV non-disclosure law
over-criminalizes women with HIV who experienced child abuse, punishing them for
making what is deemed to be the wrong decision when their personal safety and
autonomy is at risk. On the basis of this reasoning, interventions which restore autonomy
to women with HIV by way of education, empowerment, and national policy change are
recommended. This includes explicit decriminalization of HIV non-disclosure at the
national level.
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Appendices
Appendix 1: Hierarchy of HIV exposure categories
Source: Public Health Agency of Canada19
1.

MSM: Men who have sex with men. This category includes men who report
either homosexual or bisexual sexual contact.

2.

MSM/IDU: Men who have sex with men and use injection drugs.

3.

IDU: Injection drug use.

4.

Blood/blood products
a. Recipient of blood/clotting factor: Before 1998, it was not possible to
separate this exposure category. However, where possible, it has been
separated into subcategories b and c.
b. Recipient of blood: Received transfusion of whole blood or blood
components, such as packed red cells, plasma, platelets, or cryoprecipitate.
c. Recipient of clotting factor: Received pooled concentrates of clotting
factor VIII or IX for treatment of hemophilia/coagulation disorder.

5.

Heterosexual contact
a. Origin from an HIV-endemic country (Het-Endemic): People who were
born in a country where HIV is endemic. An HIV-endemic country is
defined as having an adult (ages 15–49) prevalence of HIV that is 1.0% or
greater and one of the following: • 50% or more of HIV cases attributed to
heterosexual transmission • a male to female ratio of 2:1 or less • HIV
prevalence greater than or equal to 2% among women receiving prenatal
care Before 1998, it was not always possible to separate Origin from an
HIV-endemic country and sexual contact with a person at risk. However,
where possible, it has been separated into subcategories a and b.
b. Sexual contact with a person at risk (Het-Risk): People who report
heterosexual contact with someone who is either HIV-infected or who is at
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increased risk of HIV infection (e.g. a person who injects drugs, a bisexual
male, or a person from an HIV-endemic country).
c. No Identified Risk-Heterosexual (NIR-Het): If heterosexual contact is the
only risk factor reported and nothing is known about the HIV-related
factors associated with the partner, the case is classified as NIR–Het.
6.

Occupational exposure: Exposure to HIV-contaminated blood or body fluids,
or concentrated virus in an occupational setting. This applies only to reported
AIDS cases and not to HIV-cases where the occupational exposure category is
captured under “other”. The Canada Communicable Disease Report (CCDR)
contains more information about occupational exposure.

7.

Perinatal transmission: The transmission of HIV from a woman infected with
HIV to her infant, either in utero, during childbirth, or through breastfeeding.

8.

Other: Used to classify cases where the mode of HIV transmission is known
but cannot be classified into any of the major exposure categories listed here;
for example, a recipient of semen from an HIV-positive donor.

9.

No identified risk (NIR): Used when the history of exposure to HIV through
any of the other modes listed is unknown, or there is no reported history (e.g.
because of death, or loss to follow-up).

10.

Not reported: In certain provinces and territories, exposure categories are not
reported to the Public Health Agency of Canada and are classified as Not
Reported.
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Appendix 2: SAS Code
File 1: Data cleaning, generating propensity scores, evaluating balance diagnostics
*Import macros;
%include 'U:\SAS\Macros\twang_mac.sas';
/*-IMPORT AND SORT W1/W2 DATA BY PART_ID*/
LIBNAME USB 'E:\Data';
DATA CHIWOSW1;
SET USB.CHIWOSW1;
PROC SORT DATA=CHIWOSW1;
BY PART_ID;
DATA CHIWOSW2;
SET USB.CHIWOSW2;
PROC SORT DATA=CHIWOSW2;
BY PART_ID;
/*CREATE TEMP DATASET WITH COMBINED W1+W2 by variable PART_ID (matchmerging)*/
DATA CHIWOSW1_2;
MERGE CHIWOSW1 CHIWOSW2;
BY PART_ID;
/*DEFINE ALL ARRAYS. AAA=SRPS W1&2; BBB=Y,N,DK,PA; CCC=MOS-SSS; DDD=HIV
Stigma W1&2; EEE=HAT-QoL-Disclosure; FFF=HIV Stigma w1&w2; GGG=HAT QoL
Disclosure W1&W2;*/
ARRAY AAA S8Q24j_1-S8Q24j_15 W2S9Q15_0-W2S9Q15_14;
ARRAY BBB S7Q2a W2S8Q02 S7Q5a W2S8Q14 S7Q6a S7Q8a S1Q5a S1Q24 S1Q26
S1Q27 S1Q8O_1-S1Q8O_7;
ARRAY CCC S9Q4_1-S9Q4_4;
ARRAY DDD S5Q1_1-S5Q1_10 W2S6Q01_0-W2S6Q01_9;
ARRAY EEE S5Q5_1-S5Q5_6 W2S6Q02_0-W2S6Q02_5;
ARRAY FFF S5Q1_1-S5Q1_10 W2S6Q01_0-W2S6Q01_9;
ARRAY GGG S5Q5_1-S5Q5_5 W2S6Q02_0-W2S6Q02_4;
/*-------------- REMOVE MISSINGS -------------------*/
DO OVER AAA;
IF AAA=5 then AAA=.;
END;
DO OVER BBB;
IF BBB= 3 then BBB=.;
IF BBB= 4 then BBB=.;
END;
DO OVER CCC;
IF CCC= 6 then CCC=.;
IF CCC= 7 then CCC=.;
END;
DO OVER DDD;
IF DDD= 6 then DDD=.;
END;
DO OVER EEE;
IF EEE= 6 then EEE=.;
END;
/*-------------- OUTCOMES

------------------*/
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*(a) Sexual Relationship Power Scale (SRPS) Relationship Control
Subscale Waves 1 and 2;
*1. Summing total of 15 items [CHECKED];
sum_SRPSw1 = sum(of S8Q24j_1-S8Q24j_15);
sum_SRPSw2 = sum(of W2S9Q15_0-W2S9Q15_14);
*2. Determining number of items answered;
total_SRPSw1 = n(of S8Q24j_1-S8Q24j_15);
total_SRPSw2 = n(of W2S9Q15_0-W2S9Q15_14);
*3 Calculating scale value as SUM of items/#nonmissing items (average
of answered items).
*When instructions they say missing items *automatically* assigned mean
score for completed items, this is what they mean;
SRPSw1 = sum_SRPSw1/total_SRPSw1;
*Score is average across
completed items;
SRPSw2 = sum_SRPSw2/total_SRPSw2;
*Those missing 3 or more (15-3=12) items are dropped;
if total_SRPSw1 le 12 then SRPSw1=.; *Missing SRPSw1=;
if total_SRPSw2 le 12 then SRPSw2=.; *Missing SRPSw2=;
/*(b) Adult physical abuse, ever (W1 ever, W2 since last CHIWOS
interview) W1: S7Q2a, W2: W2S8Q02
If w1 missing and w2 is no --> missing. If w1 is missing and w2 is yes
--> yes. If w2 is missing always default to w1 answer*/
APABUSE=.;
if S7Q2a=2 and W2S8Q02=2 then APABUSE=0; *no adult physical abuse ever;
if S7Q2a=. and W2S8Q02=2 then APABUSE=.; *n=65 if w1 missing and w2
(since) is no --> missing since this is not "ever";
if S7Q2a=2 and W2S8Q02=. then APABUSE=0; *no adult physical abuse ever
as reported to CHIWOS;
if S7Q2a=1 or W2S8Q02=1 then APABUSE=1; *yes adult physical abuse ever
(including if w1 missing and w2(since) is yes --> if happened since,
this is part of "ever";
if S7Q2a=. and W2S8Q02=. then APABUSE=.; *if both waves missing, var is
missing;
*Checking source of missingness;
if s7q1=1 then w1section7=1;
if s7q1=2 then w1section7=2;
if s7q1=3 then w1section7=.;
if w2s8q01=1 then w2section8=1;
if w2s8q01=2 then w2section8=2;
if w2s8q01=3 then w2section8=.;
/*(c) Adult sexual abuse (W1 ever, W2 since last CHIWOS interview)W1:
S7Q5a, W2: W2S8Q14 [CHECKED]
If w1 missing and w2 is no --> missing. If w1 is missing and w2 is yes
--> yes. If w2 is missing always default to w1 answer*/
ASABUSE=.;
if S7Q5a=2 and W2S8Q14=2 then ASABUSE=0; *no adult sexual abuse ever;
if S7Q5a=. and W2S8Q14=2 then ASABUSE=.; *if w1 missing and w2 (since)
is no --> missing since this is not "ever";
if S7Q5a=2 and W2S8Q14=. then ASABUSE=0; *no adult sexual abuse ever as
reported to CHIWOS;
if S7Q5a=1 or W2S8Q14=1 then ASABUSE=1; *yes adult sexual abuse ever
(including if w1 missing and w2(since) is yes --> if happened since,
this is part of "ever";
if S7Q5a=. and W2S8Q14=. then ASABUSE=.; *if both waves missing, var is
missing;
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/*(d) Social Support [Medical Outcomes Study – Social Support Scale 4
item]. W1: S9Q4_1 to S9Q4_4, DV: MOS_SSS_Score (W1).*/
*1. Reverse code all items (not officially RC, response options just
asked in opposite order in CHIWOS) (see
http://www.theanalysisfactor.com/easy-reverse-code/);
S9Q4_RC_1=6-S9Q4_1;
S9Q4_RC_2=6-S9Q4_2;
S9Q4_RC_3=6-S9Q4_3;
S9Q4_RC_4=6-S9Q4_4;
*2. Summing all 4 items;
MOSSw1 = sum(of S9Q4_RC_1-S9Q4_RC_4);
*3. Determining number of items answered;
total_MOSSw1 = n(of S9Q4_RC_1-S9Q4_RC_4);
*4. If any item is missing, drop from analysis;
if total_MOSSw1 lt 4 then MOSSw1=.; *Results in n=55 missing;
/*(e) HIV Stigma Scale W1: S5Q1_1 to S5Q1_10; W2: W2S6Q01_0 to
W2S6Q01_9; DV: None*/
*1. Recode response options [CHECKED];
DO OVER FFF;
FFF=5-FFF;
END;
*2. Sum all 10 items for each wave [CHECKED: scales range from 0-40];
STIGMAw1 = sum(of S5Q1_1-S5Q1_10);
STIGMAw2 = sum(of W2S6Q01_0-W2S6Q01_9);
*3. If missing 2 or more items on scale of 10, drop from analysis;
total_STIGMAw1 = n(of S5Q1_1-S5Q1_10);
total_STIGMAw2 = n(of W2S6Q01_0-W2S6Q01_9);
if total_STIGMAw1 le 8 then STIGMAw1=.;
if total_STIGMAw2 le 8 then STIGMAw2=.;
*(g)Sexual Inactivity (6 months) W2: S902 (Have you had consensual sex
in the past 6 months 1 yes 2 no 3 DKPN);
if W2S9Q02=1 then inactivityw2=0; *Yes to consensual sex --> not
inactive;
if W2S9Q02=2 then inactivityw2=1; *No to consensual sex --> not active;
if W2S9Q02=. then inactivityw2=.;
/*-------------- EXPLANATORY VARIABLES

------------------*/

/*1a. CPSA W1: S7Q6a [physical] W1: S7Q8a [sexual]*/
CPSA=.;
if S7Q6a=2 and S7Q8a=2 then CPSA=0; *no physical or sexual abuse;
if S7Q6a=1 or S7Q8a=1 then CPSA=1; *yes physical and/or sexual abuse;
if S7Q6a=. and S7Q8a=. then CPSA=.; *if both are missing, var is
missing;
/*1b. Child physical abuse S7Q6a*/
if S7Q6a=2 then CPA=0; *no physical abuse;
if S7Q6a=1 then CPA=1; *yes physical abuse;
if S7Q6a=. then CPA=.;
/*1c. Child sexual abuse S7Q8a*/
if S7Q8a=2 then CSA=0; *no sexual abuse;
if S7Q8a=1 then CSA=1; *yes sexual abuse;
if S7Q8a=. then CSA=.;
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/*2. Race/ethnicity W1: S1Q7_1 to S1Q7_18 and S1Q7_18_sp (other,spec).
Black african=S1Q7_3, Black Caribbean=S1Q7_4, Black Other=S1Q7_5, DV:
S1Q7_dv. */
RACE=.;
if S1Q7_dv=1 then RACE=1; *Aboriginal;
if S1Q7_dv=2 and S1Q7_3=3 then RACE=2; *Black African;
if S1Q7_dv=2 and S1Q7_4=4 then RACE=3; *Black Caribbean;
if S1Q7_dv=2 and S1Q7_5=5 and S1Q7_3=. and S1Q7_4=. then RACE=5; *Black
other with no other black ID=other [5/11 "Black other" fall into this
category];
if S1Q7_dv=3 then RACE=4; *Caucasian;
if S1Q7_dv=4 then RACE=5; *Other;
if S1Q7_dv=. then RACE=.;
/*-------------- PS VARIABLES

------------------*/

/*1. Gender Identity. W1/DV: S1Q2a_dv. Combine transwomen and other
[checked]*/
GENDERID=.;
if S1Q2a_dv=1 then GENDERID=0; *cis women;
if S1Q2a_dv=2 or S1Q2a_dv=3 then GENDERID=1; *trans women and other;
if S1Q2a_dv=. then GENDERID=.;
/*2. Leaving home country at or before age 16. W1:
S1Q5a (Were you
born in Canada); W1: S1Q5c_1 (in what year did you come to Canada to
live);W1: S0QDOB_Y (Year of birth) [CHECKED]*/
*A. Create var for age of immigration (year of imm to canada subtract
birth year);
IMMAGE=sum(S1Q5c_1-S0QDOB_Y);
*B. Dichotomize IMMAGE into le 16, gt 16;
if IMMAGE le 16 then IMLE16=1; *immigrated at or before 16;
if IMMAGE gt 16 or S1Q5a=1 then IMLE16=0; *immigrated after 16 or not
an immigrant;
if S1Q5a=. or S0QDOB_Y=. then IMLE16=.;
if PART_ID in(REDACTED FOR DATA SECURITY) then IMLE16=.; *immigrants
without year of immigration;
if PART_ID in REDACTED FOR DATA SECURITY) then IMLE16=0; *Nonimmigrants without year of birth;
if PART_ID in (REDACTED FOR DATA SECURITY) then IMLE16=.; *immigrants
without year of birth;
/*3. Stress-related reason for immigration during childhood. W2:
W2S1Q14_1 to W2S1Q14_16 and W2S1Q14_14_SP (Reason for moving to Canada
- check all)*/
*if IMLE16=1;
*A. Create non age-restricted stress related immigration var;
if S1Q5a=1 then IMSTRESS=0; *not an immigrant;
if S1Q5a ne 1 and W2S1Q14_3 ne 3 and W2S1Q14_7 ne 7 and W2S1Q14_8 ne 8
and W2S1Q14_9 ne 9 and W2S1Q14_10 ne 10 and W2S1Q14_11 ne 11 then
IMSTRESS=0; *immigrant w/no stress related reason;
if W2S1Q14_3=3 or W2S1Q14_7=7 or W2S1Q14_8=8 or W2S1Q14_9=9 or
W2S1Q14_10=10 or W2S1Q14_11=11 then IMSTRESS=1; *yes any stress related
reason;
if S1Q5a=. then IMSTRESS=.; *if born in Canada is missing, item is
missing;
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if S1Q5a=2 and W2S1Q14_1=. and W2S1Q14_2=. and W2S1Q14_3=. and
W2S1Q14_4=. and W2S1Q14_5=. and W2S1Q14_6=. and W2S1Q14_7=. and
W2S1Q14_8=. and W2S1Q14_9=. and W2S1Q14_10=. and W2S1Q14_11=. and
W2S1Q14_12=. and W2S1Q14_13=. and W2S1Q14_14=. and W2S1Q14_15=. and
W2S1Q14_16=. then IMSTRESS=.; *immigrant w/no answers for reason of
immigration;
if PART_ID in(REDACTED FOR DATA SECURITY) then IMSTRESS=1; *other
specify indicating stress where not captured in quant vars;
*B. Create IMSTRESS <=16;
if IMLE16=0 or IMSTRESS=0 then IMSTRESS16=0; *didn't immigrate
at/before 16 or didn't experience immigration stress;
if IMLE16=1 and IMSTRESS=1 then IMSTRESS16=1; *immigrated at/before 16
AND experienced immigration stress;
if IMLE16=. OR IMSTRESS=. then IMSTRESS16=.;
/*4. Attendance at residential school W1: RACE (aboriginal=1), S1Q8k
(skip section?), S1Q8L (did you attend)*/
if RACE ne 1 then SELFATTEND=0; *not aboriginal in Canada;
if RACE=1 and S1Q8k=2 then SELFATTEND=.; *Aboriginal but skip
residential school section;
if RACE=1 and S1Q8k=1 and S1Q8L=2 then SELFATTEND=0; *aboriginal,
answered, didn't attend;
if RACE=1 and S1Q8k=1 and S1Q8L=1 then SELFATTEND=1; *aboriginal,
answered, attended;
if RACE=1 and S1Q8k=1 and (S1Q8L=4 or S1Q8L=.) then SELFATTEND=.;
*aboriginal, answered, missing self attendance;
/*5. Any family attended residential school*/
if S1Q8O_dv=0 then FAMATTEND=0; *not aboriginal in Canada;
if S1Q8O_dv=1 then FAMATTEND=1; *at least 1 fam said yes;
if S1Q8O_dv=2 then FAMATTEND=0; *all family members said no;
if S1Q8O_dv=5 then FAMATTEND=0; *does not id as first nation;
if S1Q8O_dv=8 then FAMATTEND=.; *skipped rschool questions;
if S1Q8O_dv=9 then FAMATTEND=.; *DK/PA;
/*6. Sexual orientation - S1Q3_dv (prev sex minority = 12.66%)*/
if S1Q3_dv=1 then sexid=0; *heterosexual;
if S1Q3_dv=2 then sexid=1; *not heterosexual;
if S1Q3_dv=9 then sexid=.; *missing;
/*7. Age. var=age*/
/*Remove obs with no outcome data (n=115) and unused vars*/
DATA mainanalysis;
SET CHIWOSW1_2(KEEP=CPSA CSA CPA GENDERID IMLE16 IMSTRESS16
SELFATTEND FAMATTEND PART_ID RACE SRPSw1 SRPSw2 APABUSE ASABUSE MOSSw1
STIGMAW1 STIGMAW2 inactivityw2 sexid age);
IF CPSA ne .;
/*-------------

END OF DATA STEP

------------*/

/*-----------------Analysis with TWANG Macros -----------------*/
*ESTIMATE PSs USING GBM, EVALUATE QUALITY USING COVARIATE BALANCE;
%ps(treatvar=CPSA,
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vars=GENDERID IMLE16 IMSTRESS16 SELFATTEND FAMATTEND sexid
age,
class=GENDERID IMLE16 IMSTRESS16 SELFATTEND FAMATTEND sexid,
dataset=mainanalysis,
ntrees=5000,
intdepth=3,
shrinkage=0.01,
permtestiters=500,
stopmethod=ks.mean es.mean,
sampw=,
estimand=ATT,
output_dataset=USB.mainanalysis,
Rcmd=C:\Program Files\R\R-3.4.3\bin\x64\R.exe,
plotname=Weight_QualityCPSA.pdf,
objpath=U:\SAS\TWANG);
RUN;
/*----------------- END OF PS CODE -----------------*/

File 2: Outcome analysis
*IMPORT AND SORT W1/W2 DATA BY PART_ID;
LIBNAME USB 'E:\Data';
DATA chiwosw1_2_attwgtsv7;
SET USB.chiwosw1_2_attwgtsv7;
*Indicator variables for missingness of PS vars;
ARRAY AAA age sexid genderid imle16 imstress16 selfattend famattend;
ARRAY BBB ageNA sexidNA genderidNA imle16NA imstress16NA selfattendNA
famattendNA;
do over AAA;
if AAA=. then BBB=1;
if AAA=1 then BBB=0;
if AAA=0 then BBB=0;
end;
*recode race with white reference group;
if race=4 then raceref=0; *white;
if race=1 then raceref=4; *Indigenous;
if race=2 then raceref=3; *Black African;
if race=3 then raceref=2; *Black Caribbean;
if race=5 then raceref=1; *Other;
if race=. then raceref=.;
LABEL raceref="Race (((4=Indig, 3=BA, 2=BC, 1=Other, 0=White)))";
/*-----------------

END OF DATA STEP

-----------------------*/

PROC SORT DATA=chiwosw1_2_attwgtsv7;
BY descending raceref descending CPSA;
/*--------------------

APABUSE (BINARY)

------------------------*/

PROC GENMOD DATA=chiwosw1_2_attwgtsv7 order=data desc;
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CLASS PART_ID raceref CPSA;
MODEL APABUSE=CPSA|raceref /dist=poisson link=log;
REPEATED sub=PART_ID / type=ind;
SLICE CPSA*raceref /sliceby=raceref exp diff cl plots=none; *stratum
specific effects;
TITLE "APABUSE: Unw, Slice";
PROC GENMOD DATA=chiwosw1_2_attwgtsv7 order=data desc;
CLASS PART_ID raceref CPSA;
MODEL APABUSE=CPSA|raceref /dist=poisson link=log;
WEIGHT ks_mean_att;
REPEATED sub=PART_ID / type=ind; *gives risk estimates relative to
white women;
SLICE CPSA*raceref /sliceby=raceref exp diff cl plots=none; *stratum
specific effects;
TITLE "APABUSE: Weighted, slice, relative";
PROC GENMOD DATA=chiwosw1_2_attwgtsv7 order=data desc;
CLASS PART_ID;
MODEL APABUSE=CPSA /dist=poisson link=log;
WEIGHT ks_mean_att;
REPEATED sub=PART_ID / type=ind;
ESTIMATE 'Beta' CPSA 1 / exp;
TITLE "APABUSE: Weighted, OVERALL";
/*--------------------

ASABUSE (BINARY)

------------------------*/

PROC GENMOD DATA=chiwosw1_2_attwgtsv7 order=data desc;
CLASS PART_ID raceref CPSA;
MODEL ASABUSE=CPSA|raceref /dist=poisson link=log;
REPEATED sub=PART_ID / type=ind;
SLICE CPSA*raceref /sliceby=raceref exp diff cl plots=none; *stratum
specific effects;
TITLE "ASABUSE: Unw, Slice";
PROC GENMOD DATA=chiwosw1_2_attwgtsv7 order=data desc;
CLASS PART_ID raceref CPSA;
MODEL ASABUSE=CPSA|raceref /dist=poisson link=log;
WEIGHT ks_mean_att;
REPEATED sub=PART_ID / type=ind; *gives risk estimates relative to
white women;
SLICE CPSA*raceref /sliceby=raceref exp diff cl plots=none; *stratum
specific effects;
TITLE "ASABUSE: Weighted, slice, relative";
PROC GENMOD DATA=chiwosw1_2_attwgtsv7 order=data desc;
CLASS PART_ID;
MODEL ASABUSE=CPSA /dist=poisson link=log;
WEIGHT ks_mean_att;
REPEATED sub=PART_ID / type=ind;
ESTIMATE 'Beta' CPSA 1 / exp;
TITLE "ASABUSE: Weighted, OVERALL";
/*--------------------

INACTIVITYW2 (BINARY) -----------------------*/

PROC GENMOD DATA=chiwosw1_2_attwgtsv7 order=data desc;
CLASS PART_ID raceref CPSA;
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MODEL INACTIVITYW2=CPSA|raceref /dist=poisson link=log;
REPEATED sub=PART_ID / type=ind;
SLICE CPSA*raceref /sliceby=raceref exp diff cl plots=none; *stratum
specific effects;
TITLE "INACTIVITYW2: Unw, Slice";
PROC GENMOD DATA=chiwosw1_2_attwgtsv7 order=data desc;
CLASS PART_ID raceref CPSA;
MODEL INACTIVITYW2=CPSA|raceref /dist=poisson link=log;
WEIGHT ks_mean_att;
REPEATED sub=PART_ID / type=ind; *gives risk estimates relative to
white women;
SLICE CPSA*raceref /sliceby=raceref exp diff cl plots=none; *stratum
specific effects;
TITLE "INACTIVITYW2: Weighted, slice, relative";
PROC GENMOD DATA=chiwosw1_2_attwgtsv7 order=data desc;
CLASS PART_ID;
MODEL INACTIVITYW2=CPSA /dist=poisson link=log;
WEIGHT ks_mean_att;
REPEATED sub=PART_ID / type=ind;
ESTIMATE 'Beta' CPSA 1 / exp;
TITLE "INACTIVITYW2: Weighted, OVERALL";
/*--------------------

SRPSW2 (CONTINUOUS)

------------------------*/

PROC GENMOD DATA=chiwosw1_2_attwgtsv7 order=data;
CLASS PART_ID raceref CPSA;
MODEL SRPSw2=CPSA|raceref /dist=normal link=id;
REPEATED sub=PART_ID / type=ind;
SLICE CPSA*raceref /sliceby=raceref diff cl plots=none; *stratum
specific effects;
TITLE "SRPSw2: Unw, Slice";
PROC GENMOD DATA=chiwosw1_2_attwgtsv7 order=data;
CLASS PART_ID raceref CPSA;
MODEL SRPSw2=CPSA|raceref /dist=normal link=id;
WEIGHT ks_mean_att;
REPEATED sub=PART_ID / type=ind; *gives risk estimates relative to
white women;
SLICE CPSA*raceref /sliceby=raceref diff cl plots=none; *stratum
specific effects;
TITLE "SRPSw2: Weighted, slice, relative";
PROC GENMOD DATA=chiwosw1_2_attwgtsv7 order=data;
CLASS PART_ID;
MODEL SRPSw2=CPSA /dist=normal link=id;
WEIGHT ks_mean_att;
REPEATED sub=PART_ID / type=ind;
ESTIMATE 'lincomb' intercept 1 CPSA 1;
TITLE "SRPSw2: Weighted, OVERALL";
/*--------------------

MOSSW1 (CONTINUOUS)

------------------------*/

PROC GENMOD DATA=chiwosw1_2_attwgtsv7 order=data;
CLASS PART_ID raceref CPSA;
MODEL MOSSw1=CPSA|raceref /dist=normal link=id;
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REPEATED sub=PART_ID / type=ind;
SLICE CPSA*raceref /sliceby=raceref diff cl plots=none; *stratum
specific effects;
TITLE "MOSSw1: Unw, Slice";
PROC GENMOD DATA=chiwosw1_2_attwgtsv7 order=data;
CLASS PART_ID raceref CPSA;
MODEL MOSSw1=CPSA|raceref /dist=normal link=id;
WEIGHT ks_mean_att;
REPEATED sub=PART_ID / type=ind; *gives risk estimates relative to
white women;
SLICE CPSA*raceref /sliceby=raceref diff cl plots=none; *stratum
specific effects;
TITLE "MOSSw1: Weighted, slice, relative";
PROC GENMOD DATA=chiwosw1_2_attwgtsv7 order=data;
CLASS PART_ID;
MODEL MOSSw1=CPSA /dist=normal link=id;
WEIGHT ks_mean_att;
REPEATED sub=PART_ID / type=ind;
ESTIMATE 'lincomb' intercept 1 CPSA 1;
TITLE "MOSSw1: Weighted, OVERALL";
/*--------------------

STIGMAW1 (CONTINUOUS)

----------------------*/

PROC GENMOD DATA=chiwosw1_2_attwgtsv7 order=data;
CLASS PART_ID raceref CPSA;
MODEL STIGMAW1=CPSA|raceref /dist=normal link=id;
REPEATED sub=PART_ID / type=ind;
SLICE CPSA*raceref /sliceby=raceref diff cl plots=none; *stratum
specific effects;
TITLE "STIGMAW1: Unw, Slice";
PROC GENMOD DATA=chiwosw1_2_attwgtsv7 order=data;
CLASS PART_ID raceref CPSA;
MODEL STIGMAW1=CPSA|raceref /dist=normal link=id;
WEIGHT ks_mean_att;
REPEATED sub=PART_ID / type=ind; *gives risk estimates relative to
white women;
SLICE CPSA*raceref /sliceby=raceref diff cl plots=none; *stratum
specific effects;
*SLICE CPSA*raceref /sliceby=CPSA exp diff cl plots=none; *pairwise if
necessary;
TITLE "STIGMAW1: Weighted, slice, relative";
PROC GENMOD DATA=chiwosw1_2_attwgtsv7 order=data;
CLASS PART_ID;
MODEL STIGMAW1=CPSA /dist=normal link=id;
WEIGHT ks_mean_att;
REPEATED sub=PART_ID / type=ind;
ESTIMATE 'lincomb' intercept 1 CPSA 1;
TITLE "STIGMAW1: Weighted, OVERALL";
*MISSINGNESS OF PS COVARIATES;
PROC SURVEYFREQ DATA=chiwosw1_2_attwgtsv7;
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tables ageNA sexid sexidNA genderid genderidNA imle16 imle16NA
imstress16 imstress16NA selfattend selfattendNA famattend famattendNA
/row;
title "Missingness of PS Covariates";
*BALANCE DIAGNOSTICS;
PROC SORT DATA=chiwosw1_2_attwgtsv7;
BY CPSA;
PROC SURVEYFREQ DATA=chiwosw1_2_attwgtsv7;
tables CPSA*(sexid sexidNA genderid genderidNA imle16 imle16NA
imstress16 imstress16NA selfattend selfattendNA famattend famattendNA)
/row wchisq;
weight ks_mean_att;
title "Weighted balance diagnostics for binary PS vars";
PROC SURVEYFREQ DATA=chiwosw1_2_attwgtsv7;
tables CPSA*(ageNA sexid sexidNA genderid genderidNA imle16 imle16NA
imstress16 imstress16NA selfattend selfattendNA famattend famattendNA)
/row wchisq;
title "Unweighted balance diagnostics for binary PS vars";
PROC TTEST;
class cpsa;
var age;
weight ks_mean_att;
title "Weighted balance diagnostic for age";
PROC TTEST;
class cpsa;
var age;
title "Unweighted balance diagnostic for age";
*BALANCE DIAGNOSTICS BY ETHNORACIAL (i.e. testing for differences
across CPSA within ethnoracial groups);
PROC SORT DATA=chiwosw1_2_attwgtsv7;
BY race;
PROC SURVEYFREQ DATA=chiwosw1_2_attwgtsv7;
tables CPSA*(sexid sexidNA genderid genderidNA imle16 imle16NA
imstress16 imstress16NA selfattend selfattendNA famattend famattendNA)
/row wchisq;
weight ks_mean_att;
by race;
title "Weighted balance diagnostics for binary PS vars";
PROC SURVEYFREQ DATA=chiwosw1_2_attwgtsv7;
tables CPSA*(ageNA sexid sexidNA genderid genderidNA imle16 imle16NA
imstress16 imstress16NA selfattend selfattendNA famattend famattendNA)
/row wchisq;
by race;
title "Unweighted balance diagnostics for binary PS vars";
PROC TTEST;
by race;
class cpsa;
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var age;
weight ks_mean_att;
title "Weighted balance diagnostic for age by ethnoracial";
PROC TTEST;
by race;
class cpsa;
var age;
title "Unweighted balance diagnostic for age by ethnoracial";
RUN;
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Appendix 3: GBM optimization for main CPSA analysis, ES mean and KS
mean stopping points

“Balance measure” represents the absolute standardized mean difference (ES mean) and the mean
Kolmogorov Smirnov test statistic (KS mean), respectively. Figures created using RAND corporation’s
TWANG macro.209
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Appendix 4: Boxplots of propensity scores by exposure group
“Treatment” indicates CPSA status with 2 representing the CPSA+ group and 1
representing the CPSA- group. Figures created using RAND corporation’s TWANG
macro.209

Boxplot 1: Propensity score overlap for main CPSA analysis, ES mean and KS mean
stopping points
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Boxplot 2: Propensity score overlap for CPA sensitivity analysis, KS mean stopping
point

Boxplot 3: Propensity score overlap for CSA sensitivity analysis, KS mean stopping
point
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Appendix 5: Absolute standardized effect size differences pre and post
AEE weighting

ES mean refers to the absolute standardized effect size difference, while KS mean refers to the mean
Kolmogorov Smirnov test statistic. Blue lines represent decreases in absolute standardized difference for
covariates across exposure groups post-weighting, while red lines represent increases post-weighting. An
absolute standard difference ≤0.20 is considered balanced. Figures created using RAND corporation’s
TWANG macro.209
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Appendix 6: Stratum-specific balance diagnostics
Table 1: Unweighted stratum-specific balance diagnostics for effect of CPSA
Indigenous

Black African

Black
Caribbean

N=288
N=302
PS Covariate
Age - years (SE)
CPSA37.9 (1.46)
43.1 (0.77)
CPSA+
40.9 (0.62)
39.8 (0.79)
P-value
0.0598
0.0032
Sexual Minority - % (SE)
CPSA17.9 (4.69)
1.32 (0.93)
CPSA+
21.8 (2.79)
6.71 (2.05)
P-value
0.4753
0.0175
Gender Minority - % (SE)
CPSA5.97 (2.90)
0.66 (0.66)
CPSA+
6.76 (1.69)
0
P-value
0.8148
N/A
Immigrated at or before age 16 - % (SE)
CPSA2.67 (1.32)
CPSA+
4.76 (1.76)
P-value
0.3413
Immigration-related stress at or before age 16 - % (SE)
CPSA0.74 (0.74)
CPSA+
3.05 (1.51)
P-value
0.1692
Survivor of residential school - % (SE)
CPSA8.70 (5.90)
CPSA+
7.92 (2.70)
P-value
0.9051
Family member(s) attended residential school - % (SE)
CPSA51.7 (9.31)
CPSA+
67.5 (4.29)
P-value
0.1331
-

White

Other

N=64

N=554

N=103

45.4 (2.13)
45.1 (1.79)
0.9196

44.0 (0.89)
44.7 (0.55)
0.4957

43.4 (1.87)
43.6 (1.16)
0.9492

2.94 (2.92)
10.0 (5.52)
0.2627

7.28 (1.81)
19.3 (2.14)
<.0001

10.3 (5.68)
13.51 (3.99)
0.6495

0
10.0 (5.52)
N/A

2.90 (1.17)
4.68 (1.14)
0.2765

3.44 (3.40)
16.2 (4.31)
0.0253

9.09 (5.04)
33.3 (8.68)
0.0187

4.37 (1.43)
3.81 (1.04)
0.7524

10.3 (5.68)
24.7 (5.07)
0.0672

0
11.5 (6.32)
N/A

0.49 (0.49)
0.30 (0.30)
0.7341

7.69 (5.25)
10.4 (3.76)
0.6710

-

-

-

-

-

-

SE denotes standard error.
P-values for continuous variables were derived from unweighted t-tests (PROC SURVEYMEANS) while
P-values for binary variables were derived from unweighted Wald Chi Square tests (PROC
SURVEYFREQ).
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Table 2: AEE Weighted stratum-specific balance diagnostics for effect of CPSA
Indigenous

Black African

Black
Caribbean

N=288
N=302
PS Covariate
Age - years (SE)
CPSA39.2 (1.20)
43.4 (0.71)
CPSA+
40.9 (0.62)
39.8 (0.79)
P-value
0.2156
0.0008
Sexual Minority - % (SE)
CPSA23.6 (6.62)
2.81 (2.26)
CPSA+
21.8 (2.79)
6.71 (2.05)
P-value
0.8006
0.1996
Gender Minority - % (SE)
CPSA9.78 (5.08)
1.28 (1.27)
CPSA+
6.76 (1.69)
0
P-value
0.5752
N/A
Immigrated at or before age 16 - % (SE)
CPSA3.37 (1.77)
CPSA+
4.76 (1.76)
P-value
0.5772
Immigration-related stress at or before age 16 - % (SE)
CPSA0.65 (0.65)
CPSA+
3.05 (1.51)
P-value
0.1448
Survivor of residential school - % (SE)
CPSA8.17 (5.74)
CPSA+
7.92 (2.70)
P-value
0.9687
Family member(s) attended residential school - % (SE)
CPSA70.1 (8.49)
CPSA+
67.5 (4.29)
P-value
0.7901
-

White

Other

N=64

N=554

N=103

45.8 (1.99)
45.1 (1.79)
0.7883

44.0 (0.79)
44.7 (0.55)
0.4385

42.8 (1.67)
43.6 (1.16)
0.7020

8.93 (8.33)
10.0 (5.52)
0.9151

16.4 (4.12)
19.3 (2.14)
0.5574

21.0 (10.7)
13.5 (3.99)
0.5222

0
10.0 (5.52)
N/A

7.00 (3.78)
4.68 (1.14)
0.5597

4.44 (4.37)
16.2 (4.31)
0.0621

11.7 (6.50)
33.3 (8.68)
0.0504

7.24 (2.41)
3.81 (1.04)
0.1947

23.1 (11.5)
24.7 (5.07)
0.9022

0
11.5 (6.32)
N/A

1.25 (1.24)
0.30 (0.30)
0.4552

21.3 (12.4)
10.4 (3.76)
0.4300

-

-

-

-

-

-

SE denotes standard error.
P-values for continuous variables were derived from weighted t-tests (PROC SURVEYMEANS) while Pvalues for binary variables were derived from weighted Wald Chi Square tests (PROC SURVEYFREQ).
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Appendix 7: Sensitivity analyses
Table 1: Effect of CPA on barriers to HIV disclosure, weighted to control for the effect of
child sexual abuse and other potential confounders

Social
support ±

HIV
Stigma ±

Sexual
relationship
power ±

Sexual
inactivity ¶

Adult
sexual
abuse ¶

Adult
physical
abuse ¶

Outcome

Ethnoracial
group
White
Indigenous
Black African
Black Caribbean
Other
White
Indigenous
Black African
Black Caribbean
Other
White
Indigenous
Black African
Black Caribbean
Other
White
Indigenous
Black African
Black Caribbean
Other
White
Indigenous
Black African
Black Caribbean
Other
White
Indigenous
Black African
Black Caribbean
Other

Stratum-specific estimates
Unweighted
AEE Weighted
1.58 (1.38, 1.81)
1.87 (1.49, 2.34)
2.10 (1.64, 2.68)
3.32 (1.75, 6.31)
1.58 (1.07, 2.33)
1.63 (1.34, 1.98)
1.78 (1.28, 2.45)
1.68 (1.27, 2.23)
2.11 (1.03, 4.32)
1.97 (1.14, 3.38)
1.03 (0.88, 1.21)
1.02 (0.78, 1.32)
1.11 (0.87, 1.41)
1.00 (0.65, 1.54)
0.78 (0.54, 1.12)
-0.18 (-0.33, -0.04)
-0.11 (-0.35, 0.13)
-0.08 (-0.27, 0.10)
0.01 (-0.37, 0.39)
0.24 (-0.21, 0.70)
2.17 (0.84, 3.51)
0.89 (-1.26, 3.04)
3.72 (2.01, 5.43)
-0.37 (-3.75, 3.01)
-1.22 (-4.12, 1.69)
-0.83 (-1.56, -0.10)
-0.54 (-1.53, 0.45)
-0.67 (-1.66, 0.31)
0.98 (-1.13, 3.09)
-2.45 (-4.31, -0.59)

1.23 (1.04, 1.44)
1.20 (1.02, 1.42)
2.03 (1.41, 2.92)
4.43 (1.97, 9.96)
0.92 (0.72, 1.17)
1.27 (0.98, 1.63)
0.98 (0.72, 1.32)
1.40 (0.95, 2.05)
2.20 (0.92, 5.27)
1.21 (0.68, 2.14)
1.17 (0.91, 1.51)
0.97 (0.65, 1.45)
1.10 (0.79, 1.53)
1.31 (0.67, 2.54)
0.88 (0.54, 1.45)
-0.13 (-0.30, 0.03)
-0.03 (-0.24, 0.18)
0.05 (-0.22, 0.31)
-0.10 (-0.42, 0.22)
0.59 (0.17, 1.02)
2.09 (0.24, 3.94)
1.73 (-0.91, 4.37)
1.40 (0.44, 5.92)
0.50 (-2.54, 3.54)
-2.83 (-6.49, 0.83)
0.09 (-0.89, 1.07)
-0.25 (-1.78, 1.27)
-1.35 (-2.58, -0.11)
1.09 (-0.81, 3.00)
-2.72 (-4.88, -0.56)

Effect modification
REF
0.98 (0.78, 1.23)
1.65 (1.11, 2.46)
3.61 (1.58, 8.24)
0.75 (0.56, 1.00)
REF
0.77 (0.52, 1.14)
1.10 (0.70, 1.74)
1.73 (0.70, 4.31)
0.95 (0.51, 1.78)
REF
0.83 (0.52, 1.33)
0.94 (0.62, 1.42)
1.12 (0.55, 2.28)
0.75 (0.43, 1.32)
REF
0.10 (-0.16, 0.37)
0.18 (-0.13, 0.49)
0.04 (-0.32, 0.39)
0.73 (0.27, 1.19)
REF
-0.36 (-3.59, 2.86)
1.09 (-2.22, 4.40)
-1.59 (-5.15, 1.97)
-4.92 (-9.02, -0.82)
REF
-0.34 (-2.15, 1.47)
-1.43 (-3.01, 0.14)
1.01 (-1.14, 3.15)
-2.81 (-5.18, -0.44)

¶ Indicates binary outcome variables. Effect estimates are prevalence ratios and their robust 95%
confidence intervals. Shaded cells represent those where the confidence interval does not cross the null
value of 1.
± Indicates continuous outcome variables. Effect estimates are coefficients from linear regression (i.e.
estimated difference in mean outcome for CPSA+ compared to CPSA-) and their 95% confidence intervals.
Shaded cells represent those where the confidence interval does not cross the null value of 0.
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Table 2: Effect of CSA on barriers to HIV disclosure, weighted to control for the effect of
child physical abuse and other potential confounders

Social
support ±

HIV
Stigma ±

Sexual
relationship
power ±

Sexual
inactivity ¶

Adult
sexual
abuse ¶

Adult
physical
abuse ¶

Outcome

Ethnoracial
group
White
Indigenous
Black African
Black Caribbean
Other
White
Indigenous
Black African
Black Caribbean
Other
White
Indigenous
Black African
Black Caribbean
Other
White
Indigenous
Black African
Black Caribbean
Other
White
Indigenous
Black African
Black Caribbean
Other
White
Indigenous
Black African
Black Caribbean
Other

Stratum-specific estimates
Unweighted
Weighted
1.56 (1.38, 1.76)
1.64 (1.38, 1.94)
1.48 (1.18, 1.86)
1.56 (0.90, 2.70)
1.68 (1.21, 2.31)
1.91 (1.60, 2.29)
2.45 (1.77, 3.41)
1.61 (1.22, 2.13)
1.31 (0.58, 2.96)
2.93 (1.80, 4.77)
0.95 (0.80, 1.12)
0.91 (0.72, 1.17)
0.92 (0.65, 1.29)
0.37 (0.11, 1.25)
0.89 (0.61, 1.31)
-0.35 (-0.49, -0.21)
-0.13 (-0.37, 0.11)
-0.08 (-0.32, 0.16)
-0.05 (-0.44, 0.33)
-0.23 (-0.62, 0.16)
1.68 (0.33, 3.03)
0.14 (-1.80, 2.09)
2.83 (0.56, 5.09)
2.31 (-2.19, 6.81)
1.30 (-1.59, 4.18)
-1.35 (-2.09, -0.61)
-1.00 (-1.96, -0.04)
0.03 (-1.23, 1.29)
0.87 (-2.13, 3.87)
-2.21 (-4.16, -0.26)

1.26 (1.09, 1.47)
1.18 (0.99, 1.41)
1.12 (0.88, 1.43)
0.99 (0.59, 1.68)
1.19 (0.88, 1.62)
1.49 (1.18, 1.88)
1.97 (1.21, 3.21)
1.32 (0.96, 1.81)
1.06 (0.45, 2.53)
2.92 (1.53, 5.55)
0.96 (0.77, 1.20)
1.01 (0.68, 1.51)
0.81 (0.56, 1.16)
0.35 (0.10, 1.21)
1.07 (0.64, 1.78)
-0.41 (-0.57, -0.24)
0.32 (-0.12, 0.76)
-0.05 (-0.31, 0.21)
-0.16 (-0.65, 0.33)
-0.08 (-0.52, 0.36)
1.75 (0.08, 3.41)
0.55 (-2.07, 3.17)
2.34 (-0.21, 4.90)
2.65 (-1.83, 7.13)
1.84 (-1.33, 5.02)
-0.94 (-1.91, 0.01)
-0.40 (-2.11, 1.31)
0.19 (-1.27, 1.64)
0.57 (-2.63, 3.77)
-1.82 (-4.29, 0.65)

Effect modification
REF
0.93 (0.74, 1.18)
0.89 (0.67, 1.18)
0.78 (0.45, 1.36)
0.94 (0.67, 1.32)
REF
1.32 (0.77, 2.27)
0.89 (0.60, 1.31)
0.71 (0.29, 1.76)
1.96 (0.99, 3.89)
REF
1.06 (0.67, 1.67)
0.84 (0.55, 1.29)
0.37 (0.10, 1.28)
1.11 (0.64, 1.94)
REF
0.73 (0.26, 1.20)
0.36 (0.05, 0.67)
0.25 (-0.27, 0.76)
0.33 (-0.15, 0.80)
REF
-1.20 (-4.31, 1.91)
0.59 (-2.46, 3.64)
0.90 (-3.88, 5.69)
0.10 (-3.48, 3.68)
REF
0.54 (-1.42, 2.50)
1.13 (-0.61, 2.87)
1.51 (-1.83, 4.86)
-0.88 (-3.53, 1.77)

¶ Indicates binary outcome variables. Effect estimates are prevalence ratios and their robust 95%
confidence intervals. Shaded cells represent those where the confidence interval does not cross the null
value of 1.
± Indicates continuous outcome variables. Effect estimates are coefficients from linear regression (i.e.
estimated difference in mean outcome for CPSA+ compared to CPSA-) and their 95% confidence intervals.
Shaded cells represent those where the confidence interval does not cross the null value of 0.
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